ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
k141_475_10 # 9313 # 12438 # 1 # ID=251_10;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=15bp;gc_cont=0.441	k141_475_10	9313	12438	+	Strict	750	765.763	adeF	41.65	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAGTAAGTTTCTTCATAGACAGGCCGGTATTCTCGGCCGTCATCTCAATACTTATTGTCATAGTGGGTATCATCGGTCTGATGATGCTTCCTATAGACCAGTATCCCCAGATAACGCCTCCGGTGGTGAAAATCAGTGCTTCATATCCGGGCGCAAGTGCAGTAACAGTTTCCCAGGCAGTTGCAACTCCTATTGAACAGGAACTTAACGGTACTCCGGGAATGCTCTACATGGAATCAAGCAGTTCAAACTCGGGAGGTTTCTCGGCAACCGTTACATTCGATATTTCCGCTGACCCTGATATGGCATCGGTAGAAATACAGAACCGAGTAAAATTAGCAGAGTCAAGACTTCCGGCTGAAGTAGTACAGAACGGTATTACTGTAGAAAAACAGGCTGCCAGCCAGCTTATGACTCTTACACTGATGTCGGACGACCCTAAATTCGATGAAATATACCTGAGTAACTTTGCTACTCTTTACGTGCTCGACCTTCTTCGCCGTATTCCGGGAGTAGGTAGAGTATCAAATATCGGTAGCCGATATTACGCTATGCAGATTTGGGTAGATCCTGCCAAGCTTGCCAACTTCGGACTTACAGTACAGGATTTACAGAATGCTCTTAAGGACCAGAACCGTGAATCAGCAGCAGGTGTCTTGGGACAGCAGCCTATGTCAAACGGTATAGACATAACAATACCTATCACAGCTCAAGGTCGTCTTTCTTCAGCATCACAGTTTGAAGAAATTGTACTTAGGGCAAACCCGGACGGTTCTCTCATCAGAATGAAGGACGTGGCAAGAGTTTCACTCGAAGCCTCATCATACAGTACTGAAAGTGGTATCAACGGTGGAAACGCTGCGGTACTCGGTATCTATATGCTTCCGGGAGCAAACGCTATGGAAGTGGCAAACAATGTAAAAGAGGCGATGAAGGAAATCAGTAAGACATTCCCTGAGGGACTGGAATACAATTTTCCTTTCGATATGACAGACTATATCTCACAGTCTATACATGAGGTTTACAAGACTCTGTTTGAAGCCTTGTTTCTGGTTATCGTAGTGGTATTCCTTTCATTGCAGAGCTGGAGAGCAACACTTATTCCTGTTGTGGCAGTGCCTATTTCGCTTATCGGTACATTCGGATTTATGCTGATATTCGGTTTCTCACTGAACATGCTTACATTGTTAGGACTTGTTCTTGCCATCGGTATTGTGGTGGACGATGCCATCGTTGTGGTGGAAAACGTAGAACGAATTATGGAGGAAGAGAAACTCAGTCCATATGAGGCTACAAAGAAAGCAATGGAAGGACTTGTAGGAGCGGTAATCGCAACATCTCTTGTACTTGCAGCTGTATTCGTTCCGGTAAGTTTCCTTTCGGGTATTACAGGTCAGTTGTACCGCCAGTTTACTGTTACAATTGTAGTATCAGTACTTTTGTCAACGGTTGTAGCCTTGACTCTAAGTCCTGTAATGTGTTCTCTTATTCTGAAACCTACAGACCCGAACAAACCTAAGAACAAGGTTTTCAACTGGATAAACAAATGGTTGGGTATAGGTAACAATCATTATGTGAAATACATAAACAGAGTTATCAAACATCCGCGTCGCGTAATGGCCGGTTTTGGAATGGTACTGGTATTCATATATGTATTCCACAGACTTGTTCCTACCAGTTTCCTTCCGGTAGAAGACCAGGGATACTTCACTGTGGAACTTGAGTTACCTGAGACAGCTACACTCGAACGTACACGTGAAGTTACTGACAGGGCTATTGATTTCATAATGAAAGACCCTGCAGTAGAATACATCCAGAACGTAACAGGTAGCAGCCCACGTGTAGGTACAAGCCAGGCCAGAAGCCAGCTTACAGTTATTCTGAAAGAATGGAAAGAACGTAACAACACTACCATAGATGAAGTGATGGAACGTGTGCAGAAAGAACTTGAGAAATATCCTGAAAGCAAGGTATTCCTTTCTACTCCACCGGTAATCCCGGGCCTCGGTACAGCCGGAGGTTTCGAAATGCAGCTTGAAGCCAGAGGTGAAGCCACTTACGATGACCTGGTCCGTGCAACAGATACACTTATGCATTACGCATCAATGCATAAGGAAATAGCCGGTCTGTCATCATCACTTCAGGCAGAGATTCCACAGTTGTATTTCGATGTAGACCGTGACAAGGTTAAGCTTGCAGGAGTTCCAATGGCTGATGTATTCTCAACAATGAAGACTTATACAGGTTCGGTATATGTAAACGACTTCAATATGTTCAACCGTATCTACCGTGTATATATCCAGGCTGAGGCTCCTTATCGCCAGCAACGTGAAAACATCGGACTGTTCTTTGTAAAAGGTTCATCGGGTGATATGATTCCGCTTACAGCTCTCGGAACAACTGATTATACCACAGGCCCCGGAAGTATCAAGCGTTTCAATATGTTCAATACTTCAGTTATACGTGGTACAACAGCCAACGGAGCCAGTTCAGGACAGGTAATGGAGATATTGGAACAGATAGCCAGAGAAAAATTACCGGACAACATCGGAGTGGAATGGAGTGGTCTGTCATATCAGGAGAAACAGGCCGGAGGTCAGACAGGAATCATTTTATCACTGGTATTCCTGTTCGTATTCCTCTTCCTGGCAGCACTTTATGAAAGCTGGACAGTACCTATCGCAGTATTGATTTCGCTTCCTGTAGCAGTGCTCGGTGCATATGCCGGAGTAACATTATGCGGACTCGAAAATGATACTTACTTCCAGATTGGTCTTGTAATGCTTATAGGTCTGGCAGCAAAGAACGCCATCCTTATCGTAGAGTTCGCCAAAGATGAAATTGACAAAGGAAGAGATGTAATAGAATCTGCCATACATGCAGCAAGACTCCGTTTCCGCCCTATCCTGATGACATCACTGGCATTTATCCTCGGTATGTTGCCTATGGTTTTAGCCTCAGGTCCGGGTTCTGCCAGCCGACAGGCAATTGGTACAGGTGTATTCTTCGGAATGATTGTAGCTGTTACTATAGGAATAGTACTTGTGCCGTTCTTCTTCGTTATGATATACAAAATAACAGGAAAGGCTAAACAGAAAAGTATCAACATTAAGAAAGCATAA	MKVSFFIDRPVFSAVISILIVIVGIIGLMMLPIDQYPQITPPVVKISASYPGASAVTVSQAVATPIEQELNGTPGMLYMESSSSNSGGFSATVTFDISADPDMASVEIQNRVKLAESRLPAEVVQNGITVEKQAASQLMTLTLMSDDPKFDEIYLSNFATLYVLDLLRRIPGVGRVSNIGSRYYAMQIWVDPAKLANFGLTVQDLQNALKDQNRESAAGVLGQQPMSNGIDITIPITAQGRLSSASQFEEIVLRANPDGSLIRMKDVARVSLEASSYSTESGINGGNAAVLGIYMLPGANAMEVANNVKEAMKEISKTFPEGLEYNFPFDMTDYISQSIHEVYKTLFEALFLVIVVVFLSLQSWRATLIPVVAVPISLIGTFGFMLIFGFSLNMLTLLGLVLAIGIVVDDAIVVVENVERIMEEEKLSPYEATKKAMEGLVGAVIATSLVLAAVFVPVSFLSGITGQLYRQFTVTIVVSVLLSTVVALTLSPVMCSLILKPTDPNKPKNKVFNWINKWLGIGNNHYVKYINRVIKHPRRVMAGFGMVLVFIYVFHRLVPTSFLPVEDQGYFTVELELPETATLERTREVTDRAIDFIMKDPAVEYIQNVTGSSPRVGTSQARSQLTVILKEWKERNNTTIDEVMERVQKELEKYPESKVFLSTPPVIPGLGTAGGFEMQLEARGEATYDDLVRATDTLMHYASMHKEIAGLSSSLQAEIPQLYFDVDRDKVKLAGVPMADVFSTMKTYTGSVYVNDFNMFNRIYRVYIQAEAPYRQQRENIGLFFVKGSSGDMIPLTALGTTDYTTGPGSIKRFNMFNTSVIRGTTANGASSGQVMEILEQIAREKLPDNIGVEWSGLSYQEKQAGGQTGIILSLVFLFVFLFLAALYESWTVPIAVLISLPVAVLGAYAGVTLCGLENDTYFQIGLVMLIGLAAKNAILIVEFAKDEIDKGRDVIESAIHAARLRFRPILMTSLAFILGMLPMVLASGPGSASRQAIGTGVFFGMIVAVTIGIVLVPFFFVMIYKITGKAKQKSINIKKA	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	98.30	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_1032_2 # 478 # 555 # -1 # ID=556_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.577	k141_1032_2 	478	555	-	Strict	1500	18.8606	rphB	100.0	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	TATGAGGCGCTGCGGCAGAACGGCTTTGACCATATGAAAACGCAGGGGGAGCTGCACAGACTGCGCTGGGAGGATTGA	YEALRQNGFDHMKTQGELHRLRWED	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	2.83	gnl|BL_ORD_ID|2297|hsp_num:0	2528	True	loose hit with at least 95 percent identity pushed strict
k141_1221_1 # 1 # 93 # -1 # ID=658_1;partial=10;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.333	k141_1221_1 	1	93	-	Strict	550	19.2458	vgbA	100.0	3001307	protein homolog model	n/a	n/a	streptogramin antibiotic	antibiotic inactivation	streptogramin vgb lyase	ATGCATGACAGAGATAGACAAGTTCCTTCTTTTACACATGGTAAAATAAGAGAATATGAAGGGGGAAGCACGATGAAAAATCCTAAATCATTT	MHDRDRQVPSFTHGKIREYEGGSTMKNPKSF	MEFKLQELNLTNQDTGPYGITVSDKGKVWITQHKANMISCINLDGKITEYPLPTPDAKVMCLTISSDGEVWFTENAANKIGRITKKGIIKEYTLPNPDSAPYGITEGPNGDIWFTEMNGNRIGRITDDGKIREYELPNKGSYPSFITLGSDNALWFTENQNNAIGRITESGDITEFKIPTPASGPVGITKGNDDALWFVEIIGNKIGRITPLGEITEFKIPTPNARPHAITAGAGIDLWFTEWGANKIGRLTSNNIIEEYPIQIKSAEPHGICFDGETIWFAMECDKIGKLTLIKDNME	10.37	gnl|BL_ORD_ID|1498|hsp_num:0	1594	True	loose hit with at least 95 percent identity pushed strict
k141_6119_10 # 7172 # 9091 # -1 # ID=3370_10;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.412	k141_6119_10	7172	9091	-	Perfect	1200	1324.69	tet32	100.0	3000196	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAAAATAATCAATATCGGCATTCTGGCCCATGTAGACGCAGGAAAAACTACATTGACAGAAAGTCTGCTATACACCAGTGGAGCGATTGCGGAACAGGGAAACGTGGATAAAGGGACCACAAGAACAGACACTATGATTTTGGAACGGCAACGGGGAATTACCATTCAGACAGCGGTTACTTCTTTTTATTGGAATGATTATAAAATCAATATCGTGGACACTCCCGGTCATATGGATTTTTTAACCGAAGCATACCGCTCTTTATCTGTCCTTGACGGAGCTGTTTTAGTCATTTCAGCAAAAGACGGCGTACAGGCACAAACCCGTATATTATTCCATGCGCTTCAGAAAATGGACATTCCGACAATTATCTTTATAAATAAGATAGACCAAAATGGGATCGACCTGCAGTGTGTTTACCAAAGCATTAAAGATAAACTTACCAGTGATATGATTGTCATGCAGGAGGTTTCCCTGTCGCCAAAGATAACCATGACCGATATTTCTGATTTAGACAAATGGGATATGATTATTTCCGGAAGCGATGAACTATTAGAACGATATGTTGCAGAGGATTCTTTGGATATACAGGAATTACAATATGAAAAGTGCAAAAGAACCAGATGCTGCTCTTTGTTTCCTGTTTATCATGGGAGTGCAAAAGACAATTTAGGAACAGAAAAACTGATTGAAGCGATTATAGAAACTTTCATTACAGAAACGGACGATATTCAGTCTGAATTATGTGGATATGTTTTTAAGGTTGAGTATACAGAGCGGAAAAAACGGCTTTCTTATTTACGCCTGTATCATGGGACGCTCCATTTACGGGATACCCTGCTGCTGTCAAAAAAGGAAAAAATAAAGATTACAGAAATGTGTATTCCGTCAAATGGTGAAATCGTCCCGGCTGACCATGCCTGTCCGGGAGAAATTGTTATTTTAGCTGATGATACTTTGAAACTGAACGACATTCTGGGAAATGAAAAACTCCTGCCTCACAAAACACGGATTGATAATCCCATGCCATTACTTCGGACAACGGTAGAGCCGCAAAAGCCGGAGCAAAGGGAAGCCCTGTTAAATGCCCTCGCAGAGATTGCTGATACAGACCCTCTTTTGCATTTTGACATTGATACTGTTACCCATGAGATTATGTTATCTTTTTTGGGAAAAGTACAGTTAGAAGTTATTTGTTCGCTATTAGAAGAAAAATATCATGTGGGCGTGGCTATGAAAGAGCCTTCGGTTATTTATCTGGAAAGACCGCAAAAAAAAGCGAGCTGCACGATTCATATTGAAGTGCCGCCGAATCCGTTTTGGGCATCTATTGGTTTGACTGTAACACCGCTTCCTGTTGGAAGCGGAACACAATATAAAAGCGAGGTATCTCTCGGCTATTTAAACCAAAGTTTTCAAAATGCCGTCATGGAGGGTGTGCGTTATGGAATGGAGCAGGGCTTATATGGCTGGGGAGTGACAGACTGCCAAATTTGTTTTGATTATGGAGTTTATTACAGCCCGGTCAGCACCCCCGCTGATTTTCGTTTTCTTGCGCCTGTCGTGTTGGAGCAGGCATTGAAAAAAGCAGGGACACAACTGTTGGAACCATACCTTTCCTTTACCCTTTTTGCACCGCAGGAATATCTTTCACGGGCTTATAATGATGCACCAAAGTATTGCGCAATCATTGAATCAACCAGACTTGAAAAAGATGAAGTTATTTTTAAGGGGGAAATCCCTGCCCGTTGTATCGGTGAATATAGAAATGATTTGAATTTTTATACAAATGGAAGAAGTGTCTGCATTACAGAATTAAAAGGGTATCAGGAAACTTCCGGCGAGCCTGTGTTTCAGCCACGCCGCCCGAACAGCCGTTTAGACAAGATCCGGCATATGTTTCAGAAGATAATGTAA	MKIINIGILAHVDAGKTTLTESLLYTSGAIAEQGNVDKGTTRTDTMILERQRGITIQTAVTSFYWNDYKINIVDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMDIPTIIFINKIDQNGIDLQCVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIISGSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAIIETFITETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNGEIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREALLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIYLERPQKKASCTIHIEVPPNPFWASIGLTVTPLPVGSGTQYKSEVSLGYLNQSFQNAVMEGVRYGMEQGLYGWGVTDCQICFDYGVYYSPVSTPADFRFLAPVVLEQALKKAGTQLLEPYLSFTLFAPQEYLSRAYNDAPKYCAIIESTRLEKDEVIFKGEIPARCIGEYRNDLNFYTNGRSVCITELKGYQETSGEPVFQPRRPNSRLDKIRHMFQKIM	MKIINIGILAHVDAGKTTLTESLLYTSGAIAEQGNVDKGTTRTDTMILERQRGITIQTAVTSFYWNDYKINIVDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMDIPTIIFINKIDQNGIDLQCVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIISGSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAIIETFITETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNGEIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREALLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIYLERPQKKASCTIHIEVPPNPFWASIGLTVTPLPVGSGTQYKSEVSLGYLNQSFQNAVMEGVRYGMEQGLYGWGVTDCQICFDYGVYYSPVSTPADFRFLAPVVLEQALKKAGTQLLEPYLSFTLFAPQEYLSRAYNDAPKYCAIIESTRLEKDEVIFKGEIPARCIGEYRNDLNFYTNGRSVCITELKGYQETSGEPVFQPRRPNSRLDKIRHMFQKIM	100.00	gnl|BL_ORD_ID|1162|hsp_num:0	1233		
k141_6213_3 # 2123 # 2236 # -1 # ID=3418_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.447	k141_6213_3 	2123	2236	-	Strict	760	20.4014	macA	100.0	3000533	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GCCGTGCTTTACTTGCGTAGCGGTAATGTTGATGCTGCTCGTGTGTTGGTTCGACAATTATCGGGGAGATATCCGAATCCTGACGGAAAACTTTTAAAAGAGGAGGGTAAGTAA	AVLYLRSGNVDAARVLVRQLSGRYPNPDGKLLKEEGK	MAKMMKWSAVAAVAAAAVWGGWHYLKPEPQAAYITETVRRGGISRTVSATGEISPSNLVSVGAQASGQIKKLYVKLGQQVKKGDLIAEINSTTQTNTLNMEKSKLETYQAKLVSAQIALGSAEKKYKRQTALWKDDATSKEDLESAQDALAAAKANVAELKALIRQSKISINTAESDLGYTRITATMDGTVVAIPVEEGQTVNAAQSTPTIVQLANLDMMLNKMQIAEGDITKVKAGQDISFTILSEPDTPIKAKLDSVDPGLTTMSSGGYNSSTDTASNAVYYYARSFVPNPDGKLATGMTTQNTVEIDGVKNVLLIPSLTVKNRGGKAFVRVLGADGKAAEREIRTGMRDSMNTEVKSGLKEGDKVVISEITAAEQQESGERALGGPPRR	9.44	gnl|BL_ORD_ID|1584|hsp_num:0	1680	True	loose hit with at least 95 percent identity pushed strict
k141_7077_2 # 459 # 1274 # 1 # ID=3879_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.444	k141_7077_2	459	1274	+	Strict	500	557.37	APH(3')-Ia	98.15	3002641	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGAGCCATATTCAACGGGAAACGTCTTGCTCGAGGCCGCGATTAAATTCCAACCTGGATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGCATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGCTCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGCGTTCCTGCGCCGGTTGCATTCGATTCCTGTTAGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAGCTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAATTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTGA	MSHIQRETSCSRPRLNSNLDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTALPGKTAFQVLEEYPDSGENIVDALAAFLRRLHSIPVSNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF	MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF	100.00	gnl|BL_ORD_ID|270|hsp_num:0	291		
k141_7077_8 # 4549 # 5178 # 1 # ID=3879_8;partial=00;start_type=TTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.451	k141_7077_8	4549	5178	+	Strict	400	420.239	catI	98.51	3002683	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	TTGATATATCCCAATGGCATCGTAAAGAACATTTACGAGGCATTTCAGTCAGTTGCTCAATGTACCTATAACCAGACCGTTCAGCTGGATATTACGGCCTTTTTAAAGACCGTAAAGAAAAATAAGCACAAGTTTTATCCGGCCTTTATTCACATTCTTGCCCGCCTGATGAATGCTCATCCGGAATTCCGTATGGCAATGAAAGACGGTGAGCTGGTGATATGGGATAGTGTTCACCCTTGTTACACCGTTTTCCATGAGCAAACTGAAACGTTTTCATCGCTCTGGAGTGAATACCACGACGATTTCCGGCAGTTTCTACACATATATTCGCAAGATGTGGCGTGTTACGGTGAAAACCTGGCCTATTTCCCTAAAGGGTTTATTGAGAATATGTTTTTCGTCTCAGCCAATCCCTGGGTGAGTTTCACCAGTTTTGATTTAAACGTGGCCAATATGGACAACTTCTTCGCCCCCGTTTTCACCATGGGCAAATATTATACGCAAGGCGACAAGGTGCTGATGCCGCTGGCGATTCAGGTTCATCATGCCGTTTGTGATGGCTTCCATGTCGGCAGAATGCTTAATGAATTACAACAGTACTGCGATGAGTGGCAGGGCGGGGCGTAA	MIYPNGIVKNIYEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA	MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA	95.43	gnl|BL_ORD_ID|719|hsp_num:0	763		
k141_7077_13 # 10813 # 11346 # 1 # ID=3879_13;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.579	k141_7077_13	10813	11346	+	Strict	300	355.525	ANT(2'')-Ia	99.44	3000230	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(2'')	ATGGACACAACGCAGGTCACATTGATACACAAAATTCTAGCTGCGGCAGATGAGCGAAATCTGCCGCTCTGGATCGGTGGGGGCTGGGCGATCGATGCACGGCTAGGGCGTGTAACACGCAAGCACGATGATATTGATCTGACGTTTCCCGGCGAGAGGCGCGGCGAGCTCGAGGCAATAGTTGAAATGCTCGGCGGGCGCGTCATGGAGGAGTTGGACTATGGATTCTTAGCGGAGATCGGGGATGAGTTACTTGACTGCGAACCTGCTTGGTGGGCAGACGAAGCGTATGAAATCGCGGAGGCTCCGCCGGGCTCGTGCCCAGAGGCGGCTGAGGGCGTCATCGCCGGGCGGCCAGTCCGTTGTAACAGCTGGGAGGCGATCATCTGGGATTACTTTTACTATGCCGATGAAGTACCACCAGTGGACTGGCCTACAAAGCACATAGAGTCCTACAGGCTCGCATGCACCTCACTCGGGGCGGAAAAGGTTGAGGTCTTGCGTGCCGCTTTCAGGTCGCGATATGCGGCCTAA	MDTTQVTLIHKILAAADERNLPLWIGGGWAIDARLGRVTRKHDDIDLTFPGERRGELEAIVEMLGGRVMEELDYGFLAEIGDELLDCEPAWWADEAYEIAEAPPGSCPEAAEGVIAGRPVRCNSWEAIIWDYFYYADEVPPVDWPTKHIESYRLACTSLGAEKVEVLRAAFRSRYAA	MDTTQVTLIHKILAAADERNLPLWIGGGWAIDARLGRVTRKHDDIDLTFPGERRGELEAIVEMLGGRVMEELDYGFLAEIGDELLDCEPAWWADEAYEIAEAPQGSCPEAAEGVIAGRPVRCNSWEAIIWDYFYYADEVPPVDWPTKHIESYRLACTSLGAEKVEVLRAAFRSRYAA	100.00	gnl|BL_ORD_ID|1289|hsp_num:0	1372		
k141_7077_14 # 11404 # 12195 # 1 # ID=3879_14;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.518	k141_7077_14	11404	12195	+	Strict	450	519.235	aadA2	99.23	3002602	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGAGGGAAGCGGTGACCATCGAAATTTCGAACCAACTATCAGAGGTGCTAAGCGTCATTGAGCGCCATCTGGAATCAACGTTGCTGGCCGTGCATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCATACAGCGATATTGATTTGTTGGTTACTGTGGCCGTAAAGCTTGATGAAACGACGCGGCGAGCATTGCTCAATGATCTTATGGAGGTTTCGGCTTTCCCTGGCGAGAGCGAGACGCTCCGCGCTATAGAAGTCACCCTTGTCGTGCATGACGACATCATCCCGTGGCGTTATCCGGCTAAGCGCGAGCTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCGGGTATCTTCGAGCCAGCCATGATCGACATTGATCTAGCTATCCTGCTTACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCGGCAGCGGAGGAATTCTTTGACCCGGTTCCTGAACAGGATCTATTCGAGGCGCTGAGGGAAACCTTGAAGCTATGGAACTCGCAGCCCGACTGGGCCGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAATAACCGGCAAAATCGCGCCGAAGGATGTCGCTGCCGACTGGGCAATAAAACGCCTACCTGCCCAGTATCAGCCCGTCTTACTTGAAGCTAAGCAAGCTTATCTGGGACAAAAAGAAGATCACTTGGCCTCACGCGCAGATCACTTGGAAGAATTTATTCGCTTTGTGAAAGGCGAGATCATCAAGTCAGTTGGTAAATGA	MREAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRALLNDLMEVSAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK	MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK	101.54	gnl|BL_ORD_ID|1156|hsp_num:0	1227		
k141_7077_15 # 12359 # 12709 # 1 # ID=3879_15;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.496	k141_7077_15	12359	12709	+	Strict	190	214.927	qacEdelta1	99.14	3005010	protein homolog model	n/a	n/a	acridine dye	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAAGGCTGGCTTTTTCTTGTTATCGCAATAGTTGGCGAAGTAATCGCAACATCCGCATTAAAATCTAGCGAGGGCTTTACTAAGCTTGCCCCTTCCGCCGTTGTCATAATCGGTTATGGCATCGCATTTTATTATTTTCTTTCTCTGGTTCTGAAATCCATCCCTGTCGGTGTTGCTTATGCAGTCTGGTCGGGACTCGGCGTCGTCATAATTACAGCCATTGCCTGGTTGCTTCATGGGCAAAAGCTTGATGCGTGGGGCTTTGTAGGTATGGGGCTCATAATTGCTGCCTTTTTGCTCGCCCGATCCCCATCGTGGAAGTCGCTGCGGAGGCCGACGCCATGGTGA	MKGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYYFLSLVLKSIPVGVAYAVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLARSPSWKSLRRPTPW	MKGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYAVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLARSPSWKSLRRPTPW	100.87	gnl|BL_ORD_ID|2803|hsp_num:0	3755		
k141_7077_16 # 12703 # 13542 # 1 # ID=3879_16;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.617	k141_7077_16	12703	13542	+	Strict	500	550.051	sul1	99.28	3000410	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	ATGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGACCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGGATTTTTCTTGAGCCCCGCACCGGAAACATCGCTGCACGTGCTGTCGAACCTTCAAAAGCTGAAGTCGGCGTTGGGGCTTCCGCTATTGGTCTCGGTGTCGCGGAAATCCTTCGTGGGCGCCACCGTTGGCCTTCCTGTAAAGGATCTGGGTCCAGCGAGCCTTGCGGCGGAACTTCACGCGATCGGCAATGGCGCTGACTACGTCCGCACCCACGCGCCTGGAGATCTGCGAAGCGCAATCACCATCTCGGAAACCCTCGCGAAATTTCGCAGTCGCGACGCCAGAGACCGAGGGTTAGATCATGCCTAA	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFVGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITISETLAKFRSRDARDRGLDHA	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	100.00	gnl|BL_ORD_ID|1005|hsp_num:0	1070		
k141_7077_22 # 16725 # 17528 # 1 # ID=3879_22;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.563	k141_7077_22	16725	17528	+	Strict	500	541.191	APH(3'')-Ib	99.63	3002639	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3'')	TTGAATCGAACTAATATTTTTTTTGGTGAATCGCATTCTGACTGGTTGCCTGTCAGAGGCGGAGAATCTGGTGATTTTGTTTTTCGACGTGGTGACGGGCATGCCTTCGCGAAAATCGCACCTGCTTCCCGCCGCGGTGAGCTCGCTGGAGAGCGTGACCGCCTCATTTGGCTCAAAGGTCGAGGTGTGGCTTGCCCCGAGGTGATCAACTGGCAGGAGGAACAGGAGGGTGCATGCTTGGTGATAACGGCAATTCCGGGAGTACCGGCGGCTGATCTGTCTGGAGCGGATTTGCTCAAAGCGTGGCCGTCAATGGGGCAGCAACTTGGCGCTGTTCACAGCCTATCGGTTGATCAATGTCCGTTTGAGCGCAGGCTGTCGCGAATGTTCGGACGCGCCGTTGACGTGGTGTCCCGCAATGCCGTCAATCCCGACTTCTTACCGGACGAGGACAAGAGTACGCCGCAGCTCGATCTTTTGGCTCGTGTCGAACGAGAGCTACCGGTGCGGCTCGACCAAGAGCGCACCGATATGGTTGTTTGCCATGGTGATCCCTGCATGCCGAACTTCATGGTGGACCCTAAAACTCTTCAATGCACGGGTCTGATCGACCTTGGGCGGCTCGGAACAGCAGATCGCTATGCCGATTTGGCACTCATGATTGCTAACGCCGAAGAGAACTGGGCAGCGCCAGATGAAGCAGAGCGCGCCTTCGCTGTCCTATTCAATGTATTGGGGATCGAAGCCCCCGACCGCGAACGCCTTGCCTTCTATCTGCGATTGGACCCTCTGACTTGGGGTTGA	MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG	MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLLVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG	100.00	gnl|BL_ORD_ID|1729|hsp_num:0	1830		
k141_7077_23 # 17528 # 18364 # 1 # ID=3879_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.557	k141_7077_23	17528	18364	+	Strict	500	565.844	APH(6)-Id	99.28	3002660	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	ATGTTCATGTCGCCTGTTTTTCCTGCTCATTGGCACGTTTCGCAACCTGTTCTCATTGCGGACACCTTTTCCAGCCTCGTTTGGAAAGTTTCATTGCCAGACGGGACTCCTGCAATCGTCAAGGGATTGAAACCTATAGAAGACATTGCTGATGAACTACGCGGGGCCGACTATCTGGTATGGCGCAATGGGAGGGGAGCAGTCCGGTTGCTCGGTCGTGAGAACAATCTGATGTTGCTCGAATATGCCGGGGAGCGAATGCTCTCTCACATCGTTGCCGAGCACGGCGACTACCAGGCGACCGAAATTGCAGCGGAACTAATGGCGAAGCTGTATGCCGCATCTGAGGAACCCCTGCCTTCTGCCCTTCTCCCGATCCGGGATCGCTTTGCAGCTTTGTTTCAGCGGGCGCGCGATGATCAAAACGCAGGTTGTCAAACTGACTACGTCCACGCGGCGATTATAGCCGATCAAATGATGAGCAATGCCTCGGAACTGCGTGGGCTACATGGCGATCTGCATCATGAAAACATCATGTTCTCCAGTCGCGGCTGGCTGGTGATAGATCCCGTCGGTCTGGTCGGTGAAGTGGGCTTTGGCGCCGCCAATATGTTCTACGATCCGGCTGACAGAGACGACCTTTGTCTCGATCCTAGACGCATTGCACAGATGGCGGACGCATTCTCTCGTGCGCTGGACGTCGATCCGCGTCGCCTGCTCGACCAGGCGTACGCTTATGGGTGCCTTTCCGCAGCTTGGAACGCGGATGGAGAAGAGGAGCAACGCGATCTAGCTATCGCGGCCGCGATCAAGCAGGTGCGACAGACGTCATACTAG	MFMSPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEQEQRDLAIAAAIKQVRQTSY	100.00	gnl|BL_ORD_ID|973|hsp_num:0	1031		
k141_8176_1 # 225 # 725 # 1 # ID=4480_1;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.259	k141_8176_1	225	725	+	Perfect	300	335.495	LnuP	100.0	3004601	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	GTGATTGGAATAAATGATGCTTGTGAAATATTGAGTTGGGCATATAATAATAATATAGAAATATGGTTAGATGGTGGTTGGGGTGTAGATGCTTTACTTGGAAAAGAAACACGTCAGCATAATGACATTGATTTATTTGTAGAAGAAAAAAACTATAATAAATTTATTGAAATAATTAAAAATAAAGGATTTAATGAAATTGTAGTGGAGTATACAAGTGAAGTACATACTATTTGGTCTGATAATAAATTACGAATTATTGATTTACATATGTTTAAAGATAACTGTGATGGAACCATATGTTATGAAGGCGAAGTTTTTCAAAAAAATATATTCGATGGTGTTGGAAAAATAGGAAATATTATGGTTTCTTGTATAAATGCTAAAAATCAAGTCTTATTTCACTTAGGGTATGAATTTGGAGAAAGTGATATTCATGATGTAAAATTATTATGTAAAGAATTTAACATTCCGATACCTAAAGAATATGAAAATTTTTAA	MIGINDACEILSWAYNNNIEIWLDGGWGVDALLGKETRQHNDIDLFVEEKNYNKFIEIIKNKGFNEIVVEYTSEVHTIWSDNKLRIIDLHMFKDNCDGTICYEGEVFQKNIFDGVGKIGNIMVSCINAKNQVLFHLGYEFGESDIHDVKLLCKEFNIPIPKEYENF	MIGINDACEILSWAYNNNIEIWLDGGWGVDALLGKETRQHNDIDLFVEEKNYNKFIEIIKNKGFNEIVVEYTSEVHTIWSDNKLRIIDLHMFKDNCDGTICYEGEVFQKNIFDGVGKIGNIMVSCINAKNQVLFHLGYEFGESDIHDVKLLCKEFNIPIPKEYENF	100.00	gnl|BL_ORD_ID|2042|hsp_num:0	3301		
k141_8180_5 # 3047 # 4252 # -1 # ID=4483_5;partial=00;start_type=ATG;rbs_motif=AAA;rbs_spacer=10bp;gc_cont=0.413	k141_8180_5	3047	4252	-	Strict	700	792.727	Mef(En2)	99.5	3004659	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAATCATTGGAAATCAACTTTGGCCGTGATAGGAATAGGCCAACTCATATCTATTTTAACAAGTACGATTGTTGGCTTCTCCATTATTTTTTGGATTAGCAACGAATTTAAATCCCCGACAGCTTTATCTCTGGCTATTTTAGCTGGATTTTTACCACAATTTGTATTAGGCTTGTTTGCCGGGGTCTATGTTGACAGATGGAATCGAAAGAAAACGATGTTTTATTCGGACTTGTTCATCGCGTTCTGTACCCTATGTCTTTTTATTGTGATAACCAAGGGTTATAAAGACCTTTCTTTTTTTTATCTATTGACTGCTTGTCGTTCAATAGGCAGTACGTTTCATGCACCTGCTTTACAGGCAAGCATCCCTCTACTGGTTCCCAAGCACCATCTTGTCAGGGTATCAGGTTTGTACCATTCCATTCAATCCTTCAGTGAGGTGATAGCTCCCGTTGTAGGGGCAAGCCTCGTTGTTTGGCTTCCCATACAGTATATTCTGCTCATAGATGTGATCGGAGCTGTTGCTGCTTGTCTGACCTTACTTTGTGTCCAGATTCCTTCTCTTCAAAAAACGAAAGTTCTTCCAGATTTCAAAAAAGAACTGACGGAATGTTGGCATACCTTGCGGCGTACAATGGGCATTTTGCCTTTATTCGTATGCTTTACGCTGGTGACTTTTGTCCTTATGCCTGTTTTTACGTTATTTCCTTTTATGACGCTTCTGCATTTCAACGGAAACATTTTGCAAATGGGAGTTGTGGAAATGGGTTGGGGCTCAGGGGCATTGTTGGGCGGTTTAGTACTTGCCTGTAAGGCTTTGAAAAGCAAGCAAACATTAGTGATGCATACGGCTTATGTGATATTGGGATTGTATCTGATTAGCGCCAGTTATTTACCATCAAGCGCATTTATAGGTTTTGTTTGCCTAACATTTACAGGAGGCATAGCCTATTCCATTTACCATGCGCTTTTCATCGCTATTATTCAGCAGAACTTGGCTTCGGACATGCTTGGACGGACTTTTTCTCTCATCTTTAGTTTGAGTACCTTTCCATCAATGCTGGGTATCGTAGCTTCAGGATATTGGGTGGAAGCATGGGGTATCACATCCGTCTTTATGATCAGCGGATGGGTTATCTTTCTGATTGGAGTGGGTGCAAATTTTATTTCTTCAATCAAGCAGTTGGATAATTACGCATAG	MNHWKSTLAVIGIGQLISILTSTIVGFSIIFWISNEFKSPTALSLAILAGFLPQFVLGLFAGVYVDRWNRKKTMFYSDLFIAFCTLCLFIVITKGYKDLSFFYLLTACRSIGSTFHAPALQASIPLLVPKHHLVRVSGLYHSIQSFSEVIAPVVGASLVVWLPIQYILLIDVIGAVAACLTLLCVQIPSLQKTKVLPDFKKELTECWHTLRRTMGILPLFVCFTLVTFVLMPVFTLFPFMTLLHFNGNILQMGVVEMGWGSGALLGGLVLACKALKSKQTLVMHTAYVILGLYLISASYLPSSAFIGFVCLTFTGGIAYSIYHALFIAIIQQNLASDMLGRTFSLIFSLSTFPSMLGIVASGYWVEAWGITSVFMISGWVIFLIGVGANFISSIKQLDNYA	MNHWKSTLAVIGIGQLISILTSTIVGFSIIFWISNEFKSPTALSLAILAGFLPQFVLGLFAGVYVDRWNRKKTMFYSDLFIAFCTLCLFIVITKGYKDLSFFYLLTACRSIGSTFHAPALQASIPLLVPKHHLVRVSGLYHSIQSFSEVIAPVVGASLVVWLPIQYILLIDVIGAVAACLTLLCVQIPSLQKTKVLPDFKKELTEWLHTLRRTMGILPLFVCFTLVTFVLMPVFTLFPFMTLLHFNGNILQMGVVEMGWGSGALLGGLVLACKALKSKQTLVMHTAYVILGLYLISASYLPSSAFIGFVCLTFTGGIAYSIYHALFIAIIQQNLASDMLGRTFSLIFSLSTFPSMLGIVASGYWVEAWGITSVFMISGWVIFLIGVGANFISSIKQLDNYA	100.00	gnl|BL_ORD_ID|2255|hsp_num:0	3359		
k141_8473_1 # 1 # 99 # -1 # ID=4628_1;partial=10;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.323	k141_8473_1 	1	99	-	Strict	750	20.0162	mefC	100.0	3003745	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGTGATGGAAAATCGAAAATGGATTAGTTGTCCGAGTTGTGGAAATAAAACAAGACTTAAAATACGACAAGATACGATTTTAAAGAACTTTCCACTT	MVMENRKWISCPSCGNKTRLKIRQDTILKNFPL	MENRKWFKTYMFIWAGQFASMLTSYAVQFAIVIWLSLEYKSAEVLAYAGIAAMLPQALIGLIAGVYVDRLNRKYVMIFSDAFIALCALLLLVILQNENVNLIWIYILLGLRSVGNAFHAPALQAIAPLIVPQNELIKVAGINQVLHSVCRIGGPAIGTLAIAYLPISKVLYLDLIGALLAILSLVMVKIPNVVAKSKSSAHSIATEFSEGFQTVSKNKGLRYLFLYAMAITFVIMPAAIMFPLLTTGHFAGGKWEIGIVEVVWGGGMLIGGVILSIFKLKGSKVVAVNVMYVLLGLTFILSGVLPASWFVGFVMVTAIGGISLSVFNGCFTAIVQTEVSPEKLGRVFSLYYSLAVLPSVIGLLFTGLIAEVIGVNITFIISGCLAILVGILSFSTRNLMQLGKIKNI	8.11	gnl|BL_ORD_ID|2101|hsp_num:0	2262	True	loose hit with at least 95 percent identity pushed strict
k141_16987_16 # 15396 # 15617 # 1 # ID=9289_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.387	k141_16987_16 	15396	15617	+	Strict	600	21.557	cfrA	100.0	3003441	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGAAAGATGTGATTGTTAGTAAAAGCGCTCGGATTGTCAATCGAAGGGGCGATGGTTGTAACTTTGGGTGCCTATTAGCGAGGTTATTAAAACGAATCTTAAAAAAAGTGGACGGGTTCATCCTTAAATTTAGACTCAAGTGTGGTCCTAGTTATATGACAGCACCTGGTACTAAAAAGGTGGAAGTTATGACAACCGGGATATTATCTTACGAAAATTAG	MKDVIVSKSARIVNRRGDGCNFGCLLARLLKRILKKVDGFILKFRLKCGPSYMTAPGTKKVEVMTTGILSYEN	MNFNNKTKYGKIQEFLRSNNEPDYRIKQITNAIFKQRISRFEDMKVLPKLLREDLINNFGETVLNIKLLAEQNSEQVTKVLFEVSKNERVETVNMKYKAGWESFCISSQCGCNFGCKFCATGDIGLKKNLTVDEITDQVLYFHLLGHQIDSISFMGMGEALANRQVFDALDSFTDPNLFALSPRRLSISTIGIIPSIKKITQEYPQVNLTFSLHSPYSEERSKLMPINDRYPIDEVMNILDEHIRLTSRKVYIAYIMLPGVNDSLEHANEVVSLLKSRYKSGKLYHVNLIRYNPTISAPEMYGEANEGQVEAFYKVLKSAGIHVTIRSQFGIDIDAACGQLYGNYQNSQ	20.92	gnl|BL_ORD_ID|655|hsp_num:0	696	True	loose hit with at least 95 percent identity pushed strict
k141_17038_1 # 3 # 83 # -1 # ID=9320_1;partial=10;start_type=ATG;rbs_motif=TAAA;rbs_spacer=15bp;gc_cont=0.432	k141_17038_1 	3	83	-	Strict	450	18.8606	Chryseobacterium meningosepticum BlaB	100.0	3000579	protein homolog model	n/a	n/a	carbapenem; penam	antibiotic inactivation	BlaB beta-lactamase	ATGAGTACAGAAAAGAAACTTCGCTTTGAGACACTTCAGTTGCATGTAGGTCAGGAAAATCCAGATCCAGCTACCGACGCT	MSTEKKLRFETLQLHVGQENPDPATDA	MLKKIKISLILALGLTSLKAFGQENPDVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVTDKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYSTKMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGCIIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQHTLDLINEYQQKQKASN	10.84	gnl|BL_ORD_ID|2563|hsp_num:0	237	True	loose hit with at least 95 percent identity pushed strict
k141_17039_1 # 3 # 83 # -1 # ID=9321_1;partial=10;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.432	k141_17039_1 	3	83	-	Strict	450	18.8606	Chryseobacterium meningosepticum BlaB	100.0	3000579	protein homolog model	n/a	n/a	carbapenem; penam	antibiotic inactivation	BlaB beta-lactamase	ATGAGTACAGAAAAGAAACTTCGCTTTGAGACACTTCAGTTGCATGTAGGTCAGGAAAATCCAGATCCAGCTACCGACGCT	MSTEKKLRFETLQLHVGQENPDPATDA	MLKKIKISLILALGLTSLKAFGQENPDVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVTDKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYSTKMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGCIIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQHTLDLINEYQQKQKASN	10.84	gnl|BL_ORD_ID|2563|hsp_num:0	237	True	loose hit with at least 95 percent identity pushed strict
k141_17229_1 # 3 # 86 # -1 # ID=9438_1;partial=10;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.536	k141_17229_1 	3	86	-	Strict	590	18.8606	BES-1	100.0	3004751	protein homolog model	n/a	n/a	penam	antibiotic inactivation	BES Beta-lactamase	ATGGTGGACACCCCCGCCCCAGAACAGGGCGCCCCCGGTCTGCCATTAAAATATAACGAGCGTTGCATATTTCCAAAACGACGA	MVDTPAPEQGAPGLPLKYNERCIFPKRR	MWQWLGKVRWLLVVIALLGGKVMAASELDSALARLEQQHHGRLGLAYIDSGSGESYSYRGEERFAFCSTFKAVLAGAVLQRSVSQPGLLDKRVHYAATDLLAYAPITKTHLDKGMRIGELAAAAVQYSDNTAANLLLQEIGGVQALNRFVQGLGDPAFRLDRIEPHLNSAEPGDVRDTTTPLAMAHTLQAMTLGKGLPQAQQAQLVSWLKGNTTGAQRIQAGVPAGWQVGDKTGTGGYGTTNDIAILWPEQGAPKVLAIYFTQPAADAEANRAILAEATRLVLQDKSINKIK	9.59	gnl|BL_ORD_ID|2471|hsp_num:0	3560	True	loose hit with at least 95 percent identity pushed strict
k141_21743_1 # 2 # 136 # 1 # ID=11921_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.215	k141_21743_1 	2	136	+	Strict	500	21.557	tet(W/N/W)	100.0	3004442	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	AAACAAGCAAATAGAAAAATTAAGAAAGATAAATTCTCAGCTTTTGAATATGGTTTATATTATATTAAACAATTAGATGAAAGTAAAAAGAAACGAAAAAAAGCAAAAATATCAGACTTTATGTTCTATTCATAG	KQANRKIKKDKFSAFEYGLYYIKQLDESKKKRKKAKISDFMFYS	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVYQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRLVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAHKGEIVILPSDSLRLNDILGDKTQLPREMWSDVPFPMLRTTITPKTAEQRDRLLDALTQIADTDPLLHYEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQATVGEPIIQPRRPNSRLDKVRHMFSKIP	6.89	gnl|BL_ORD_ID|2556|hsp_num:0	2882	True	loose hit with at least 95 percent identity pushed strict
k141_23300_21 # 23283 # 26393 # 1 # ID=12755_21;partial=00;start_type=ATG;rbs_motif=AATAA;rbs_spacer=9bp;gc_cont=0.457	k141_23300_21	23283	26393	+	Strict	750	767.689	adeF	41.63	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAGTAAACTTTTTCATTGACAGGCCCGTATTCTCGGCTGTCATCTCCATATTAATTGTCATCGTGGGAGTTATTGGCTTAACCATGCTTCCCGTTGACCAATACCCGCAAATCACCCCTCCTGTGGTTAAAATCAGTGCATCTTATCCGGGAGCCAGTGCCTTAACCGTATCACAAGCCGTAGCAACTCCTATCGAACAGGAATTAAACGGAACTCCGGGAATGCTTTATATGGAATCAAGCAGTTCTAACTCCGGAGGGTTCTCAGCAACTGTTACATTCGATATTTCTGCCGACCCTGATTTGGCTGCGGTAGAAATACAAAACCGTATCAAATTGGCAGAATCTCGTCTGCCGGCTGAAGTGGTACAAAATGGTATTTCCATCGAAAAGCAAGCAGCCAGCCAGCTGATGACAATCTGTTTGACATCTGATGACCCTAAGTTTGATGAAATCTATTTGAGTAACTTTGCCACAATCAATGTGCTCGACTTGATTCGCCGTATTCCAGGCGTAGGTCGTGTTTCGAATATCGGAGGTCGATACTATGCGATGCAGATTTGGGTAGACCCGGCTCGCCTTGCCAACTTTGGACTGACCGTGCAAGATATACAAAATGCGCTTAAAGACCAGAACAGAGAATCGGCTGCCGGAGTTTTAGGACAACAGCCTGTTTCAGGATTGGATATTACGATTCCTATTACCGCTCAAGGACGTTTGTCGACTGCCGCCCAGTTCGAAGAAATCGTAGTACGAGCCAATGCTGATGGTTCACTGATCCGTCTGCGCGATGTAGCCCGTGTATCACTGGAAGCGCAATCGTATAATACCGAAAGTGGTATCAACGACGGAAACGCAGCCGTATTAGGTATCTACATGCTTCCGGGAGCCAATGCCATGGAAGTGGCTGAAAATGTAAAAAAAGCCATAGCAGAAATCAGCAAAACCTTCCCGGAAGGCCTGGAATACGAAGTTACATTTGATATGACAACTTACATTTCAGAGTCTATTCATGAAGTGTATAAAACCTTGTACGAGGCTTTATTCCTGGTAATCATCGTGGTATTCCTTTCACTACAGAGCTGGCGTGCCACTATCATCCCGATTGTAGCCGTTCCTATCTCATTGATCGGAACATTCGGTTTCATGCTTATATTTGGCTTCTCGCTTAATATGCTTACACTCTTGGGACTGGTTCTTGCCATCGGTCTTGTGGTTGACGACGCCATTGTGGTCGTAGAAAACGTAGAACGTATCATGGAGGAAGAGCATCTCAGTCCTTATGAGGCCACCAAGAAAGCGATGGACGGATTGACCGGAGCTTTGATTGCAACCTCACTGGTTTTGGCTGCTGTATTCGTTCCGGTAAGCTTCCTTTCAGGTATCACCGGACAGCTGTACCGCCAGTTTAGTGTGACCATCGCCGTTTCTGTGTTGCTGTCTACAGTCGTAGCCTTGACTTTGAGCCCAGTAATGTGTTCTCTTATCTTGAAGCCGACTGACCATAACAAACCTAAGAACAAAATATTCCGTGCCATCAACCGCTGGATTGATTTAGGTAACAACAAATACGTGACCGGTATCAAACATGTATTAAAGCACCCACGCCGCGTCACACTCGGTTTTGCAACCGTAATCTTGTTTATTTTTGTTCTTTACAAAGTAATTCCGACCAGCTTCTTGCCTACAGAAGACCAAGGTTACTTTACTGTAGAGCTCGAACTTCCTGAAGGAGCGACTCTTGAAAGAACCCGTACGGTAACAAACCGGGCCATTGACTTTATCATGCAAAATCCGGCTGTAGAATACGTTCAAAACGTAACCGGTACCAGCCCGCGTATCGGAACGAGCCAGTCTCGAAGCCAGCTTACCGTCATCTTGAAGCAGTGGAAAAAGCGTGATGACACCAGCATTGGTGAAATTATGGCTGAAGTACAAAACGAGATGAAGAAGTACCCGGAATGCAAGATATACTTGTCTACCCCGCCGGTTATTCCAGGACTTGGAACATCGGGAGGTTTTGAAATGCAGCTTGAAGCCAGAGGTGATGCCAGCTATGAAGATTTAGTACAAGCTACAGATACATTGATGTATTATGCTTCTAAATGTGATGAACTGAGCGGTCTGTCTTCTTCAATACAGGCAGAAATTCCCCAGCTGTATTTCGATGTTGACCGTGATAAGGTAAAATTGTCGGGAGTGCCCATGGCAGATGTTTTCTCTACCATGAAAGCTTATACCGGTTCGGTTTATGTAAACGACTTCAACATGTTTAACCGTATCTACCGTGTATACCTACAGGCAGAAGCTCCGTACCGTGAACACCGCGATAACATCAACCTGTTCTTCGTACGCGGAAGCGACGATTCAATGATCCCGCTTACCTCATTGGGTAATACGCAGTACACCACCGGACCTGGAAGTATTCAGCGCTTTAACATGTTTAATACATCAGTAATCCGCGGAGAAGCTGCACATGGCTACAGTTCGGGGCAAGCAATGGAAGTTATTGAAAGACTAGCCCGTGAACATTTGCCTGAAAACATTGGTATAGAATGGAGTGGACTTTCATTCCAGGAAAAACAAGCAGGAGGACAAACCGGTATGATTTTGACCCTGGTATTCCTATTTGTATTCTTGTTCCTTGCAGCACTTTATGAAAGCTGGAGTATTCCGGTAGCCGTTTTGTTATCACTGCCTGTTGCCGCACTCGGAGCCTATGCGGGAGTAGCTATCAGCGGACTGGAAAACGATACTTACTTCCAGATTGGTCTGGTAATGCTTGTGGGTCTTGCAGCAAAGAATGCCATCTTGATTGTTGAGTTTGCCAAAGATGAAGTTGATGCAGGAAAAGACCTGATTGAATCCACACTTCATGCTGCCCGTCTGCGTTTCCGCCCGATTCTGATGACCTCACTGGCCTTCATCTTAGGTATGCTGCCGATGGTTATCGCCAGCGGTCCGGGTTCAGCAAGCCGTCAAGCCATCGGTACCGGTGTATTCTACGGAATGATTGTAGCAGTTACCGTGGGAATCTTCCTTGTTCCCTTCTTCTTTGTAATGATTTACAAAGCAAAAAATAAACTGAAAGCAAAACATACAAATTAA	MKVNFFIDRPVFSAVISILIVIVGVIGLTMLPVDQYPQITPPVVKISASYPGASALTVSQAVATPIEQELNGTPGMLYMESSSSNSGGFSATVTFDISADPDLAAVEIQNRIKLAESRLPAEVVQNGISIEKQAASQLMTICLTSDDPKFDEIYLSNFATINVLDLIRRIPGVGRVSNIGGRYYAMQIWVDPARLANFGLTVQDIQNALKDQNRESAAGVLGQQPVSGLDITIPITAQGRLSTAAQFEEIVVRANADGSLIRLRDVARVSLEAQSYNTESGINDGNAAVLGIYMLPGANAMEVAENVKKAIAEISKTFPEGLEYEVTFDMTTYISESIHEVYKTLYEALFLVIIVVFLSLQSWRATIIPIVAVPISLIGTFGFMLIFGFSLNMLTLLGLVLAIGLVVDDAIVVVENVERIMEEEHLSPYEATKKAMDGLTGALIATSLVLAAVFVPVSFLSGITGQLYRQFSVTIAVSVLLSTVVALTLSPVMCSLILKPTDHNKPKNKIFRAINRWIDLGNNKYVTGIKHVLKHPRRVTLGFATVILFIFVLYKVIPTSFLPTEDQGYFTVELELPEGATLERTRTVTNRAIDFIMQNPAVEYVQNVTGTSPRIGTSQSRSQLTVILKQWKKRDDTSIGEIMAEVQNEMKKYPECKIYLSTPPVIPGLGTSGGFEMQLEARGDASYEDLVQATDTLMYYASKCDELSGLSSSIQAEIPQLYFDVDRDKVKLSGVPMADVFSTMKAYTGSVYVNDFNMFNRIYRVYLQAEAPYREHRDNINLFFVRGSDDSMIPLTSLGNTQYTTGPGSIQRFNMFNTSVIRGEAAHGYSSGQAMEVIERLAREHLPENIGIEWSGLSFQEKQAGGQTGMILTLVFLFVFLFLAALYESWSIPVAVLLSLPVAALGAYAGVAISGLENDTYFQIGLVMLVGLAAKNAILIVEFAKDEVDAGKDLIESTLHAARLRFRPILMTSLAFILGMLPMVIASGPGSASRQAIGTGVFYGMIVAVTVGIFLVPFFFVMIYKAKNKLKAKHTN	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	97.83	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_24688_1 # 254 # 2227 # -1 # ID=13523_1;partial=00;start_type=GTG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.398	k141_24688_1	254	2227	-	Strict	1200	1318.91	tetQ	96.96	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GTGCGTTTCGACAATGCATCTATTGTAGTATATTATTGCTTAATCCAAATGAATATTATAAATTTAGGAATTCTTGCTCACATTGATGCAGGAAAAACTTCCGTAACCGAGAATCTGCTGTTTGCCAGTGGAGCAACGGAAAAGTGCGGCTGTGTGGATAATGGTGACACCATAACGGACTCTATGGATATAGAGAAACGTAGAGGAATTACTGTTCGGGCTTCTACGACATCTATTATCTGGAATGGTGTGAAATGCAATATCATTGACACTCCGGGACACATGGATTTTATTGCGGAAGTGGAGCGGACATTCAAAATGCTTGATGGAGCAGTCCTCATCTTATCCGCAAAGGAAGGCATACAAGCGCAGACAAAGTTGCTGTTCAGTACTTTACAAAAGCTGCAAATCCCGACAATTATATTTATCAATAAGATTGACCGTGCCGGTGTGAATTTGGAGCGTTTGTATATGGATATAAAAACAAATCTGTCGCAAGATGTCCTGTTTATGCAAACTGTTGTCGATGGATCGGTTTATCCGGTTTGCTCCCAAACATATATAAAGGAAGAATACAAAGAATTTGTATGCAACCATGACGACAATATATTAGAACGATATTTGGCGGATAGCGAAATTTCACCGGCTGATTATTGGAATACGATAATCGCTCTTGTGGCAAAAGCCAAAGTCTATCCGGTGCTACATGGATCAGCAATGTTCAATATCGGTATCAATGAGTTGTTGGACGCCATCACTTCTTTTATACTTCCTCCGGCATCGGTCTCAAACAGACTTTCATCTTATCTTTATAAGATAGAGCATGACCCCAAAGGACATAAAAGAAGTTTTCTAAAAATAATTGACGGAAGTCTGAGACTTCGAGACGTTGTAAGAATCAACGATTCGGAAAAATTCATCAAGATTAAAAATCTAAAAACTATCAATCAGGGCAGAGAGATAAATGTTGATGAAGTGGGCGCCAATGATATCGCGATTGTAGAGGATATGGATGATTTTCGAATCGGAGATTATTTAGGTGCTGAACCTTGTTTGATTCAAGGATTATCTCATCAGCATCCCGCTCTCAAATCCTCCGTCCGGCCAGACAGGCCCGAAGAGAGAAGCAAGGTGATATCCGCTCTGAATACATTGTGGATTGAAGACCCGTCTTTGTCCTTTTCCATAAACTCATATAGTGATGAATTGGAAATCTCGTTATATGGTTTAACCCAAAAGGAAATCATACAGACATTGCTGGAAGAACGATTTTCCGTAAAGGTCCATTTTGATGAGATCAAGACTATATACAAAGAACGACCTGTAAAAAAGGTCAATAAGATTATTCAGATCGAAGTGCCGCCCAACCCTTATTGGGCCACAATAGGGCTGACTCTTGAACCCTTACCGTTAGGGACAGGGTTGCAAATCGAAAGTGACATCTCCTATGGTTATCTGAACCATTCTTTTCAAAATGCCGTTTTTGAAGGGATTCGTATGTCTTGCCAATCCGGGTTACATGGATGGGAAGTGACTGATCTGAAAGTAACTTTTACTCAAGCCGAGTATTATAGCCCGGTAAGTACACCTGCTGATTTCAGACAGCTGACCCCTTATGTCTTCAGGCTGGCCTTGCAACAGTCAGGTGTGGACATTCTCGAACCGATGCTCTATTTTGAGTTGCAGATACCCCAAGCGGCAAGTTCCAAAGCTATTACAGATTTGCAAAAAATGATGTCTGAGATTGAAGACATCAGTTGCAATAATGAGTGGTGTCATATTAAAGGGAAAGTTCCATTAAATACAAGTAAAGACTATGCATCAGAAGTAAGTTCATACACTAAGGGCTTAGGCATTTTTATGGTTAAGCCATGTGGGTATCAAATAACAAAAGACGGTTATTCTGATAATATCCGCATGAACGAAAAAGATAAACTTTTATTCATGTTCCAAAAATCAATGTCATTAAAATAA	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGCVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFSTLQKLQIPTIIFINKIDRAGVNLERLYMDIKTNLSQDVLFMQTVVDGSVYPVCSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAITSFILPPASVSNRLSSYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTINQGREINVDEVGANDIAIVEDMDDFRIGDYLGAEPCLIQGLSHQHPALKSSVRPDRPEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGIFMVKPCGYQITKDGYSDNIRMNEKDKLLFMFQKSMSLK	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	100.00	gnl|BL_ORD_ID|1116|hsp_num:0	1183		
k141_25761_2 # 111 # 1106 # 1 # ID=14105_2;partial=00;start_type=ATG;rbs_motif=TATAA;rbs_spacer=3bp;gc_cont=0.358	k141_25761_2	111	1106	+	Strict	600	670.618	CfxA6	99.09	3003097	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	ATGTTAAACTATAGTGTTGCGGAATTAAGGAACATGAAAAAAAACAGAAAAAAGCAAATCGTAGTTTTGTGTATAGCTTTAGTTTGCATCTTCATCTTGGTGTTCTCATTGTCCCATAAATCAGCTACAAAAGGTAGCGCGAATCCTCCATTAACAGATGTTTTGACTGATAGCATTTCTCAGATTGTCTCGGCTTGTCCTGGTGAAATTGGTGTGGCGGTTATTATTAATAACACAGATACGGTTAGTGTTAATAATAAAAGCATTTATCCTATGATGAGTGTATTTAAGGTTCATCAGGCATTAGCTCTTTGCAATGATTTTGACAAAAAAGGCCTTTCCCTTGATACCTTGGTAAAGATAAATAGGGAAAAACTTGATCCAAAGACATGGAGCCCTATGATGAAAGATTATTCAGCACCAGTTATATCGTTGACAGTAAGAGATCTGTTGCGCTATACTCTTTCCCAGAGCGACAATAATGCAAGCAATATCATGTTTAAGAATATGCTCAATACTGCACAAACAGACAGTTTTATAGCGAAACTCATACCACATTCGAGTTTTCAGATAGCTTATACAGAAGAGGAAATGTCCGCTGACCATGACAAAGCTTACTCTAATTACACATCTCCTCTTGGTGCTGCAATGTTGATGAATCGTTTGTTTACAGAAAGTCTTATCAGTAATGAGAAACAAGATTTCATTAAGAATGCATTGAAAGAATGTAAAACAGGTATAGATAGGATAGTAGCTCCACTTCTTGATAAAGAAGGGGTTGTAATAGCACATAAGACAGGTTCTGGTTGTGTCAATGAAAATGGTATTCTTGCAGCTCAGAATGATGTAGCGTATATATGTCTGCCTAATAAGGTCTGCTATACCTTAGCTGTATTTGTTAAGGATTTCAAGGGAAATGAATCACAAGCGTCACAATTTGTTGCGCATATATCAGCGGTAGTATATTCTTTATTAATCAATACTGCGTTAAATTAA	MLNYSVAELRNMKKNRKKQIVVLCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSISQIVSACPGEIGVAVIINNTDTVSVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVKINREKLDPKTWSPMMKDYSAPVISLTVRDLLRYTLSQSDNNASNIMFKNMLNTAQTDSFIAKLIPHSSFQIAYTEEEMSADHDKAYSNYTSPLGAAMLMNRLFTESLISNEKQDFIKNALKECKTGIDRIVAPLLDKEGVVIAHKTGSGCVNENGILAAQNDVAYICLPNKVCYTLAVFVKDFKGNESQASQFVAHISAVVYSLLINTALN	MSNYSVAELRNMKKNRKKQIVVLCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSISQIVSACPGEIGVAVIINNTDTVSVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVKINREKLDPKTWSPMMKDYSAPVISLTVRDLLRYTLSQSDNNASNIMFKNMLNTAQTDSFIAKLIPRSSFQIAYTEEEMSADHDKAYSNYTSPLGAAMLMNRLFTESLISNEKQDFIKNALKECKTGIDRIVAPLLDKEGVVIAHKTGSGNVNENGILAAQNDVAYICLPNKVCYTLAVFVKDFKGNESQASQFVAHISAVVYSLLINTALN	100.00	gnl|BL_ORD_ID|248|hsp_num:0	268		
k141_25773_1 # 1 # 66 # -1 # ID=14112_1;partial=10;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=3-4bp;gc_cont=0.606	k141_25773_1 	1	66	-	Strict	1000	18.4754	eptB	100.0	3005047	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACAGAAGGAGCTCTGGTGCTGGAGGGAGGTTCGCTGCGCTGCATGTTCACAGCAGGAGTCCTG	MTEGALVLEGGSLRCMFTAGVL	MPQRQAVFYSSFSRFACMKYIRTMTQQKLSFWLALYIGWFMNVAVFFRRFDGYAQEFTFWKGLSGVVELVATVFVTFFLLRLLSLFGRRIWRILATLIVLFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSKEVIGWHLILWLVVVSAPPLLFIWSNRCRHTLLRQLRTPGQRVKNVLIVVLAGLIVWGPIRLLELRQHDVERHSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVAPEGLDDTYVVFIIGETTRWDHMGILDYSRNTTPELEKEKNLVAFRGYLCDTATKLSLRCMFVREGGAEDNPQRTLKEQNVFAVLHQLGFSGNLYAMQSEMWFYSNTMANNIAYREQIGAEPRNRGKSVDDMLLVDEMKRGMAQGNASGKHLIILHTKGSHFNYTQRYPRSFAQWKPECVGVDNKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEREHLHGTPRKMAPPEQFRVPMMVWMSDKYLENPDHAAAFAHLQQQAAMKVPRRHVELYDTIMGCLGYTSPDGGINENNNWCRWKK	3.83	gnl|BL_ORD_ID|2836|hsp_num:0	3791	True	loose hit with at least 95 percent identity pushed strict
k141_27205_2 # 560 # 643 # 1 # ID=14917_2;partial=01;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.429	k141_27205_2 	560	643	+	Strict	550	21.1718	SHV-9	100.0	3001068	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SHV beta-lactamase	ATGGACGAAAAAATATATGATCTAATTGTAATAGGCGGAGGGCCTGCGGGACTTACAGCAGGTATATATGCAGGAAGAGCTATG	MDEKIYDLIVIGGGPAGLTAGIYAGRAM	MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLRTVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRNVLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	9.82	gnl|BL_ORD_ID|520|hsp_num:0	557	True	loose hit with at least 95 percent identity pushed strict
k141_27263_7 # 7935 # 11066 # 1 # ID=14950_7;partial=00;start_type=ATG;rbs_motif=AAA;rbs_spacer=11bp;gc_cont=0.496	k141_27263_7	7935	11066	+	Strict	750	771.541	adeF	42.04	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAGTAAACTTCTTTATAGACCGGCCTGTATTCTCGGCCGTTATATCCATCGTGATCGTTGTGGTGGGCATCATTGGACTAACCATGCTCCCTATCGATCAATATCCGCAGATTACGCCGCCTGTAGTCAAAATTAGCGCCTCGTACCCCGGTGCAAGTGCACTCACGGTATCGCAAGCGGTTGCCACCCCCATTGAACAGGAACTGAATGGTACACCTGGCATGCTCTATATGGAATCGAACAGTTCGAACTCGGGCGGCTTTTCGGCCACTGTTACCTTCGACATCGACACTGACCCCGATTTGGCTGCCGTTGAAATTCAAAACCGTATCAAACTAGCCGAATCGCGCCTGCCAGCCGAAGTTGTATCGAATGGTATATCGGTTGAAAAGCAGGCAGCCAGCCAGTTGCTTACGCTCTGTATCACCTCGACTGACCCTAAATTCGACGAGATTTACCTCAGTAACTTTGCTACGCTCAATGTACTCGACCTGCTCCGCCGTATTCCTGGCGTAGGCCGCGTATCAAACATTGGCAGCCGTTACTATGCTATGCAAATTTGGGTACAACCCGACAAATTAGCCAGTTTCGGGCTTACGGTTGCTGACCTGCAAACAGCACTCAAGGACCAAAACCGCGAGTCGGCCGCTGGTGTGCTCGGACAGCAACCAGTCAAAGGACTCGACATTACCATTCCCATTACCACACAAGGACGTTTGTCGACCGTAAGCCAGTTTGAAGAGATTGTCGTACGTGCAGCTCCCGACGGCTCCATCATCCGCCTGCGCGATGTAGCACGCATCTCGCTCGAAGCACAATCGTATAACACCGAGAGTAGCATCAATGGTAAAAATGCCGCTGTGCTGGCCATCTACATGCTTCCCGGTGCCAACGCTATGGAAGTTGCCCAAAAGGTAAAAGACGCCATGAAGGAAATCAGTGCCAACTTCCCCGAAGGCATGAGTTACAACATTCCTTCGGACATGACAACCTACATTTCGGAATCAATCAGCGAGGTCTATAAAACGCTCCTCGAGGCACTGGTGCTCGTTATCATAGTAGTTTACCTTTCATTACAGAGTTGGCGGGCCACTCTCATCCCGCTGGTAGCTGTACCCATCTCGCTTATCGGTACTTTCGGCTTCATGCTGATATTCGGTTTCTCGCTCAACATCCTTACCCTGCTCGGATTAGTATTGGCCATCGGTATTGTGGTGGACGATGCCATTGTCGTGGTCGAAAACGTAGAGCGCATCATGGAAGAAGAAAACCTTCCACCCTACGAAGCAACCAAAAAAGCCATGGAAGGACTGACCGGTGCCATTATTGCCACTTCGCTTGTACTGGCTGCGGTTTTTGTTCCGGTTAGCTTCTTAGCCGGTATTACCGGACAGCTCTATCGGCAATTCTCGGTCACCATCGTTGTGTCTGTACTTCTCTCAACTGTTGTGGCACTCACACTTAGCCCGGTTATGTGTTCGCTCATTCTGCGCCCGGTTGACAAGACGAAACGCAAAAACATCGTGTTCCGTTATATCAATGCCTGGATAAACATTGGCAACAACCGCTACGTAGGCTTTATTACGCGTACCATCAAACACCCACGCCGCATTCTCAGTGCCTTCGGTATGGTGTTGATAGCCGTACTGCTCATTCATAAACTTTTGCCCACCAGTTTCCTTCCTGCCGAGGACCAAGGCTACTTTAAAATAGAGTTGGAACTTCCCGAAGGCACAACTCTTGAACGCACACGTACGGTAACGGAACGTGCCGTTGACTATTTAATGAAGAATCCGGCCGTTGACTATGTGCAAAGTGTAGCAGGAAGCAGTCCGCGAGTTGGCAGCAGTCAGGCCCGAAGCGAACTAACGGTAATTCTCAAGCCTTGGGAAAAACGCGAAGGTACCTCGGTCGACGACTTGATTGCTCAGGTTAAAAAGGATATGGCCGAATATCCTGAATGCAAGGTCTACTTCTCTACACCACCAGTTATTCCGGGTCTTGGCAGTTCGGGCGGTTTCGAAATGCAACTCGAGGCTCGCGGCGAAGCCACCTTCGACAACCTGGTACAAGCTACAGATACCCTTATGTACTATGCATCCAAGCGCAAAGAACTCTCGGGGTTGTCCTCTTCACTACAAGCTGACATCCCGCAGCTCTACTTTGACGTTGACCGCGATAAAGCAAAATTTGCAGGTGTTCCCTTAGCTGATGTCTTCTCAACCATGAAGGCATATACCGGTTCGGTCTATGTAAACGACTTTAATATGTTTAACCGCATATATCGTGTGTATATCCAGGCCGAAGCCCCCTATCGCGAACACCAGGACAACATCAACCTGTTCTTTGTACGTGGTGCCGGAGATGCTATGATTCCACTTACTTCAATTGGTACTACATCGTACACCACCGGCCCCGGAAGCATCAAACGCTTTAATATGTTCAACAGTTCGGTAATTCGCGGCGAAGCAGCCGATGGCTACAGTTCAGGACAGGCCATGGAAATTATGGAACAAATTGCACGAGAACACCTACCCGACAACATAGGCGTTGAATGGAGCGGACTATCCTATCAGGAAAAACAAGCCGGAGGACAGACTGCCATGGTTCTCACCTTGGTATTCCTCTTTGTATTCCTTTTCTTAGCTGCGCTTTACGAAAGCTGGATGGTACCTGCTGCCGTACTCATCTCGCTGCCAGTAGCAGCCCTCGGTGCATACCTTGGTGTTTGGGGATGTGGACTGGAAAACGATGTTTACTTCCAAATTGGACTGGTAATGCTTGTAGGTCTTGCAGCCAAGAACGCCATTCTGATTGTTGAATTTGCCAAGGAACAAGTAGACCGCGGTGTTGATATCGTACAAGCAGCCATTCATGCCTCTCAGCTACGCTTCCGCCCTATCTTGATGACCTCTTTGGCTTTCATCTTGGGCATGCTGCCGATGGTTATAGCCTCCGGACCGGGTTCTGCAAGCCGCCAAGCCATCGGTACTGGCGTATTCTTCGGCATGATATTCGCCGTTACCTTCGGCATTCTGCTTGTCCCCTTCTTCTTCGTACTCATTTATAAAATGAAACGCAAGATGAAGCGAAACAAAACCATAACCCAACAAGTACCTAAGCAATGA	MKVNFFIDRPVFSAVISIVIVVVGIIGLTMLPIDQYPQITPPVVKISASYPGASALTVSQAVATPIEQELNGTPGMLYMESNSSNSGGFSATVTFDIDTDPDLAAVEIQNRIKLAESRLPAEVVSNGISVEKQAASQLLTLCITSTDPKFDEIYLSNFATLNVLDLLRRIPGVGRVSNIGSRYYAMQIWVQPDKLASFGLTVADLQTALKDQNRESAAGVLGQQPVKGLDITIPITTQGRLSTVSQFEEIVVRAAPDGSIIRLRDVARISLEAQSYNTESSINGKNAAVLAIYMLPGANAMEVAQKVKDAMKEISANFPEGMSYNIPSDMTTYISESISEVYKTLLEALVLVIIVVYLSLQSWRATLIPLVAVPISLIGTFGFMLIFGFSLNILTLLGLVLAIGIVVDDAIVVVENVERIMEEENLPPYEATKKAMEGLTGAIIATSLVLAAVFVPVSFLAGITGQLYRQFSVTIVVSVLLSTVVALTLSPVMCSLILRPVDKTKRKNIVFRYINAWINIGNNRYVGFITRTIKHPRRILSAFGMVLIAVLLIHKLLPTSFLPAEDQGYFKIELELPEGTTLERTRTVTERAVDYLMKNPAVDYVQSVAGSSPRVGSSQARSELTVILKPWEKREGTSVDDLIAQVKKDMAEYPECKVYFSTPPVIPGLGSSGGFEMQLEARGEATFDNLVQATDTLMYYASKRKELSGLSSSLQADIPQLYFDVDRDKAKFAGVPLADVFSTMKAYTGSVYVNDFNMFNRIYRVYIQAEAPYREHQDNINLFFVRGAGDAMIPLTSIGTTSYTTGPGSIKRFNMFNSSVIRGEAADGYSSGQAMEIMEQIAREHLPDNIGVEWSGLSYQEKQAGGQTAMVLTLVFLFVFLFLAALYESWMVPAAVLISLPVAALGAYLGVWGCGLENDVYFQIGLVMLVGLAAKNAILIVEFAKEQVDRGVDIVQAAIHASQLRFRPILMTSLAFILGMLPMVIASGPGSASRQAIGTGVFFGMIFAVTFGILLVPFFFVLIYKMKRKMKRNKTITQQVPKQ	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	98.49	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_28517_5 # 3460 # 3699 # -1 # ID=15650_5;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.362	k141_28517_5 	3460	3699	-	Strict	350	22.7126	SatA	100.0	3005045	protein homolog model	n/a	n/a	nucleoside antibiotic	antibiotic inactivation	streptothricin acetyltransferase (SAT)	TGCCACAAAAAAGGATATGGAAGAGCTTTGATAGAGTTTATTGCGGCAAAATACAGAGAACAATATTGTATTTTGCAGGTAGGAACAGGGGATTCTCCCCTGACCATTCCTTTTTATGAAAAATGCGGGTTTGTCCGTTCGCATTCTGTGAAAAACTTTTTTACAGATAATTATGACCACCCTATTTATGAAGGCGGCGTACAGTTAAAAGATATGATTTATCTGAGAAAACAACTGTAA	CHKKGYGRALIEFIAAKYREQYCILQVGTGDSPLTIPFYEKCGFVRSHSVKNFFTDNYDHPIYEGGVQLKDMIYLRKQL	MSLLIRELETNDLDNFPEIDDSFIVNARLMLSLSKVNRRIEYTVEDVPSYEKSYLQNDNEELVYNEYINKPNQIIYIALLHNQIIGFIVLKKNWNNYAYIEDITVDKKYRTLGVGKRLIAQAKQWAKEGNMPGIMLETQNNNVAACKFYEKCGFVIGGFDFLVYKGLNMTSDEVAIYWYLHFDS	42.93	gnl|BL_ORD_ID|2833|hsp_num:0	3788	True	loose hit with at least 95 percent identity pushed strict
k141_38175_1 # 1 # 99 # -1 # ID=21059_1;partial=10;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.313	k141_38175_1 	1	99	-	Strict	900	19.2458	AAC(6')-Ie-APH(2'')-Ia	100.0	3002597	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2''); AAC(6')	ATGATATTACAAAGACTAATTTTGTACCCTAAAACGGATGAGATAGATTCTCTGCTTTATACATCAAATGGAAACATAGAAAAGGCAGAAAATCAAATG	MILQRLILYPKTDEIDSLLYTSNGNIEKAENQM	MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFRVIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLIFEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYDDNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKEKAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKRDIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNATTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTNFGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYKD	6.89	gnl|BL_ORD_ID|1714|hsp_num:0	1814	True	loose hit with at least 95 percent identity pushed strict
k141_40586_17 # 24658 # 27783 # -1 # ID=22410_17;partial=00;start_type=ATG;rbs_motif=AAA;rbs_spacer=11bp;gc_cont=0.499	k141_40586_17	24658	27783	-	Strict	750	782.711	adeF	43.06	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGTAAAGTAGATTTCTTTATAGACCGCCCGGTGTTTTCTGCGGTGGTGAGTATCGTGATTGTGCTGGTGGGTCTTATCGGACTGACTTTGTTGCCGGTGGACCAGTATCCGCAGATTACACCTCCGGTGGTGAAAGTGAGTGCCTCATATCCTGGTGCCGGTGCACTCACAGTGGCACAAGCTGTTGCTACGCCTATCGAACAAGAATTAAACGGAACTCCAGGTATGCTTTATATGGAGAGCAGCAGCTCCAATTCGGGAGGCTTCTCGGCCACAGTGACTTTTGATGTGGCGGCTGATGCCGATTTGGCTGCCGTAGAAATCCAGAATCGCGTGAAGCTGGCAGAAAGCCGACTGCCGGCAGAGGTGGTTCAAAATGGTATTTCGGTGGAAAAACAGGCGCCCAGCCAGCTGATGACTATCTGCCTGACATCCAATGACCCGAAGTTTGACGAGATTTATCTGAGTAACTTTGCCACGCTCAACGTGCAGGATGTGTTGCGCCGTATTCCGGGAGTGGGACGTGTAGGTAATGTAGGTGGACGTTATTATGCCATGCAAATTTGGCTTCAGCCAGACAAGATGGCTCATTACGGATTGACCGTGAAGGATTTGCAGACTGCTTTGAAGGACCAAAACAGCGAGGCGGCAGCCGGTGTGTTGGGACAGCAGCCGATGAACGGCCCCGATATCACGATTCCGATTTCTACCCGTGGGCGCTTGTCGTCGGCCGAACAGTTTGAGGAAGTGGTGGTGCGCGCCAATCCGGATGGTTCTATCATCCGTTTGCGTGATGTGGCTCGCATCAGTCTGGAAGCATCTTCGTATAGTACTGAGAGTGGTATCAACGGAGGTAATGCCGCCGTGCTGACCATTTATATGTTGCCCGGTGCCAATGCCATGGAAGTGGCCGACCGTGTGAAGGAAGCCATGAAGCAACTTAGTGAAAATTTCCCGGAGGGACTTTCGTATGAGGTGACTTTCGATATGACCGAATATATCTCTTCTTCGATTCACGAAGTGTATAAAACACTGTTCGAAGCATTGGTTCTGGTTATCTTGGTAGTATTCCTTTCTTTGCAAAACTGGCGCGCTACGCTTATTCCGGTGGTGGCTGTGCCCATCTCGCTGATTGGTACATTTGGTTTGATGCTTATTTTTGGCTTTTCTCTGAATATGCTGACACTGCTTGGCTTGGTTTTGGCTATCGGTATTGTGGTGGACGATGCCATTGTGGTGGTGGAAAATGTGGAACGTATCATGCATGAGGAACACCTGCCGGCCTATGAGGCTACGAAAAAGGCAATGGACGGACTCGTTGGTGCATTGATAGCCACTTCGCTGGTGCTGGTTGCCGTTTTTGTTCCCGTAAGTTTCCTGAGTGGCATTACGGGTATGTTGTACCGTCAGTTTACCGTAACCATTGCCGTGTCGGTGATTATCTCTACGGTGGTGGCGTTGACTCTGAGCCCGGTGATGTGTTCGCTTATCCTGAAACCCAGTGTACCGGATCATAAAAAGAATATAGTATTCCGTAAGATTAATCATTGGTTGGGATTGGGAAACAGACAGTATGTGCGTGGCATCCGGGGATTCGTTGGCAATCCGCGTAGAGTCATGTCGGCCTTTGGCGTATCGTTGGTAGTGATTCTGCTTTTGCACCGCATTGTGCCTACGAGTTTCTTGCCTGTAGAAGACCAAGGCTATTTCAAAGTCGAGCTGGAATTGCCGGAGGGTGCTACATTGCCTCGTACCAGAACGGTGACCGACCGGGCCATTGCCTTCGTTAAACGCTTGCCGGCAGTGGACTATGTACAGAATGTGACGGGTAGCAGTCCGCGTGTAGGTACGAGTCAGGCACGCAGTGAACTGACTGTGATTTTGAAACCTTGGGATGAGCGCGGCGGAGTAACGATTGAAGAAGTGATGGCAGAAGTACGCAAGGAACTGGAAACTTATCCGGAATGCAAGGTTTATCTGTCCACACCTCCGGTAATTCCGGGACTCGGTTCATCCGGTGGTTTTGAGTTGCAGTTGGAAGCAAGAGGAGAGGCTTCTTTCCAAAACCTGGTGGATGCGGTAGACACGCTGATGTTTTATGCATCTAAGCGCAAGGAGCTGACCGGACTGTCATCGTCTTTGCAGGCTGAGATACCGCAACTGTATTTCGATGTAGACCGCGACAAGGTGAAATTTTCGGGAGTACCTCTGGCTGATGTATTCTCTACGATGAAAGCGTATACCGGTTCGCTCTACGTGAACGACTTCAATATGTTCAACCGTGTATATAAGGTATATTTGCAGGCCGAAGCGCCTTATCGTGCCAACAAAGAAAATATCAACCTGTTCTTTGTACGCGGTGAGGACGGACAGATGATTCCGCTGACTTCGTTTGGTGAGGCTTCTTTCACCACAGGACCGGGTAGTGTAAAGCGTTTCAACATGTTTACCTCGTCGGTTGTTCGCGGTGAGGCAGCAAAAGGCTATTCTACCGGTCAAGCCATGGCGGCTTTAGAAGAGATAGCCCAAAAACATCTTCCACAGAATATTGCCGTAGAGTGGAGCGGTTTGTCTTATCAGGAAAAACAAGCCGGCGGACAGACTGGACTGGTTATGGCACTGGTGTTTGTGTTTGTCTTTCTTTTCCTGGCAGCCTTGTACGAAAGTTGGCTCATTCCGGCAGCTGTGTTGCTCTCATTGCCTGTGGCTGCCTTAGGAGCTTATCTGGGTGTTTGGGCCTGCGGTTTGGAAAATGACGTATATTTTCAGATCGGTTTGGTGATGCTGATGGGTTTGGCTGCCAAGAATGCCATTCTTATTGTGGAGTTTGCCAAAGAACAGATGGATGCAGGTCACGGACTTATCGAAGCAACTCTGCACGCTGCACAGTTGCGCTTCCGCCCGATTCTGATGACATCCTTGGCGTTTATCCTCGGTATGGTGCCTATGGTTTTGGCTACAGGACCGGGATCTGCCAGCCGAAGAGCTATCGGAACAGGTGTGTTCTTTGGAATGGTGGTGGCCGTGATTATCGGAATCCTGCTGGTTCCCTTCTTCTTTGTATATATCAACAAAGCGAAGAATAAGCTGGTGGCTAAATGGACCTCAAGACGGACTAACTAA	MSKVDFFIDRPVFSAVVSIVIVLVGLIGLTLLPVDQYPQITPPVVKVSASYPGAGALTVAQAVATPIEQELNGTPGMLYMESSSSNSGGFSATVTFDVAADADLAAVEIQNRVKLAESRLPAEVVQNGISVEKQAPSQLMTICLTSNDPKFDEIYLSNFATLNVQDVLRRIPGVGRVGNVGGRYYAMQIWLQPDKMAHYGLTVKDLQTALKDQNSEAAAGVLGQQPMNGPDITIPISTRGRLSSAEQFEEVVVRANPDGSIIRLRDVARISLEASSYSTESGINGGNAAVLTIYMLPGANAMEVADRVKEAMKQLSENFPEGLSYEVTFDMTEYISSSIHEVYKTLFEALVLVILVVFLSLQNWRATLIPVVAVPISLIGTFGLMLIFGFSLNMLTLLGLVLAIGIVVDDAIVVVENVERIMHEEHLPAYEATKKAMDGLVGALIATSLVLVAVFVPVSFLSGITGMLYRQFTVTIAVSVIISTVVALTLSPVMCSLILKPSVPDHKKNIVFRKINHWLGLGNRQYVRGIRGFVGNPRRVMSAFGVSLVVILLLHRIVPTSFLPVEDQGYFKVELELPEGATLPRTRTVTDRAIAFVKRLPAVDYVQNVTGSSPRVGTSQARSELTVILKPWDERGGVTIEEVMAEVRKELETYPECKVYLSTPPVIPGLGSSGGFELQLEARGEASFQNLVDAVDTLMFYASKRKELTGLSSSLQAEIPQLYFDVDRDKVKFSGVPLADVFSTMKAYTGSLYVNDFNMFNRVYKVYLQAEAPYRANKENINLFFVRGEDGQMIPLTSFGEASFTTGPGSVKRFNMFTSSVVRGEAAKGYSTGQAMAALEEIAQKHLPQNIAVEWSGLSYQEKQAGGQTGLVMALVFVFVFLFLAALYESWLIPAAVLLSLPVAALGAYLGVWACGLENDVYFQIGLVMLMGLAAKNAILIVEFAKEQMDAGHGLIEATLHAAQLRFRPILMTSLAFILGMVPMVLATGPGSASRRAIGTGVFFGMVVAVIIGILLVPFFFVYINKAKNKLVAKWTSRRTN	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	98.30	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_41751_1 # 2 # 142 # -1 # ID=23051_1;partial=10;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.426	k141_41751_1 	2	142	-	Strict	960	21.1718	cmeC	100.0	3000785	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; fusidic acid	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACAAGATATGAATCAGCAAAAGAAATTTATGCAAAATTAGGTGTGGATACAGATGCTGCAATTGAAACCTGTATGCAGGTTCCGGTCTCTCTTCACTGCTGGCAGGGGGATGATGTGATTGGGTTTGACCATGATGGT	MTRYESAKEIYAKLGVDTDAAIETCMQVPVSLHCWQGDDVIGFDHDG	MNKIISISAIASFTLLISACSLSPNLNIPEANYSIDNKLGALSWEKENNSSITKNWWKDFDDENLNKVVDLALKNNNDLKLAFIHMEQAAAQLGIDFSSLLPKFDGSASGSRAKTAINAPSNRTGEVSYGNDFKMGLNLSYEIDLWGKYRDTYRASKSSFKASEYDYEAARLSVISNTVQTYFNLVNAYENENALKEAYESAKEIYRINDEKFQVGAVGEYELAQARANLESMALQYNEAKLNKENYLKALKILTSNDLNDILYKNQSYQVFNLKEFDIPTGISSTILLQRPDIGSSLEKLTQQNYLVGVARTAFLPSLSLTGLLGFESGDLDTLVKGGSKTWNIGGNFTLPIFHWGEIYQNVNLAKLNKDEAFVNYQNTLITAFGEIRYALVARKTIRLQYDNAQASEQSYKRIYEIAKERYDIGEMSLQDYLEARQNWLNAAVAFNNTKYSYANSIIDVIKAFGGGFEQSEDTSKNIKEESKNLDMSFRE	9.55	gnl|BL_ORD_ID|752|hsp_num:0	798	True	loose hit with at least 95 percent identity pushed strict
k141_42932_31 # 38039 # 41167 # -1 # ID=23711_31;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=14bp;gc_cont=0.456	k141_42932_31	38039	41167	-	Strict	750	768.844	adeF	42.35	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAGTAACCTTCTTTATTGATCGTCCGGTATTCTCTATTGTAATATCGATTTTAATTGTACTGGTGGGGGTCATCGGACTTACGATGTTGCCCGTTGACCAATATCCTCAGATTACACCTCCCGTGGTGCGTATCAGTGCTTCCTATCCGGGTGCCAGTGCCATGACTGTGTCGCAGGCTGTGGCTACTCCGATTGAACAAGAGTTGAATGGTACACCGGGTATGCTTTATATGGAGTCTAACAGTTCAAACTCTGGAGGCTTTTCAGCAGTGGTGACATTCGATGTGTCTGCCGATCCGGATTTGGCTGCGGTGGAAATACAGAATCGTGTGAAATTGGCTGAAAGCCGTTTGCCGGCTGAAGTGATTCAGAATGGTATCAGTGTGGAAAAACAGGCGGCCAGTCAGTTGATGACCATCTGTTTGACATCCAGCGATCCGAAGTTTGATGAAATTTATTTGAGTAACTTTGCTACGATTAATGTACTTGACTTGCTTCGTCGTATTCCTGGTGTGGGACGTGTTTCTAATATCGGTAGCCGTTATTATGCCATGCAGATTTGGGCTATGCCTGACCGCTTGGCGAATTTTGGACTGACGGTAGCGGATTTGCAGAATGCACTGAAGGATCAGAACCGTGAATCGGCAGCGGGTGTATTGGGGCAGCAACCAGTAACCGGGTTGGATATTACCATTCCTATTACAACACAGGGGCGCTTGAGTACAGCTAAGCAGTTTGAAGATATTGTGGTGCGTGCCAATGCTGACGGATCTATTATCCGACTCCGTGATGTGGCTCGTGTATCGCTCGAAGCTTCTTCTTATAGTACAGAAAGTGGCATTAATGGTGAAAATGCGGCTGTGCTCGGTATTTTTATGTTGCCGGGTGCGAATGCCATGGATGTGGCTAAGGAAGTTAAAAAAGCCATGCAGGAAATCAGTGCGAATTTTCCGGAAGGTATGAGCTATGAAATACCTTTTGATATGACTACTTATATCTCGGAGTCTATTAATGAGGTATACAAAACGTTATTTGAAGCTTTGGTGCTGGTGGTTTTGGTGGTATATCTTTCTTTGCAAAGCTGGCGGGCTACCATTATTCCGGTAGTGGCTGTACCTATCTCGCTGATTGGTACGTTCGGATTCATGCTGATCTTTGGTTTTTCGCTGAATATGCTGACTTTGCTGGGGTTGGTACTGGCTATCGGTATTGTGGTGGATGATGCGATTGTGGTGGTGGAAAATGTGGAACATTTGATGGAAACGGAGAAACTTTCTCCTTATGAAGCTACTAAGAAAGCTATGACAGGACTGACAAGTGCCGTGATTGCTACTTCATTAGTACTCTGTGCCGTGTTTGTGCCAGTTAGTTTTTTGAGTGGTATTACCGGTCAGCTGTATCGTCAGTTCACGATTACCATTGCGGTGTCTGTGCTTCTTTCTACTGTGGTAGCTCTGACGTTGAGTCCGGTGATGTGTTCGCTGATTCTTCGTCCGGATAGTGGTAAACAGAAGAATATTGTTTTCCGTAAGATCAACGAGTGGCTGGCTATCGGAAATAATAAATATGTGGGTGTAATAACGCGTGTCATCAAGCACCCTCGCCGGCTGATGAGTGCATTTGGTATGGTATTGATATCTATCTTCCTGATTCATAATTTGATTCCGACCAGTTTCTTGCCGGAAGAAGACCAAGGTTTCTTTACTGTAGAATTGGAGTTGCCCGAAGGTGCTACGTTGGAACGTACACGCGAAGTAACGGAGCGTGCGGTTGCTTTCCTGAAACAAGATCCGAATGTGGCGTATGTGCAGAACGTAACGGGTAGTAGTCCGCGTGTAGGTACCAATCAGGGCCGAAGCCAGCTTACGGTGATTCTGAAACCCTGGGAAGAAAGAGAAGGCATGGATATCAAGACTGTGATGGATAAGGTGGAACGTGAATTTACTGAATATCCTGAATGTAAGGTATATCTTAGTACGCCGCCGGTAATTCCGGGTCTGGGTACGTCGGGCGGTTTTGAAATGCAACTGGAAGCCCGTGGAGATGCCTCTTTTGAAAGTCTGGTGAATGCGGCTGATACGTTATTGCATTATGCCAGCCAGCGTAAGGAATTGACAGGTTTATCCTCTTCTTTGCAAGCTGAAATTCCACAGCTCTATTTTGATGTGGATCGTGATAAGGTGAAAATGCTGGGAGTGCCTTTGGCCGACGTATTTTCTACGATGAAAGCGTATACGGGTTCTGTATATGTCAATGACTTTAATATGTTTAACCGTATTTACCGTGTATATATACAGGCAGAAGCTCCCTATCGTGAGCATAAAGACAATATAAACTTGTTCTTTGTGCGGGCTGCCAACAATGCCATGGTGCCGTTGACTTCATTGGGTAATGCCTCTTATACTACTGGACCGGGTAGCATGAAGCGATTTAACATGTTTACCACGGCGGTTATCCGAGGAGCTGCAGCACAGGGCTGTAGTTCGGGACAGGCTATGGAAATTATGGAGCAAATAGCCCGTGAAAAACTACCCGAAAATATTGGAGTAGAGTGGAGTGGTCTTTCTTATCAGGAAAAGAAAGCTGGCGGACAAACGGGCATGGTGCTTTCGTTGGTATTCCTGTTTGTGTTCCTCTTCTTGGCGGCTCAATATGAAAGTTGGACAGTGCCTATCGCCGTACTGCTTTCCTTGCCGGTGGCTGCACTCGGAGCTTATCTAGGGGTAGCTGTCTGCGGATTGGAAAATGATGTTTACTTCCAGATTGGTCTGGTTATGCTGGTGGGATTGGCTGCCAAGAATGCAATCTTAATTGTGGAGTTTGCCAAAGAACAGGTGGATAAAGGGGAAGATTTGATTGAATCGGCTATTTATGCAGCGAAACTCCGTTTTCGTCCTATTCTGATGACTTCATTGGCCTTTGTGTTGGGTATGCTTCCTATGGTGCTGGCTAGCGGACCGGGTTCTGCCAGCCGTCAGGCAATCGGTACTGGGGTATTCTTCGGAATGATTTTTGCAATTGTATTTGGTATTGTGCTAGTGCCTTTCTTCTTCGTGATGATTTATAAGACCAAATCGAAGGTTAAGAATAAAATATCAAAAAAGCCGACTGTGGTGAGTGAATAA	MKVTFFIDRPVFSIVISILIVLVGVIGLTMLPVDQYPQITPPVVRISASYPGASAMTVSQAVATPIEQELNGTPGMLYMESNSSNSGGFSAVVTFDVSADPDLAAVEIQNRVKLAESRLPAEVIQNGISVEKQAASQLMTICLTSSDPKFDEIYLSNFATINVLDLLRRIPGVGRVSNIGSRYYAMQIWAMPDRLANFGLTVADLQNALKDQNRESAAGVLGQQPVTGLDITIPITTQGRLSTAKQFEDIVVRANADGSIIRLRDVARVSLEASSYSTESGINGENAAVLGIFMLPGANAMDVAKEVKKAMQEISANFPEGMSYEIPFDMTTYISESINEVYKTLFEALVLVVLVVYLSLQSWRATIIPVVAVPISLIGTFGFMLIFGFSLNMLTLLGLVLAIGIVVDDAIVVVENVEHLMETEKLSPYEATKKAMTGLTSAVIATSLVLCAVFVPVSFLSGITGQLYRQFTITIAVSVLLSTVVALTLSPVMCSLILRPDSGKQKNIVFRKINEWLAIGNNKYVGVITRVIKHPRRLMSAFGMVLISIFLIHNLIPTSFLPEEDQGFFTVELELPEGATLERTREVTERAVAFLKQDPNVAYVQNVTGSSPRVGTNQGRSQLTVILKPWEEREGMDIKTVMDKVEREFTEYPECKVYLSTPPVIPGLGTSGGFEMQLEARGDASFESLVNAADTLLHYASQRKELTGLSSSLQAEIPQLYFDVDRDKVKMLGVPLADVFSTMKAYTGSVYVNDFNMFNRIYRVYIQAEAPYREHKDNINLFFVRAANNAMVPLTSLGNASYTTGPGSMKRFNMFTTAVIRGAAAQGCSSGQAMEIMEQIAREKLPENIGVEWSGLSYQEKKAGGQTGMVLSLVFLFVFLFLAAQYESWTVPIAVLLSLPVAALGAYLGVAVCGLENDVYFQIGLVMLVGLAAKNAILIVEFAKEQVDKGEDLIESAIYAAKLRFRPILMTSLAFVLGMLPMVLASGPGSASRQAIGTGVFFGMIFAIVFGIVLVPFFFVMIYKTKSKVKNKISKKPTVVSE	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	98.39	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_45327_3 # 923 # 1024 # 1 # ID=25065_3;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.520	k141_45327_3 	923	1024	+	Strict	700	19.2458	vanSN	100.0	3002940	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGAAAGACCGCATTGAGACCCTGATCCGAGTGCAGGCGGAATGGATATCCGAAGACGAAAAGAGCCGGCCTATCGGCTATCTGAATGAGACGGAGGAAAAG	MKDRIETLIRVQAEWISEDEKSRPIGYLNETEEK	MKNKLNDPLIKRILLRYVSTVLLAIGIYGGVLLLLLFLFRLRTWYGDEPFYLFLRTLYIRFNLIGLVSSGAFLLLLMITLVYIFKLIGYLNETITATKQLLEAPEQRIQLSTELFTVQEEMNQIRENNNQANRAAKVAEQRKNDLIVYLAHDLRTSLTSVIGYLTLLKEEPQISTELRAKYTDIALDKALRLEELIGEFFEVTQFNLTKLTINKEIVDLSIMLEQISYEFLPILNEKGLKWQLAIDKGIKAEVDPNKMGRVFDNLIRNAINYSFSNSTIHLSLEKNGQNLELKITNETHTLPEEKLTQIFEPFYRVDTSRSSSTGGTGLGLSIVKDIVEASGGRIHAQSSNNQMTFTLTLPISE	9.34	gnl|BL_ORD_ID|975|hsp_num:0	1033	True	loose hit with at least 95 percent identity pushed strict
k141_45961_26 # 33009 # 36137 # 1 # ID=25411_26;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=14bp;gc_cont=0.456	k141_45961_26	33009	36137	+	Strict	750	776.163	adeF	42.63	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAGTTACATTTTTTATAGACCGGCCCGTATTCTCGATGGTGCTTTCCATCTTGATTGTATTAGTGGGGGTTATAGGCCTCACCATGTTGCCGGTAGATCAATATCCGCAAATTACGCCTCCGGTGGTGCGCATCGGGGCCTCGTATCCGGGAGCTAGTGCGTTGACTGTGTCGCAGGCAGTGGCTACACCGATTGAACAAGAATTGAACGGTACTCCGGGAATGCTCTATATGGAATCCAACAGTTCCAACTCTGGAGGCTTTTCAGCTACTGTTACTTTTGATGTGTCAGCAGATGCCGACTTGGCAGCAGTAGAAATCCAGAATCGTGTGAAATTAGCTGAAAGCCGTTTGCCGGCAGAAGTAATCCAAAACGGTATTACTGTAGAAAAGCAGGCTCCTAGTCAGTTAATGACGCTCTGTCTTACATCCAGTGACCCTAAATTTGATGAAATCTATTTAAGTAACTTTGCTACGATTAATGTGCTCGACCTTTTGCGTCGTATACCTGGTGTGGGTAGGGTATCGAACATCGGTAGCCGATATTACGCCATGCAGATTTGGGCTATGCCCGACCGATTGGCCAATTTCGGGTTGACGGTGGCCGACCTGCAGAATGCGCTCAAGGACCAAAACCGAGAGTCGGCAGCCGGTGTATTGGGGCAGCAACCTGTAACAGGATTGGATATTACCATACCTATTACTACGCAGGGACGTTTAAGTACAGCCAAGCAGTTTGAAGATATCGTGGTGCGTGCCAATGCTGACGGATCGATTATCCGTCTGCGCGATGTGGCCCGGGTTTCTTTGGAGGCTTCGTCTTATAGTACAGAGAGTGGTATCAATGGTGAAAATGCTGCAGTGTTAGGTATTTATATGTTGCCGGGTGCCAATGCCATGGATGTGGCCAAAGAAGTGAAAAAGGCTATGCAGGAAATCAGTGCCAACTTCCCGGAGGGTATGAGCTACGAGATACCTTTTGATATGACTACATACATTTCTGAATCCATTAATGAAGTGTATAAGACGCTGTTCGAAGCATTGATATTGGTGGTTCTGGTTGTGTATTTGTCGTTGCAGAGTTGGCGGGCTACCGTCATTCCTGTAGTGGCAGTGCCTATCTCATTGATAGGAACATTCGGTTTTATGTTGATTTTCGGCTTTTCACTCAATATGCTTACGTTGCTGGGCTTGGTATTGGCCATCGGTATTGTGGTGGATGATGCCATTGTGGTGGTTGAAAATGTGGAGCATTTGATGGAAACAGAACATCTGTCTCCATACGAGGCTACCAAGAAGGCGATGACTGGATTGACGAGTGCTGTTATTGCCACTTCATTGGTGCTTTGTGCCGTGTTTGTTCCGGTAAGCTTTTTGAGCGGTATTACTGGTCAGTTGTACCGTCAGTTTACAATTACGATTGCTGTATCCGTGTTGCTTTCTACGGTAGTGGCTCTCACGTTGAGTCCTGTAATGTGTTCGCTTATTTTGCGGCCTGATAGTGGCAAGCAGAAAAATATTGTATTCCGTAAGATTAACGAGTGGCTAGCTATCGGTAATAATAAATATGTAAGTGTTATAACCCGGGTTATCAAACATCCGCGCCGTTTGATGAGTGCCTTTGGCATGGTGCTGATTGCTATTTTCCTGGTTCATAACTTGATTCCTACAAGTTTCCTTCCAGAGGAAGACCAGGGGTATTTTACCGTAGAATTGGAATTGCCCGAAGGGGCTACGCTGGAGCGTACACGGGCTGTAACCGATCGTGCCGTGGCATTCCTGGAGAAAAATCCCAATGTGGCGTATGTGCAAAACGTTACAGGTAGCAGTCCGCGTGTAGGTACCAACCAGGCTCGAAGCCAGTTGACTGTGATTTTAAAATCTTGGGAAGAACGTAAAGGAACGGATATCCATACGATTATGGATGATGTGAAGCAGGAATTTACAGAATATCCCGAATGCAAGGTGTACCTCAGTACACCCCCGGTGATTCCCGGATTGGGTACCTCTGGAGGTTTTGAAATGCAACTTGAAGCGCGTGGAGAAGCAACATTTGAGAATCTGGTAGATGCTGTGGATACGTTGATGTATTATGCCGAGCAATACAAGGAACTGACAGGACTTTCGTCTTCGTTGCAGGCAGAAATACCGCAATTGTATTTTGATGTTGACCGTGATAAAGTGAAAATGCTGGGTGTACCTTTGGCAGATGTATTCTCTACAATGAAGGCTTATACAGGTTCGGTTTACGTGAACGACTTCAATATGTTCAACCGTATCTATCGTGTATATATTCAGGCCGAGGCTCCGTATCGTGAACATAAGGATAATATTAATTTGTTCTTTGTACGTGCATCGAACAATGCTATGGTGCCGCTGACATCTTTGGGCAATGCATCGTATACCACAGGACCTGGTAGCATCAAGCGTTTCAATATGTTCACCACAGCCGTGATCCGCGGTTCGGCGGCACAGGGATGCAGTTCCGGACAAGCAATGAATATTATGGAACAGATAGCGCGTGAAAAATTACCCGAAAATATCGGCGTAGAGTGGAGTGGACTTTCTTATCAGGAAAAAAAGGCCGGAGGACAGACTGGTATGGTTTTATCATTGGTATTCCTCTTTGTGTTTCTTTTTCTGGCTGCTCAGTATGAAAGTTGGACGGTTCCTATTGCTGTGTTGCTTTCGCTGCCTATCGCTGCCTTAGGTGCCTATTTGGGAGTGGCTGTATGTGGCTTGGAAAACGATGTGTATTTCCAGATTGGTTTGGTAATGTTGGTGGGTCTTGCAGCAAAGAATGCTATTCTTATCGTGGAATTTGCTAAAGATCAGGTAGATAAGGGGGAAGATTTGGTTGAATCTGCTATTTATGCGGCTAAACTTCGTTTCCGTCCTATCTTGATGACATCCTTGGCCTTTGTGTTGGGTATGTTGCCTATGGTATTGGCTAGTGGTCCTGGCTCGGCTAGCCGGCAAGCTATTGGTACAGGTGTGTTCTTCGGGATGATTTTTGCTATTGTATTTGGTATTGTGCTGGTGCCTTTCTTCTTCGTAATGATTTATAAGACTAAATCGAAGGTGAAAAGCAAAATCTCGAAAAAGCCTGTTGCGGTGAGTGAATAA	MKVTFFIDRPVFSMVLSILIVLVGVIGLTMLPVDQYPQITPPVVRIGASYPGASALTVSQAVATPIEQELNGTPGMLYMESNSSNSGGFSATVTFDVSADADLAAVEIQNRVKLAESRLPAEVIQNGITVEKQAPSQLMTLCLTSSDPKFDEIYLSNFATINVLDLLRRIPGVGRVSNIGSRYYAMQIWAMPDRLANFGLTVADLQNALKDQNRESAAGVLGQQPVTGLDITIPITTQGRLSTAKQFEDIVVRANADGSIIRLRDVARVSLEASSYSTESGINGENAAVLGIYMLPGANAMDVAKEVKKAMQEISANFPEGMSYEIPFDMTTYISESINEVYKTLFEALILVVLVVYLSLQSWRATVIPVVAVPISLIGTFGFMLIFGFSLNMLTLLGLVLAIGIVVDDAIVVVENVEHLMETEHLSPYEATKKAMTGLTSAVIATSLVLCAVFVPVSFLSGITGQLYRQFTITIAVSVLLSTVVALTLSPVMCSLILRPDSGKQKNIVFRKINEWLAIGNNKYVSVITRVIKHPRRLMSAFGMVLIAIFLVHNLIPTSFLPEEDQGYFTVELELPEGATLERTRAVTDRAVAFLEKNPNVAYVQNVTGSSPRVGTNQARSQLTVILKSWEERKGTDIHTIMDDVKQEFTEYPECKVYLSTPPVIPGLGTSGGFEMQLEARGEATFENLVDAVDTLMYYAEQYKELTGLSSSLQAEIPQLYFDVDRDKVKMLGVPLADVFSTMKAYTGSVYVNDFNMFNRIYRVYIQAEAPYREHKDNINLFFVRASNNAMVPLTSLGNASYTTGPGSIKRFNMFTTAVIRGSAAQGCSSGQAMNIMEQIAREKLPENIGVEWSGLSYQEKKAGGQTGMVLSLVFLFVFLFLAAQYESWTVPIAVLLSLPIAALGAYLGVAVCGLENDVYFQIGLVMLVGLAAKNAILIVEFAKDQVDKGEDLVESAIYAAKLRFRPILMTSLAFVLGMLPMVLASGPGSASRQAIGTGVFFGMIFAIVFGIVLVPFFFVMIYKTKSKVKSKISKKPVAVSE	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	98.39	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_46381_3 # 1769 # 1924 # -1 # ID=25633_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.250	k141_46381_3 	1769	1924	-	Strict	350	21.557	SatA	100.0	3005045	protein homolog model	n/a	n/a	nucleoside antibiotic	antibiotic inactivation	streptothricin acetyltransferase (SAT)	GACAGCCCCCTTACAATTCCTTTTTATGAAAAATGCGGATTTAAAAAATCTCATATTGTAAAAAATTTTTTTATTGATAACTATAAAAATCCAATTTATGAAGAGGGAGTTCTGTTGATTGATATGATTTATCTGCAGAAAAATTTAAAAAAATAA	DSPLTIPFYEKCGFKKSHIVKNFFIDNYKNPIYEEGVLLIDMIYLQKNLKK	MSLLIRELETNDLDNFPEIDDSFIVNARLMLSLSKVNRRIEYTVEDVPSYEKSYLQNDNEELVYNEYINKPNQIIYIALLHNQIIGFIVLKKNWNNYAYIEDITVDKKYRTLGVGKRLIAQAKQWAKEGNMPGIMLETQNNNVAACKFYEKCGFVIGGFDFLVYKGLNMTSDEVAIYWYLHFDS	27.72	gnl|BL_ORD_ID|2833|hsp_num:0	3788	True	loose hit with at least 95 percent identity pushed strict
k141_48470_3 # 2025 # 2561 # -1 # ID=26762_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.399	k141_48470_3	2025	2561	-	Perfect	275	368.622	AAC(6')-Im	100.0	3004629	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGTTGGAAAAAAAGCGAGTTTCCTTTCGCCCGATGAATGAGGATGATTTAGTTCTAATGCTAAAATGGCTGACAGATGACCGTGTTCTTGAATTCTACGACGGTAGAGATAAAAAACATACACAGAAAACGATTCGTGAGCATTATACAGAGCAATGGGCGGATGAGATTTATCGAGTCATCATTGAATATGATACAATTCCTATCGGTTACGCACAAATATATAGAATTCAGGGGGAACTTTTCGACGAATATAATTACCATGAGACGGAAGAAAAGATTTATGCGATGGACCAATTTATCGGTGAGCCGGAATATTGGAATATGGGAATCGGTGCAGAATATTGCAGAGTAGTATGCCAATATCTACGAACGGAAATGGATGCCGATGCGGTGATTCTTGACCCACGAAAAAATAATCTACGAGCAGTACGAGCATATCAGAAGGCAGGATTTAAAATTATTAAGGAACTTCCCGAACATGAGCTACACGAGGGGAAAAAGGAAGATTGTGTGCTGATGGAATGGAGAGTGTAA	MLEKKRVSFRPMNEDDLVLMLKWLTDDRVLEFYDGRDKKHTQKTIREHYTEQWADEIYRVIIEYDTIPIGYAQIYRIQGELFDEYNYHETEEKIYAMDQFIGEPEYWNMGIGAEYCRVVCQYLRTEMDADAVILDPRKNNLRAVRAYQKAGFKIIKELPEHELHEGKKEDCVLMEWRV	MLEKKRVSFRPMNEDDLVLMLKWLTDDRVLEFYDGRDKKHTQKTIREHYTEQWADEIYRVIIEYDTIPIGYAQIYRIQGELFDEYNYHETEEKIYAMDQFIGEPEYWNMGIGAEYCRVVCQYLRTEMDADAVILDPRKNNLRAVRAYQKAGFKIIKELPEHELHEGKKEDCVLMEWRV	100.00	gnl|BL_ORD_ID|2168|hsp_num:0	3328		
k141_48470_4 # 2605 # 3504 # -1 # ID=26762_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.326	k141_48470_4	2605	3504	-	Strict	550	604.749	APH(2'')-IIa	99.0	3002635	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2'')	ATGGTTAACTTGGACGCTGAGATATATGAGCACTTAAATAAACAGATAAAAATAAATGAACTCCGTTATTTATCGTCCGGCGATGATAGTGATACTTTTTTGTGTAATGAACAATATGTTGTGAAAGTTCCTAAACGAGATTCTGTTAGAATTTCTCAGAAACGAGAGTTTGAATTGTATCGTTTTTTAGAAAACTGTAAGCTATCTTATCAAATCCCTGCGGTAGTGTATCAAAGTGACCGATTTAATATTATGAAATATATTAAAGGGGAACGTATTACTTATGAGCAGTATCATAAGTTGAGTGAAAAGGAAAAGGATGCCCTTGCATATGATGAAGCGACGTTTTTGAAAGAGTTACATTCCATAGAGATTGATTGTTCTGTCAGTTTGTTTTCAGATGCTCTGGTGAATAAGAAAGATAAGTTTTTGCAAGATAAAAAATTACTTATAAGTATTCTGGAAAAGGAGCAGCTGTTAACTGATGAGATGTTGGAACATATCGAAACAATATATGAAAACATATTAAACAATGCTGTTTTATTTAAATATACCCCTTGTTTGGTACATAATGATTTCAGTGCAAATAACATGATTTTTAGAAATAATAGACTGTTTGGAGTTATTGATTTTGGCGATTTTAATGTAGGTGACCCGGATAATGATTTTTTGTGCTTGCTGGATTGTAGTACAGATGATTTCGGGAAAGAATTTGGCAGGAAGGTATTAAAATACTATCAGCATAAGGCGCCGGAAGTAGCAGAAAGAAAAGCAGAGCTTAATGATGTATATTGGTCGATAGACCAAATTATTTATGGTTATGAAAGAAAAGATAGGGAAATGTTGATTAAGGGTGTTTCTGAATTGCTACAAACACAAGCAGAGATGTTTATATTTTAG	MVNLDAEIYEHLNKQIKINELRYLSSGDDSDTFLCNEQYVVKVPKRDSVRISQKREFELYRFLENCKLSYQIPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKELHSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENILNNAVLFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGRKVLKYYQHKAPEVAERKAELNDVYWSIDQIIYGYERKDREMLIKGVSELLQTQAEMFIF	MVNLDAEIYEHLNKQIKINELRYLSSGDDSDTFLCNEQYVVKVPKRDSVRISQKRELELYRFLENCKLSYQIPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKELHSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENILSNAVLFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGRKVLKYYQHKAPEVAERKAELNDVYWSIDQIIYGYERKDREMLIKDVSELLQTQAEMFIF	100.00	gnl|BL_ORD_ID|1516|hsp_num:0	1615		
k141_48833_3 # 2009 # 2080 # 1 # ID=26974_3;partial=01;start_type=ATG;rbs_motif=TAAAA;rbs_spacer=12bp;gc_cont=0.444	k141_48833_3 	2009	2080	+	Strict	2130	21.557	mtrD	100.0	3000811	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCAAACAAGAAGTTTAACAGTTGGATCAAGAATATATGCATGGGATGGGGCTTCATCATGGCCGGCAGT	MANKKFNSWIKNICMGWGFIMAGS	MAKFFIDRPIFAWVISIFIIAAGIFGIKSLPVSQYPSVAAPTITLRATYPGASAQVMEDSVLSVIERNMNGVEGLDYMSTSADSSGSGSVSLTFTPDTDENLAQVEVQNKLSEVLSTLPATVQQYGVTVSKARSNFLMIVMLSSDVQSTEEMNDYAQRNIVPELQRIEGVGQVRLFGAQRAMRIWVDPKKLQNYNLSFADVGSALSAQNVQISAGSIGSLPAVRGQTVTATVTAQGQLGTAEEFGNVILRANTDGSNVYLKDVARVGLGMEDYSSSTRLNGVNTTGMAVMLSNSGNAMATAKAVKERMATLEKYFPQGMSWKTPYDTSKFVEISIEKVIHTLIEAMVLVFVVMYLFLQNIRYTLIPTIVVPISLLGGFAFISYMGMSINVLTMFAMVLVIGIVVDDAIVVVENVERIMAGEGLPPKEATKKAMGQISGAVIGITAVLISVFVPLAMFSGATGNIYKQFALTMASSIAFSAFLALTLTPALCATMLKTIPKGHHEEKKGFFGWFNKKFNSWTHGYEGRVAKVLRKTFRMMVVYIGLAVVGVFLFMRLPTSFLPTEDQGFVMVSVQLPAGATQERTNATLAQVTQLAKSIPEIENIITVSGFSFSGSGQNMAMGFAILKDWNERTAPGSDAVAIAGKLTGMMMGTLKDGFGIAVVPPPILELGNGSGLSINLQDRNNTGHTALLAKRNELIQKMRASGLFDPSTVRAGGLEDSPQLKIDINRAAAAAQGISFADIRTALASALSSSYVSDFPNQGRLQRVMVQADEDARMQPADILNLTVPNKSGVAVPLSTIATVSWENGTEQSVRFNGYPSMKLSASPATGVSTGQAMAAVQKMVDELGGGYSLEWGGQSREEAKGGSQTLILYGLAVAAVFLVLAALYESWSIPLAVILVIPLGLIGAAAGVTGRNLFEGLLGSVPSFANDIYFQVGFVTVMGLSAKNAILIIEFAKDLQAQGKSAVEAALEAARLRFRPIIMTSFAFILGVVPLYIAGGASSASQRAIGTTVFWGMLIGTLLSVFLVPLFYVVVRKFFKETAHEHEMAVKHAAEAGITGSDDSQH	2.25	gnl|BL_ORD_ID|1829|hsp_num:0	1938	True	loose hit with at least 95 percent identity pushed strict
k141_50512_5 # 3906 # 3980 # 1 # ID=27884_5;partial=01;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.440	k141_50512_5 	3906	3980	+	Strict	450	19.631	tet(45)	100.0	3003196	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGATATTATTCTGGTTATGCTGGCGGGAATGGTCGCAGGCCACTTTTTCTTCCCAAAAGCCTTAAAAAAGGTC	MDIILVMLAGMVAGHFFFPKALKKV	MNTPHSHSNLRHNQILLWLCVLSFFSVLNEMVLNVSLPDIASDFNKEPASINWVNSSFILTFSIGTAVYGKLSDQLGIKKLLLFGIIVNCFGSVIGFVGHFFFPVLILARFIQGVGAAAFPALVMVVIARYIPKENRGKAFGIIGSIVTMGEGVGPSVGGVIAEYAHWSYILLLPVVTIITVPFLAKLLKQEEVIKGSFDTKGIIFMSVGIVFFIMFTTCYRVSFLVVSIICFLIFVKNIRKVSNPFINPSLGKNVSFMIGIICGGLIFGTVAGFISMVPYMMKDVYQLSTAAIGSGIIFPGAMSVIVFGYIGGLLVDKKGSLFVLTTGVAFLSISFLVAALFIETTPWLITIILIFVFGGLSFTKTVISTIVSSSLEQKEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIHLLNRKLLPINAEPSTHLYSNLLLLFAGITIISWLVTIKMHKRSRGNI	5.46	gnl|BL_ORD_ID|151|hsp_num:0	17	True	loose hit with at least 95 percent identity pushed strict
k141_50729_7 # 5269 # 5343 # 1 # ID=27996_7;partial=01;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.440	k141_50729_7 	5269	5343	+	Strict	450	19.631	tet(45)	100.0	3003196	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGATATTATTCTGGTTATGCTGGCGGGAATGGTCGCAGGCCACTTTTTCTTCCCAAAAGCCTTAAAAAAGGTC	MDIILVMLAGMVAGHFFFPKALKKV	MNTPHSHSNLRHNQILLWLCVLSFFSVLNEMVLNVSLPDIASDFNKEPASINWVNSSFILTFSIGTAVYGKLSDQLGIKKLLLFGIIVNCFGSVIGFVGHFFFPVLILARFIQGVGAAAFPALVMVVIARYIPKENRGKAFGIIGSIVTMGEGVGPSVGGVIAEYAHWSYILLLPVVTIITVPFLAKLLKQEEVIKGSFDTKGIIFMSVGIVFFIMFTTCYRVSFLVVSIICFLIFVKNIRKVSNPFINPSLGKNVSFMIGIICGGLIFGTVAGFISMVPYMMKDVYQLSTAAIGSGIIFPGAMSVIVFGYIGGLLVDKKGSLFVLTTGVAFLSISFLVAALFIETTPWLITIILIFVFGGLSFTKTVISTIVSSSLEQKEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIHLLNRKLLPINAEPSTHLYSNLLLLFAGITIISWLVTIKMHKRSRGNI	5.46	gnl|BL_ORD_ID|151|hsp_num:0	17	True	loose hit with at least 95 percent identity pushed strict
k141_52339_1 # 1 # 159 # 1 # ID=28896_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.258	k141_52339_1 	1	159	+	Strict	500	20.4014	mphE	100.0	3003741	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATTTTAAAAGATAACCCTGTTTTAATTCAAACAAAAGCAGGAAAAAATAAAAATGTATTCCTTATTGATTCAACTAAAACTTTGAGAGGATCTCCAAGAATATTTCAAGCTTTAGAGGAGTTGTATATTCAATTAGACAGTGTAAACAAAGAAAAATAA	ILKDNPVLIQTKAGKNKNVFLIDSTKTLRGSPRIFQALEELYIQLDSVNKEK	MTIQDIQSLAEAHGLLLTDKMNFNEMGIDFKVVFALDTKGQQWLLRIPRRDGMREQIKKEKRILELVKKHLSVEVPDWRISSTELVAYPILKDNPVLNLDAETYEIIWNMDKDSPKYITSLAKTLFEIHSIPEKEVRENDLKIMKPSDLRPEIANNLQLVKSEIGISEQLETRYRKWLDNDVLWADFTQFIHGDLYAGHVLASKDGAVSGVIDWSTAHIDDPAIDFAGHVTLFGEESLKTLIIEYEKLGGKVWNKLYEQTLERAAASPLMYGLFALETQNESLIVGAKAQLGVI	17.69	gnl|BL_ORD_ID|2750|hsp_num:0	2614	True	loose hit with at least 95 percent identity pushed strict
k141_52490_1 # 247 # 360 # 1 # ID=28996_1;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=11bp;gc_cont=0.368	k141_52490_1 	247	360	+	Strict	230	20.4014	ramA	100.0	3000823	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	ATGAAAGCAATGACTTTAAAAAGCACTATCTTTGCCATAAAAACAGTAAAAAGATATGCTAATGAAACGTGTTGTTATCATTTCAACCAGCCTCCGGGTACGGTCGAACAGTGA	MKAMTLKSTIFAIKTVKRYANETCCYHFNQPPGTVEQ	MINQEAEGESSMTISAQIIDTIVEWIDDNLHQPLRIEEIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLLLAARDLRESDARVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENHSRAH	29.84	gnl|BL_ORD_ID|1571|hsp_num:0	1665	True	loose hit with at least 95 percent identity pushed strict
k141_52714_4 # 1673 # 2899 # 1 # ID=29108_4;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.297	k141_52714_4 	1673	2899	+	Strict	800	797.349	tetA(P)	97.79	3000180	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGTTAATAAACTTTCAGCATATAAAACTTATTTATTATTTTCAGCTATTACAGCAATGTGTTTTTCGTTAGTAGCTACAGTTATGATAGTGTATCACATTGAAATAGTTCATTTAAATCCACTTCAGCTTATACTTGTTGGAACTACTTTGGAATTAGCATGCTTTATATTTGAAATTCCTACAGGTATAGTTGCAGATGTGTATAGTCGTAAACTATCTATTGTTATTGGGGGAGTTTTAACAGGAGTGGGATTTATTTTAGAAGGTTCTATTTCTAGTTTTGTTTTCGTACTTGTAGCACAGATTGTATGGGGATTAGGGTCTACTTTTATCAGTGGCTCGCTTGAAGCTTGGATTGCGGAAGAAGAGAAGAATAAAGATTTAGATGAAATTTATATAAAGGGAGCACAAGCAGGGCAGATAGGAGCATTTATTGGAATAGTACTAAGCACTGTAATAGCTAATTTCTCTGTAAGGCTTCCTATTATAGTTAGTGGAGTTTTATTTATAATTCTTGCATTATTTTTATGGTTATATATGCCAGAAAATAATTTTAAACCATCTGCTCCTGGGGATTTAAATACATTCAAAAAGATGGTATATACATTTAAATCTGGTCTTAAATTTGTAAAAAGTAAATCTATAATTATGATTTTACTTGCAGTAACTTTATTTTATGGATTATCAAGTGAAGGTTATGATAGACTTTCTAATGCGCATTTTTTACAAGATACTACACTTCCTAAACTTGGAAACCTTAGTTCAGTGACTTGGTTTGGAATTTTTGGAATTTTAGGAATGATATTGAGCTTCATAGTAATGCATTTTATGGCAAAGAATCTTAAGAATGAGGATAATAGGAAAAATGGAAAACTATTATTATGCATAAATATACTTTATATATCGTCTATGTTGATATTTGCTCTTACAAGAAACTTTAGTTTAATGTTAATAGCTTATTTGGCAACAAATACCTTTAGAATTATAAATGAACCTATATTCAGTGCGTGGTTAAATGGGCATATAGATGATAATTCTAGAGCTACTGTGCTTTCTATAAATGGACAAATGAATTCCTTAGGTCAAATTTTAGGTGGACCGATTATAGGAATCATAGCTACAAATATTTCAGTAAGTATTGGTATAGTATGTACTTCATTATTAGTAGCACCAGTATTAGTGTTATATATTATTTCTATGATAATGGATAAAAAAATATCATGA	MVNKLSAYKTYLLFSAITAMCFSLVATVMIVYHIEIVHLNPLQLILVGTTLELACFIFEIPTGIVADVYSRKLSIVIGGVLTGVGFILEGSISSFVFVLVAQIVWGLGSTFISGSLEAWIAEEEKNKDLDEIYIKGAQAGQIGAFIGIVLSTVIANFSVRLPIIVSGVLFIILALFLWLYMPENNFKPSAPGDLNTFKKMVYTFKSGLKFVKSKSIIMILLAVTLFYGLSSEGYDRLSNAHFLQDTTLPKLGNLSSVTWFGIFGILGMILSFIVMHFMAKNLKNEDNRKNGKLLLCINILYISSMLIFALTRNFSLMLIAYLATNTFRIINEPIFSAWLNGHIDDNSRATVLSINGQMNSLGQILGGPIIGIIATNISVSIGIVCTSLLVAPVLVLYIISMIMDKKIS	MVNKLSAYKTYLLFSAITAMCFSLVATVMMVYHIEIVHLNPLQLILVGTTLELACFIFEIPTAIVADVYSRKLSIVIGGVLTGVGFILEGSISSFVFVLVAQIVWGLGSTFISGSLEAWIAEEEKNKDLDEIYIKGAQAGQIGAFIGIVLSTVIANFSVRLPIIVSGVLFIILALFLWLYMPENNFKPSAPGDLNTFKKMVYTFKSGLKFVKSKSIIMILLAVTLFYGLSSEGYDRLSNAHFLQDTTLPKLGNLSSVTWFGIFGILGMILSFIVMHFMAKNLKNEDNRKNGKLLLCINILYISSMLIFALTRNFSLMLIAYLATNTFRIINKPIFSAWLNGHIDDNSRATVLSINGQMNSLGQILGGPIIGIIATNISVSIGIVCTSLLVTPVLVLYIVAMIIDKKVDDRVGGIDYEENN	97.14	gnl|BL_ORD_ID|477|hsp_num:0	508	True	loose hit with at least 95 percent identity pushed strict
k141_53950_1 # 2 # 238 # -1 # ID=29777_1;partial=10;start_type=ATG;rbs_motif=TAA;rbs_spacer=11bp;gc_cont=0.371	k141_53950_1 	2	238	-	Strict	500	21.557	chrB	100.0	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGTCAGTATCTCTTGAATTATTAACCGATGATGCTATCATCGATTATACTAAAAGTGATGGAAAGGATCAAGTCTTATATAATCATAGAGACTTAGATTTGAAGTATAATACATTACAGCCTGTTGCAGGGGGAGTATATGATGTCGATATTTTCGGATCCCCAATGGAAGACAGATGTATTTGTGGAAAAATTCGACAGCCTTCTTCGGAACCTTGCCCTCATTGTGGAGCTAGA	MSVSLELLTDDAIIDYTKSDGKDQVLYNHRDLDLKYNTLQPVAGGVYDVDIFGSPMEDRCICGKIRQPSSEPCPHCGAR	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	28.21	gnl|BL_ORD_ID|284|hsp_num:0	305	True	loose hit with at least 95 percent identity pushed strict
k141_54128_10 # 12527 # 15631 # -1 # ID=29875_10;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=11bp;gc_cont=0.472	k141_54128_10	12527	15631	-	Strict	750	762.296	adeF	41.74	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAGTCAGCTTTTTTATTGACAGGCCCGTATTCTCGGCTGTCATCTCTATATTAATCGTGATTGTAGGTATCATCGGTTTGATGATGCTGCCTATCGACCAATACCCGCAAATTACTCCGCCTGTGGTAAAAATCAGTGCCTCCTATCCGGGAGCCAGTGCCGTAACGGTATCGCAGGCTGTAGCTACTCCTATCGAACAGGAATTGAACGGAACACCGGGTATGCTTTACATGGAATCCAGCAGTTCCAACTCAGGAGGATTCTCTGCCACTGTTACTTTCGATATTTCTGCCGACCCCGACTTAGCGGCGGTAGAAATCCAGAACCGTATCAAACTGGCGGAATCTCGTCTGCCGGCGGAAGTGATTCAGAATGGTATCTCCGTAGAAAAACAGGCACCCAGTCAGCTGATGACGCTGTGTTTGACTTCGGACGACCCCAAATTCGACGAAATTTATTTAAGTAACTTTGCCACATTAAACGTACAGGACTTGCTTCGCCGTATCCCGGGAGTAGGACGTATCTCCAACATCGGAAGCCGTTACTACGCCATGCAGATATGGGCCGACCCAGCTAAACTGGCTAACTTCGGATTGACGGTACAAGACCTTCAGAACGCATTGAAAGACCAGAACCGTGAATCAGCTGCCGGTGTACTCGGACAGCAACCTGTAAGCGGAGTAGATATTACCGTACCTATCACTGCACAGGGGCGTTTGTCATCGGCCTCTCAGTTTGAGGAAATTGTATTGCGCGCTAACCCCGACGGTTCACTTGTACGTCTGCGCGATGTGGCAAGAGTATCACTGGAAGCTTCTTCCTATAGCACAGAAAGTGGTATCAACGGAGGAAATGCAGCCATTCTTGGAATCTACATGCTTCCTGGAGCCAACGCCATGGAAGTGGCACAGAACGTCAAAGAGGCCATGAAGGAAATCAGCAAAAGTTTCCCGGAAGGTATGGAATACAACTTCCCGTTCGATATGACCACTTATATCTCGCAATCTATTCATGAGGTATACAAGACTTTGTTTGAAGCATTGGTGCTGGTAATCATCGTGGTATTCCTTTCACTGCAGAGCTGGCGTGCTACACTGATTCCGGTCGTAGCAGTTCCTATCTCTTTGATTGGTACCTTCGGATTCATGCTGATATTCGGCTTCTCACTGAACATGCTGACCTTGTTAGGACTGGTACTGGCCATTGGTATTGTAGTGGACGACGCCATCGTAGTAGTGGAAAATGTGGAACGCATTATGGAAGAAGAGAAACTCAGTCCATACGAAGCCACCAAGAAAGCCATGGAAGGTCTGGTAGGCGCTATTATTGCTACCTCACTCGTATTGGCAGCGGTATTTGTTCCTGTAAGTTTCTTGTCAGGTATCACCGGACAGCTTTATCGCCAGTTTACTATTACCATCGTAGTATCTGTGCTTCTGTCTACGGTTGTAGCGCTGACCTTGAGTCCGGTAATGTGTTCACTCATCCTGAAACCAGTAGATCCGAATAAACCCAAGAACAAGGTGTTCAGACTAATTAATGAATGGTTGGCTATCGGAAACAATAAATACATTATTTATATCAAGCATGTTGTCAAACACCCGCGCCGTATAATGGCAGGCTTTGGAATGGTATTGGTTTTCATCTATGTATTCCATCGCCTTGTTCCGACCAGCTTCCTTCCGATAGAAGACCAGGGATATTTCACCGTGGAACTGGAACTTCCGGAAACAGCCACTTTGGAAAGAACACGTATCATAACTGACAGAGCTATTGACTTCATCATGAAAGACCCGGCAGTGGAATACGTACAGAATGTAACAGGTAGCAGTCCGCGTGTAGGTACCAGCCAGGCCAGAAGCCAGTTGACCGTCATCCTGAAAGAATGGAAGGAACGTGACAACACGACCATTAACGAAGTAATGGACCGCATACAGAAAGAGCTGGAAAAATACCCGGAAAGTAAAGTGTATCTTTCTACTCCTCCGGTAATTCCCGGACTTGGTACTGCCGGTGGTTTTGAAATGCAGCTGGAAGCCCGTGGCGATGCAACGTATGACGATTTGGTAAGAGCTACGGATACGCTGATGTATTACGCTTCACAACGGAAAGAAATTGCAGGATTGTCTTCATCACTTCAGGCAGAAATTCCTCAGTTGTATTTCGATGTAGACCGTGATAAGGTTAAGTTAGCAGGTGTTCCGATGGCAGATGTATTCTCTACCATGAAAGCTTACACCGGCTCTGTTTACGTGAATGACTTTAACATGTTCAACCGTATCTACCGTGTATACATTCAGGCAGAAGCTCCGTATCGTCAGCAACGCGACAATATCGGTCTGTTCTTTGTAAGAGGATCTGATGGTGACATGATTCCGCTGACAGCCCTTGGAACTACTGATTATACAACCGGACCGGGAAGTATCAGACGCTTTAACATGTTTAATACAGCCGTTATCCGAGGAACCACAGCCAATGGAGCAAGTTCCGGTCAGGTAATGGAAACGCTGGAACAGATTGCACGCGAAAAATTACCCGACAATATCGGTGTTGAATGGAGCGGTCTGTCCTATCAGGAAAAGAAAGCCGGCGGACAAACCGGACTCATCCTGGCGCTGGTATTCCTGTTCGTCTTCCTGTTCCTGGCAGCCCTTTATGAAAGCTGGACAGTGCCTATCGCCGTATTGATTTCACTTCCGGTAGCCGTTTTAGGAGCGTATGCGGGTATTACCCTCTGCGGTTTGGAAAATGATACCTATTTTCAGATTGGTCTGGTAATGCTTATCGGTCTTGCCGCGAAGAACGCCATTTTGATTGTGGAATTCGCCAAAGACGAAGTCGATAAAGGACGTGATATCGTAGAATCTGCTCTTCATGCAGCCAGCCTGCGTTTCCGCCCCATCTTGATGACCTCACTGGCCTTCATCCTGGGTATGCTTCCAATGGTGATTGCCTCAGGTCCGGGGTCAGCCAGCCGACAAGCCATCGGTACCGGTGTATTCTTCGGAATGATAGTAGCTGTTACCGTAGGTATCTTGCTCGTGCCGTTCTTCTTTGTAATGATTTACAAAGCTACCCACAAAATTAAAGCGAAACAGTAA	MKVSFFIDRPVFSAVISILIVIVGIIGLMMLPIDQYPQITPPVVKISASYPGASAVTVSQAVATPIEQELNGTPGMLYMESSSSNSGGFSATVTFDISADPDLAAVEIQNRIKLAESRLPAEVIQNGISVEKQAPSQLMTLCLTSDDPKFDEIYLSNFATLNVQDLLRRIPGVGRISNIGSRYYAMQIWADPAKLANFGLTVQDLQNALKDQNRESAAGVLGQQPVSGVDITVPITAQGRLSSASQFEEIVLRANPDGSLVRLRDVARVSLEASSYSTESGINGGNAAILGIYMLPGANAMEVAQNVKEAMKEISKSFPEGMEYNFPFDMTTYISQSIHEVYKTLFEALVLVIIVVFLSLQSWRATLIPVVAVPISLIGTFGFMLIFGFSLNMLTLLGLVLAIGIVVDDAIVVVENVERIMEEEKLSPYEATKKAMEGLVGAIIATSLVLAAVFVPVSFLSGITGQLYRQFTITIVVSVLLSTVVALTLSPVMCSLILKPVDPNKPKNKVFRLINEWLAIGNNKYIIYIKHVVKHPRRIMAGFGMVLVFIYVFHRLVPTSFLPIEDQGYFTVELELPETATLERTRIITDRAIDFIMKDPAVEYVQNVTGSSPRVGTSQARSQLTVILKEWKERDNTTINEVMDRIQKELEKYPESKVYLSTPPVIPGLGTAGGFEMQLEARGDATYDDLVRATDTLMYYASQRKEIAGLSSSLQAEIPQLYFDVDRDKVKLAGVPMADVFSTMKAYTGSVYVNDFNMFNRIYRVYIQAEAPYRQQRDNIGLFFVRGSDGDMIPLTALGTTDYTTGPGSIRRFNMFNTAVIRGTTANGASSGQVMETLEQIAREKLPDNIGVEWSGLSYQEKKAGGQTGLILALVFLFVFLFLAALYESWTVPIAVLISLPVAVLGAYAGITLCGLENDTYFQIGLVMLIGLAAKNAILIVEFAKDEVDKGRDIVESALHAASLRFRPILMTSLAFILGMLPMVIASGPGSASRQAIGTGVFFGMIVAVTVGILLVPFFFVMIYKATHKIKAKQ	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	97.64	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_55378_2 # 856 # 939 # 1 # ID=30553_2;partial=01;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.286	k141_55378_2 	856	939	+	Strict	400	20.7866	vatF	100.0	3003744	protein homolog model	n/a	n/a	streptogramin antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	ATGTATAAAGGAGATACACACGTTCACAGCTGTTTTTCAATGGATTCAAATGAAGAATTAGAAAAAATATTTGAAAGAGCAATA	MYKGDTHVHSCFSMDSNEELEKIFERAI	MEDKPILGPDPQCKHPMVGFSQVCFIKNTTQNPNIIIGDYTYYDDPQDSENFERNVLYHYPFIGDKLIIGKFCALAHGVKFIMNGANHKMSGLSTYPFNIFGNGWERVAPSRDELPYKGDTHVGNDVWIGYDVLIMPGVTIGNGAIISSRSVVTRDVPAYSVVGGNPATLIKNRFSAEVIGKLQTIAWWDWPIDAISRNLHLIVAGDIEALARAASEIDHT	12.67	gnl|BL_ORD_ID|2099|hsp_num:0	2260	True	loose hit with at least 95 percent identity pushed strict
k141_56296_1 # 1 # 462 # -1 # ID=31074_1;partial=10;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.340	k141_56296_1	1	462	-	Strict	300	312.383	lnuC	98.05	3002837	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	ATGGTCAATATAACAGATGTAAAACAGATTCTTCAATTTGCAATAGATGCGGAGATTAAAGTCTTTCTTGATGGTGGCTGGGGTGTAGATGCTCTTCTTGGATATCAGTCAAGAGCCCATAATGATATTGACATTTTTGTAGAAAAGAACGATTATCAGAACTTTATAGAAATAATGAAAGCTAATGGCTTTTATGAGATTAAGATGGAATATACAACATTGAACCATACTGTATGGGAAGATTTGAAAAACAGAATTATTGATTTGCATTGTTTTGAATATACGGACGAAGGTGAAATTCTTTATGATGGGGATTGTTTTCCGGTAGAAACTTTTTCGGGTAAAGGAAGAATTGAGGAAATAGAGGTTTCCTGTATTGAACCATATAGTCAAGTAATGTTCCATCTGGGATACGAGTTTGATGAAAATGATGCACATGATGTGAAGTTATTGTGTGAGACA	MVNITDVKQILQFAIDAEIKVFLDGGWGVDALLGYQSRAHNDIDIFVEKNDYQNFIEIMKANGFYEIKMEYTTLNHTVWEDLKNRIIDLHCFEYTDEGEILYDGDCFPVETFSGKGRIEEIEVSCIEPYSQVMFHLGYEFDENDAHDVKLLCET	MVNITDVNQIFQFAIDAEIKVFLDGGWGVDALLGYQSRAHNDIDIFVEKNDYQNFIEIMKANGFYEIKMEYTTLNHTVWEDLKNRIIDLHCFEYTDEGEILYDGDCFPVETLSGKGRIEEIEVSCIEPYSQVMFHLGYEFDENDAHDVKLLCETLHIEIPNEYR	93.90	gnl|BL_ORD_ID|350|hsp_num:0	376		
k141_59080_1 # 2 # 109 # 1 # ID=32562_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.343	k141_59080_1 	2	109	+	Strict	300	20.0162	AAC(3)-IXa	100.0	3002543	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	CAAGATTATGCTCAAAAAGTTGCTGCTTATGAAAAAGTTTATGGTAAAAAACTAAATTATGACTTCCTAGATTGGGATATTGCAGGTTGGCGAGGTCATCTTTCGTAA	QDYAQKVAAYEKVYGKKLNYDFLDWDIAGWRGHLS	MEEMSLLNHSGGPVTRSRIKHDLADLGLKDGDVVIFHTRMSAIGYVAGGTQTIIGALLDVVGARGTLMVPCGWNNAPPYDFLDWPRDWQDALRAEHPAYDPDLSEADYNNGRLPEALPRWPGAIRSRHPDASFAALGPAAAELMAEHPWDHPHGPDTPLARLIAHSGRVLLLGAPLDTMTLLHHAEALADVRSKRFVTYEQPILVNGQRVWRQFRDIDSEEGAFDYSTVRRGVEPFEAIARDMLSAGIGRQGRVGAADSYLFDAGPVFNFAINWIEAKLKR	12.46	gnl|BL_ORD_ID|1915|hsp_num:0	2030	True	loose hit with at least 95 percent identity pushed strict
k141_63203_1 # 39 # 1958 # -1 # ID=34861_1;partial=00;start_type=ATG;rbs_motif=AAAA;rbs_spacer=4bp;gc_cont=0.404	k141_63203_1	39	1958	-	Strict	1200	1312.36	tetO	99.37	3000190	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAAAATAATTAACTTAGGCATTCTGGCTCACGTTGACGCAGGAAAGACAACATTAACGGAAAGTTTATTGTATACCAGTGGTGCAATTGCAGAACTAGGGAGCGTAGATGAAGGCACAACAAGGACAGATACAATGAATTTGGAGCGTCAAAGGGGAATCACTATCCAGACAGCAGTGACATCTTTTCAGTGGGAGGATGTAAAAGTCAACATTATAGATACGCCAGGCCATATGGATTTTTTGGCGGAAGTATACCGTTCTTTATCCGTATTAGACGGAGCAGTATTATTAGTTTCTGCAAAGGATGGCATACAGGCACAGACCCGTATACTGTTTCATGCACTACAGATAATGAAGATTCCGACAATTTTTTTCATCAATAAAATTGACCAAGAGGGGATTGATTTGCCAATGGTATATCGGGAAATGAAAGCAAAGCTTTCTTCGGAAATTATAGTGAAGCAAAAGGTTGGGCAGCATCCCCATATAAATGTAACGGACAATGACGATATGGAACAGTGGGATGCGGTAATTATGGGAAACGATGAACTATTAGAGAAATATATGTCAGGGAAACCGTTTAAAATGTCAGAACTGGAACAGGAAGAAAACAGGAGATTCCAAAACGGAACGTTATTTCCCGTTTATCACGGAAGCGCTAAAAACAATCTGGGGATTCGGCAGCTTATAGAAGTAATTGCCAGTAAATTTTATTCATCAACGCCTGAAGGTCAATCTGAACTATGCGGGCAGGTTTTTAAGATTGAATATTCAGAGAAAAGGCGGCGTTTTGTTTATGTGCGTATATATAGCGGAACATTGCATTTGAGGGATGTTATTAGAATATCTGAAAAAGAGAAAATAAAAATCACAGAGATGTGTGTTCCGACAAACGGTGAATTATATTCATCCGATACAGCCTGCTCTGGTGATATTGTAATTTTACCAAATGATGTTTTGCAGCTAAACAGTATTTTGGGGAACGAAATACTGTTGCCGCAGAGAAAATTTATTGAAAATCCTCTCCCTATGCTCCAAACAACGATTGCAGTAAAGAAATCTGAACAGCGGGAAATATTGCTTGGGGCACTTACAGAAATTTCAGATGGCGACCCTCTTTTAAAATATTATGTGGATACTACAACGCATGAGATTATACTTTCTTTTTTGGGGAATGTGCAGATGGAAGTCATTTGTGCCATCCTTGAGGAAAAATATCATGTGGAGGCAGAAATAAAAGAGCCTACTGTTATATATATGGAAAGACCGCTTAGAAAAGCAGAATATACCATCCACATAGAAGTCCCGCCAAATCCTTTCTGGGCTTCTGTCGGGTTGTCCATAGAGCCGCTCCCTATTGGAAGCGGAGTGCAGTATGAAAGCAGAGTTTCACTTGGATATTTAAATCAATCGTTCCAAAATGCGGTTATGGAGGGGGTTCTTTATGGCTGCGAGCAGGGGCTGTATGGATGGAAAGTGACAGACTGTAAAATCTGTTTTGAATATGGATTGTATTATAGTCCTGTAAGTACCCCCGCAGACTTTCGGCTGCTTTCCCCTATCGTATTGGAGCAGGCTTTAAAAAAAGCAGGGACAGAACTATTAGAGCCATATCTCCACTTTGAAATTTATGCACCGCAGGAATATCTCTCACGGGCGTATCATGATGCTCCAAGGTATTGTGCAGATATTGTAAGTACTCAGATAAAGAATGACGAGGTCATTCTGAAAGGAGAAATCCCTGCTAGATGTATTCAAGAATACAGGAACGATTTAACTTATTTCACAAATGGGCAGGGAGTCTGCTTGACAGAGTTAAAAGGATACCAGCCAGCTATTGGTAAATTTATTTGCCAACCCCGCCGCCCGAATAGCCGTATAGATAAGGTTCGGCATATGTTCCACAAGTTAGCTTAA	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMKIPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIMGNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNGELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAVKKSEQREILLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMKIPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIMGNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGTRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMYVPTNGELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMIQTTIAVKKSEQREILLGALTEISDCDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	100.00	gnl|BL_ORD_ID|1905|hsp_num:0	2020		
k141_63409_1 # 3 # 68 # -1 # ID=34969_1;partial=10;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.424	k141_63409_1 	3	68	-	Strict	400	18.0902	MUS-1	100.0	3000843	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MUS beta-lactamase	ATGGCATCACTGTGTGAACGCGGCGTTCATTCATTCAATAAAGAAGACCTTCTTGCCTGTTCAAGA	MASLCERGVHSFNKEDLLACSR	MHRILSVITMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSSNSMYVLTDEGVILIDTPWDKDQYEPLLEYIRSNHNKEVKWVITTHFHEDRSGGLGYFNSIGAQTYTYALTNEILKERNEPQAQHSFNKEKQFTFGNEKLAVYFLGEGHSLDNTVVWFPKEEVLYGGCLIKSAEATTIGNIADGNVIAWPKTIEAVKQKFKNAKVIIPGHDEWDMTGHIENTERILSAYNQQHSTKND	8.94	gnl|BL_ORD_ID|1460|hsp_num:0	1552	True	loose hit with at least 95 percent identity pushed strict
k141_65468_1 # 3 # 359 # 1 # ID=36125_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.524	k141_65468_1 	3	359	+	Strict	1300	245.358	tetW	98.31	3000194	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATTGTATTGGAACAGGCATTGAAGGAATCAGGGACGCAACTGCTGGAACCTTATCTCTCCTTCACCCTCTATGCGCCCCGGGAATATCTTTCCAGGGCTTATCATGATGCACCGAAATACTGTGCCACCATCGAAACGGCCCAGGTAAAAAAGGATGAAGTTGTCTTTACTGGCGAGATTCCCGCCCGCTGTATACAGGCATACCGTACTGATCTGGCCTTTTACACCAACGGGCGGAGCGTATGCCTTACAGAGCTGAAAGGATATCAGGCCGCTGTCGGTCAGCCGGTCATCCAGCCCCGCCGTCCAAACAGCCGCCTGGACAAGGTGCGCCATATGTTTCAGAAGGTAATGTAA	IVLEQALKESGTQLLEPYLSFTLYAPREYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM	18.47	gnl|BL_ORD_ID|362|hsp_num:0	389	True	loose hit with at least 95 percent identity pushed strict
k141_65659_5 # 3933 # 7040 # -1 # ID=36222_5;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=12bp;gc_cont=0.455	k141_65659_5	3933	7040	-	Strict	750	756.518	adeF	41.89	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAGTGAGTTTTTTTATTGACAGACCCGTCTTTTCGGCTGTCATCTCCATACTTATTGTCATAGTTGGTTTCATCGGTCTGATGATGCTTCCTATCGACCAATATCCGCAAATTACACCGCCGGTGGTGAAAATCAGCGCTTCTTATCCAGGAGCAAGTGCCGTAACAGTATCTCAAGCTGTAGCTACGCCCATTGAGCAGGAGTTGAACGGTACACCGGGAATGATCTACATGGAGTCTAACAGCTCCAACTCGGGTGGCTTTTCAGCAACTGTTACCTTTGATATTTCTGCCGATCCGGACTTGGCTGCAGTAGAGATTCAGAACCGTATCAAGCTAGCTGAGTCACGTTTGCCGGCCGAAGTAATCCAGAACGGTATTTCGGTAGAAAAGCAGGCACCCAGCCAGTTGATGACAATCTGTCTTACCTCGGATGACCCGAAGTTTGATGAAATTTATTTGAGTAACTTTGCTACCTTGAATGTACTGGATTTGCTTCGTCGTATTCCCGGAGTAGGTCGTATCTCCAATGTGGGAGGTCGTTATTATGCAATGCAAATTTGGGTTGACCCGGCTAAGCTGGCAAACTTTGGATTGACAATTCAGGATTTACAGTCGGCTTTAAAAGATCAGAACCGTGAATCTGCAGCCGGTGTTTTGGGACAGCAACCTGTTACCGGACTTGATATTACTATTCCTATCACGGCTCAGGGACGTCTTTCTACTGTTGCTCAGTTTGAAGAAATCGTACTTCGTGCTAACCCAGACGGTTCTATTATCCGTTTGCGTGATGTAGCCCGTGTGTCGCTCGAGGCATCATCCTATACGACTGAAAGTGGTATCAATGGAGGTAATGCTGCTGTGTTGGGTATCTACATGCTTCCAGGTGCCAATGCTATGGAAGTAGCCGATAATGTGAAAAAGGCGATGGAGGAAATCAGCCGGAATTTCCCGGAAGGTTTGGAGTACAACATACCCTTCGATATGACGACTTATATTTCCGAGTCTATTCACGAAGTATATAAGACATTGTTCGAAGCACTTGTACTGGTTATCATTGTGGTGTTCCTTTCTTTGCAAAACTGGCGTGCTACACTGATTCCGGTTGTGGCAGTACCTATTTCGTTGATTGGTACATTCGGCTTCATGCTGATTTTCGGCTTCTCACTGAATATGCTGACACTTTTGGGACTTGTACTGGCCATCGGTATCGTTGTGGACGATGCCATTGTGGTAGTCGAGAATGTAGAACGTATCATGGAAGAAGAAAAGCTCAGTCCGTATGAGGCGACCAAGAAAGCTATGGAAGGACTGGTTGGAGCTATCATTGCGACTTCGTTGGTACTGGCAGCTGTGTTCGTACCTGTAAGCTTTTTGGCTGGTATTACAGGACAGTTGTATCGTCAGTTTACGGTGACCATTGTTGTGTCTGTGTTGCTTTCAACAGTTGTAGCGCTTACATTGAGTCCGGTGATGTGTTCACTCATCTTGAAACCCGAAGACCCCAATAAACCAAAGAACAGAGTCTTTACGCGTATCAATCATTGGTTGAACGTGGGAAATGGCAAATATGTGCAGTCTATCCGTGGTGTTGTGAAAAACCCAAAACGTGTTATTGCCGGTTTTGGTATGGTGATTGTATTTATCTTTTTATTTCACCGTGTGGTTCCGACTAGTTTCCTTCCTATCGAAGACCAGGGATACTTTACTGTAGAATTGGAGTTACCCGAAAGTGCTACATTGGAACGTACACGTATTATAACCGATCGTGCTGTAGATTTTTTGGTAAAACACCCAGCAGTAGCATATGTACAGAATGTTACGGGTAGCAGTCCACGTGTGGGTAACAGCCAGGCACGAAGCCAGCTTACTGTAATTCTTAAAGAATGGACAGAACGTGACAATACAACAATCGACCGTATTATGGAAGAAGTACAGAATGAGATGAAAGAATATCCCGAATGTAAGGTCTTTCTGTCTACTCCGCCGGTAATTCCGGGATTAGGTACAGCCGGAGGTTTCGAGATGCAGCTTGAAGCCCGTGGTGAAGCCACATTCGACGATCTTGTACGTGCTACCGATACATTGATGTACTATGCTTCTCAGCGAAAAGAAATGGCTGGATTATCTTCTTCTTTGCAGGCTGAAATTCCGCAGCTCTATTTTGATGTAGACCGTGATAAGGTAAAACTGGCAGGTGTTCCGATGGCCGATGTCTTCTCAACCATGAAAGCTTATACCGGATCTGTTTACGTGAACGACTTCAACATGTTCAACCGTATCTACCGTGTATACATCCAGGCCGAAGCACCTTATCGTGAGCATCGTGACAATATCGGACTGTACTTTGTAAAAGGAAGCGACGGCGATATGATGCCGCTTACCGCCTTGGGTACTACTGACTATACCACCGGTCCGGGTAGTATTAAGCGCTTCAACATGTTTAACTCGGCTGTTATCCGTGGTACTGCAGCAAACGGTGCCAGCTCCGGCCAGGTAATGGAGATATTGGAACAGATTGCCCGTGAGAAACTGCCCGATAATATCGGTGTTGAATGGAGTGGTCTTTCTTATCAGGAGAAAAAGGCAGGAGGGCAGACTGGTATAATTCTCTCGCTGGTATTCCTCTTTGTATTCCTTTTCCTTGCCGCATTGTACGAAAGCTGGAGTATTCCTATTGCCGTATTGATTTCATTGCCGGTTGCCGTTTTGGGTGCGTATGCAGGTGTTGCCATCTGCGGATTGGAGAACGATACCTATTTCCAGATTGGTTTGGTAATGTTGATTGGTCTGGCTGCCAAGAATGCCATCCTTATTGTTGAGTTTGCCAAGGAAGAAGTTGATAAGGGACGCGACATCGTTGAGGCTGCTATCCATGCTTCCCAATTACGTTTCCGTCCTATTCTGATGACCTCATTGGCCTTCATCCTAGGTATGCTTCCTATGGTGATTGCTACCGGTCCGGGTTCAGCCAGCCGTCAGGCCATTGGTACAGGTGTTTTCTTCGGGATGTTGGTAGCTGTGACAATCGGAATTGTTTTGGTACCTTTCTTCTTTGTGTTGATTTATAAGGCTAAAAATAAGTTGAATACTAAACGTGCATAA	MKVSFFIDRPVFSAVISILIVIVGFIGLMMLPIDQYPQITPPVVKISASYPGASAVTVSQAVATPIEQELNGTPGMIYMESNSSNSGGFSATVTFDISADPDLAAVEIQNRIKLAESRLPAEVIQNGISVEKQAPSQLMTICLTSDDPKFDEIYLSNFATLNVLDLLRRIPGVGRISNVGGRYYAMQIWVDPAKLANFGLTIQDLQSALKDQNRESAAGVLGQQPVTGLDITIPITAQGRLSTVAQFEEIVLRANPDGSIIRLRDVARVSLEASSYTTESGINGGNAAVLGIYMLPGANAMEVADNVKKAMEEISRNFPEGLEYNIPFDMTTYISESIHEVYKTLFEALVLVIIVVFLSLQNWRATLIPVVAVPISLIGTFGFMLIFGFSLNMLTLLGLVLAIGIVVDDAIVVVENVERIMEEEKLSPYEATKKAMEGLVGAIIATSLVLAAVFVPVSFLAGITGQLYRQFTVTIVVSVLLSTVVALTLSPVMCSLILKPEDPNKPKNRVFTRINHWLNVGNGKYVQSIRGVVKNPKRVIAGFGMVIVFIFLFHRVVPTSFLPIEDQGYFTVELELPESATLERTRIITDRAVDFLVKHPAVAYVQNVTGSSPRVGNSQARSQLTVILKEWTERDNTTIDRIMEEVQNEMKEYPECKVFLSTPPVIPGLGTAGGFEMQLEARGEATFDDLVRATDTLMYYASQRKEMAGLSSSLQAEIPQLYFDVDRDKVKLAGVPMADVFSTMKAYTGSVYVNDFNMFNRIYRVYIQAEAPYREHRDNIGLYFVKGSDGDMMPLTALGTTDYTTGPGSIKRFNMFNSAVIRGTAANGASSGQVMEILEQIAREKLPDNIGVEWSGLSYQEKKAGGQTGIILSLVFLFVFLFLAALYESWSIPIAVLISLPVAVLGAYAGVAICGLENDTYFQIGLVMLIGLAAKNAILIVEFAKEEVDKGRDIVEAAIHASQLRFRPILMTSLAFILGMLPMVIATGPGSASRQAIGTGVFFGMLVAVTIGIVLVPFFFVLIYKAKNKLNTKRA	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	97.73	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_66233_8 # 8244 # 8360 # 1 # ID=36523_8;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.410	k141_66233_8 	8244	8360	+	Strict	400	20.0162	Erm(30)	100.0	3001265	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTTTCGGCCAATGCCACGTTACGGACAGCAGCTGGAGCTGAAAAAAGGCATCTGCACGCCGATACATACCATTGTGCAAATGCCTTTTTGTATTCTTATTACAGATATTTTTTAA	MFRPMPRYGQQLELKKGICTPIHTIVQMPFCILITDIF	MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR	11.31	gnl|BL_ORD_ID|1153|hsp_num:0	1224	True	loose hit with at least 95 percent identity pushed strict
k141_66951_3 # 1312 # 3270 # 1 # ID=36924_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318	k141_66951_3	1312	3270	+	Strict	1200	1298.88	tetB(P)	97.85	3000195	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAAGAAAATAATTAATATAGGAATCGTAGCACACGTGGATGCAGGAAAAACAACTATAACAGAAAACTTATTATATTATAGTGGAGCTATAAAATCAGTTGGAAGAGTTGATTTAGGCAATACACAGACGGATTCTATGGAGCTTGAGCGTAAGAGAGGGATTACCATTAAATCATCAACCATATCTTTTAATTGGAATAATGTCAAGGTTAATATTGTTGATACTCCAGGACATGTGGATTTTATTTCGGAAGTTGAACGTTCATTAAGTGTTTTAGATGGAGCGATACTAGTTATATCAGGAGTAGAGGGTATTCAGTCACAAACAAGAATATTATTTGAGACATTAAAGGAGTTAAACATTCCAACAATAATTTTTGTAAATAAGCTAGATAGAATTGGGGCAAATTTCAATAAAGTATTTGAAGATATAAAGAAGAATATGTCCAATAAAGTAGTTAGATTACAAGAAGTATATGATGTAGGAAGCAAAGCTGTTTATATAAAAAAACTATTTGATACATGCATGATAAATGATGATGCTATTGATGTTTTATCAGACTTAGACGAAGCATTTTTAGAAAGATATATTGGTGGAATAGAACCTGATAAAGAAGAAATACAAGAAAAGCTTTCATTATATGCAAGTGAAGGAAGTCTATATCCAGTATTTTGTGGTGCGGCAGCAATTGGACTTGGAGTTGAAGACTTATTAGATGGAATTTGTAGTTATTTTCCATTTGCAGGTGATGATTGTGAAAGTGATTTATCTGGAGTAGTATTTAAAATCGAAAGAACAAGTAAAAATGAAAAGAAGGTTTATGTAAGATTATTTGGAGGAAAAATATCTGTAAGAGATAAAATTCAAGTACCTAATAAGGAGATAGCAGAAAAAGTAAAGAAAATTAATAGGTTAGAAAATGGGGGAGTTGTTGAAGCACAGAGGATAGAAGCAGGGGATATAGGTATTTTATATGGACTTACAAGTTTCCAAGTGGGAGATGTTATTGGAATTTCAAATGATAAAATTAAAAATATATCTATAGCTAAACCAGCATTAAAAACAACAATTTCTGCAATTGATAAAGAAAAAAATCCAGAGCTATTTAAAGCATTAACATTACTTGCAGAGGAAGATCCACTACTAGAATTAGAGATGAATGACATAGATAAAGAAATTTATGTCAACTTATTCGGTGAAGTTCAAATGGAAATACTAAGTTCCATGTTAGATGATTTATATGGAATAAAAGTAGAGTTTTCGAATATTGAGACTATCTATAAGGAAACACCTAAAGGTTTTGGAGCGTCAATAATGCATATGCAGGAAGACTTAAATCCATTTTGGGCGACAGTAGGCTTAGAAATAGAACCAGCAGGGAGAGGCGAAGGTCTTAGGTATATTTCTAATGTTTCAGTAGGGTCATTGCCAAAATCTTTTCAAAATGCAATTGAAGAAGCAGTTATTAAGACAAGTAAACAAGGATTATTTGGATGGGAGGTTACAGATGTAAAAGTCACTCTTAGCTGTGGTGAATTTTTTAGTCCAGCCAGCACTCCAGCAGATTTTAGAAATGTGACACCTATGGTATTCATGGAAGCATTATATAAAGCACAAACTGTTTTATTAGAGCCATTACATGAGTTTGAGTTAAAGATTCCTCAAAATGCTTTAAGCAAAGCGGTATGGGATTTAGAAACTATGAGGGCAACCTTTGATAATCCTATTGTTATAGGGGATGAATTCTCAATAAAGGGATTAATTCCAGTAGAAAATTCAAAAGAATATAAAATGAAAATAGCTTCATATACAGAAGGTAGAGGAATGTTTGTGACAAAATTTTATGGGTATAAGGAAGCTTCAGCTGAATTTTCAAAAGCACGCAAAAAAACAACGTATGATCCATTGAATAAAAAAGAGTATTTGCTTCATAAACTAAACGCAATTAGAGATTAA	MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERKRGITIKSSTISFNWNNVKVNIVDTPGHVDFISEVERSLSVLDGAILVISGVEGIQSQTRILFETLKELNIPTIIFVNKLDRIGANFNKVFEDIKKNMSNKVVRLQEVYDVGSKAVYIKKLFDTCMINDDAIDVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYASEGSLYPVFCGAAAIGLGVEDLLDGICSYFPFAGDDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVPNKEIAEKVKKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKPALKTTISAIDKEKNPELFKALTLLAEEDPLLELEMNDIDKEIYVNLFGEVQMEILSSMLDDLYGIKVEFSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNVSVGSLPKSFQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVFMEALYKAQTVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVENSKEYKMKIASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD	MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERKRGITIKSSTISFNWNNVKVNIIDTPGHVDFISEVERSLNSLDGAILVISGVEGIQSQTRILFDTLKELNIPTIIFVNKLDRIGANFNKVFEEIKKNMSNKVVRLQEVYDVGSKAVYIKKLFDTCIINDDAINVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYAREGSLYPVFCGAAAIGLGIEDLLDGICSYFPFASNDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVPNKEIAEKVKKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKPALKTTISAIDKEKNPELFKALTLLAEEDPLLAFAMNDIDKEIYVNLFGEVQMEILSSMLDDLYGIKVEFSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNVSVGSLPKSFQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVFMEALYKAQTVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVENSKEYKMKIASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD	100.00	gnl|BL_ORD_ID|758|hsp_num:0	804		
k141_68315_2 # 406 # 507 # -1 # ID=37662_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.422	k141_68315_2 	406	507	-	Strict	500	20.4014	OXA-9	100.0	3001404	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	CCGAAAGCTGTCAGAGAGTGTTTAGAGTATATTTTGCCGGAGCTTATCCATGGAATTCAGATTATGACAGGAGAGACAGGAGAATGTGCGAGAACAAATTAA	PKAVRECLEYILPELIHGIQIMTGETGECARTN	MKKILLLHMLVFVSATLPISSVASDEVETLKCTIIADAITGNTLYETGECARRVSPCSSFKLPLAIMGFDSGILQSPKSPTWELKPEYNPSPRDRTYKQVYPALWQSDSVVWFSQQLTSRLGVDRFTEYVKKFEYGNQDVSGDSGKHNGLTQSWLMSSLTISPKEQIQFLLRFVAHKLPVSEAAYDMAYATIPQYQAAEGWAVHGKSGSGWLRDNNGKINESRPQGWFVGWAEKNGRQVVFARLEIGKEKSDIPGGSKAREDILVELPVLMGNK	12.04	gnl|BL_ORD_ID|226|hsp_num:0	243	True	loose hit with at least 95 percent identity pushed strict
k141_72701_2 # 559 # 801 # -1 # ID=40069_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.523	k141_72701_2 	559	801	-	Strict	500	22.7126	AIM-1	100.0	3000853	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	AIM beta-lactamase	CCTGGTCACACCCCTGGTGGCGTATGCTTCTACTGCCAAGAAGAGTGCTTTGTACTCGTGGGCGATACCCTCTTCCCAGGCTCCATTGGCAGAACCGACTTTGAAGGTGGTAACTACGCTGATCTGATCGAGTCCATTAAGACCAAGCTCTACACTCTGCCTGACAATACCGAAGTTTGCTGCGGTCACATGGGCGAGACCACCATTGGTGAGGAAAAGGCTAACAACCCTTACACTCACTAA	PGHTPGGVCFYCQEECFVLVGDTLFPGSIGRTDFEGGNYADLIESIKTKLYTLPDNTEVCCGHMGETTIGEEKANNPYTH	MKRRFTLLGSVVALALSSTALASDAPASRGCADDAGWNDPAMPLKVYGNTWYVGTCGISALLVTSDAGHILVDAATPQAGPQILANIRALGFRPEDVRAIVFSHEHFDHAGSLAELQKATGAPVYARAPAIDTLKRGLPDRTDPQFEVAEPVAPVANIVTLADDGVVSVGPLALTAVASPGHTPGGTSWTWRSCEGDDCRQMVYADSLTAISDDVFRYSDDAAHPGYLAAFRNTLARVAALDCDILVTPHPSASGLWNRIGPRAAAPLMDTTACRRYAQGARQRLEKRLAEEAATSPSSGARP	26.40	gnl|BL_ORD_ID|665|hsp_num:0	707	True	loose hit with at least 95 percent identity pushed strict
k141_75463_17 # 14585 # 15022 # 1 # ID=41573_17;partial=00;start_type=GTG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.384	k141_75463_17 	14585	15022	+	Strict	900	23.483	ANT(3'')-Ii-AAC(6')-IId fusion protein	100.0	3002598	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6'); ANT(3'')	GTGGATAGGGAGAGGGATATAATGAAGATAGAAGAAGTATGCACCATGGTATTTTTAGCAGTTAATACAGGGATGGATTTCAGAAAAAAAGAGATTTCACTGCATCTTACCGGGATTTATGCATGTGCAGGCATAATATTCAGTGTTTTATCTCAACGGGAATTATGGGACATGCTGCTGCCGCTGGCAATCGGTGTATTGTTTTTGCTTTTTTCTTTTATTTCCAAAGGTGCGCTGGGAAGTGGAGATGGATGGATTCTTCTTGCTTTGGGACTGATGATGCAAACGGAAGATTATATTAATATGATATGTTTCAGTATGATTATGGCAGCCGGTGTTTCGATATTGCTTCTGACAATATTCAGAAAGAAAGGAAAAACAGAAATACCGTTTGTACCATTTATATTTCTGGCGTATATGGGAGGTGTATTACTGTGA	MDRERDIMKIEEVCTMVFLAVNTGMDFRKKEISLHLTGIYACAGIIFSVLSQRELWDMLLPLAIGVLFLLFSFISKGALGSGDGWILLALGLMMQTEDYINMICFSMIMAAGVSILLLTIFRKKGKTEIPFVPFIFLAYMGGVLL	MSNAVPAEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAQLDETVRQALVVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPARRELQFGEWQRKDILAGIFEPATTDVDLAILLTKVRQHSLALAGSAAEDFFNPVPEGDLFKALSDTLKLWNSQPDWEGDERNVVLTLSRIWYSAATGKIAPKDIVANWAIERLPDQHKPVLLEARQAYLGRGEDCLASRADQLAAFVHFVKHEATKLLGAMPVMSKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	31.32	gnl|BL_ORD_ID|2045|hsp_num:0	339	True	loose hit with at least 95 percent identity pushed strict
k141_75834_4 # 3155 # 6316 # 1 # ID=41774_4;partial=00;start_type=TTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.373	k141_75834_4	3155	6316	+	Strict	750	796.193	adeF	42.86	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGTCAAGATTCTTTATAAATCGTCCGATATTTGCTATTGTTATATCTTTAATCATTGTAATCTTAGGTACAATTTCTGCTTTTAACTTACCAATAGCACAATATCCACAGATTTCTCCACCGACTATTACCGTAAGTACTACTTACACTGGTGCTAACTCAGATACAGTCAATGAGACCATTGCTCAGGTAGTTGAACAACAAGTCAATGGTGTTGAAGGCATGGACTATATGAGTTCTACTTCTGCCAATGATGGTAGTTACAATCTTCAAGTAGTCTTCAAACTCGGTACAAACGGTGATATGGACTCCGTAAAAGTTCAAAATAATGCTGCCACTGCTACACCAAGCTTACCATCTGATGTACAGACTTTTGGTCTTACTACTCGTAAAGCTTCTAGTGATATGGCAATGGTATTATCACTTACATCTCCAAATGGTACTTATGACAGCGTGTTCTTGAAAAACTATGCTGATATTTACCTTGTAGATAAAATCAAACGTGTTCCTGGGGTTGGGGACTTAAACGTATTCGGTTCTGACTATTCCATGCGTATTTGGATCAATCCAGATAAACTTGCTGAACTTGGTCTTACTGTTGCCGATGTCGTTAGTGCTGTAAAAGAACAAAACACTCAAGCTCCAGCTGGTACAATTGGTCAATTGCCAGCACCACGTGATCAAGAATTCCAATATACTGGTAAAATTCAAGGTCGTTTAATCACACCTGAAGAATTTGGAAATATTATTATTCGTTCTGATGCTAATAGTGGCTCATTTGTTCGTGTCAAAGACATTGCTAAAGTAGAAACAGGCGCTAGAACAAATAATATCATCGCTAAACACAATAACCAAAATGCCGTAGCATTCGGTGTTCAGCTTACTAGTGATGCCAATGCAATGGATACTGTAAGTCAAGTAAAACAAGTTCTTGAAGAATCCAAAGCCGATTTCCCTCCAGATATTGAATATGATACTGTTGTTGATAACACTACTTATATCAGTGAATCTATCAACGAAGTAATTCATACATTTATTGAAGCATTATTACTTGTAATGCTCATTGTTTATCTTTTCTTACAAAGTTGGAGAGCTACGCTCATCCCTATGCTCGCTGTTCCAGTATCTCTTATTGGTACATTTGCAACTTTCGTAGTACTTGATTTCTCCATCAATACCTTGACTCTCTTTGGTATGGTTCTTGCCATCGGTCTTGTTGTCGATGATGCTATCGTTGTTATTGAAAACGTTGAACGTCATATGGCTGAAGATGGTCTTAGTCCAAAAGAAGCAACAGGTCGTGCTATGGACGAAGTACAAGGTCCAGTTGTTGCTATTGCCTTCACTCTTGCTTCTGTATTCGTTCCAGTTGCTGGTCTTAGTGGTATGACTGGTATCTTATATCGTCAGTTCGCATTGACTATTGCTATTTCTATGGCATTATCAGCATTCGTGGCCTTGACTCTTACTCCTGCACTTTGTGCTACAATGTTAAAACCACATACTGCTGATGAAAATAAATCTAATTTTGGTGCATTTTTCATCCGTTTCAACCAATTTATGAATTGGATGACTCGTGGTTATGTGAAATATGTTGCCAAATTAATCGGTAAAGCAAAACTTTGTGTTACTGCTTTAGTTATTATCGTAGCTTTAATGTTTGGTTTATTTAAAATAATTCCAACTACATTTATTCCTGCTGAAGACCAAGGTTATTATCTTGGTGCTGTAAGCTTACCAGAAGGTACTTCTTTAAATAATACTGACGAAGTTATGACTCGTCTTGCTGAAGAATTAAAGAAAAACCCTGGTGTTTCTCAGGTAATGGGTATTTCAGGTTATGATATCTTATCTGGTGGTGCAAAATCCAGTGCAGCTACATTCTTCGTAGGTCTAGACCCTTGGAGTGAACGTACTTCACCAGAAACAAGTATCAATGCTGAAGTTGGTATGGCATTTAAACAAGGTGCTATGAGTTATCCAGAAGCCTCCATTATTGCTATGAATCCACCATCTTTACCAGGTCTTGGTATGGTTAGTGGCTTTACTTTACAGCTTCTAGATATGAGTGGTCATACTAATGAAGAATTAGATACTATCACTAAAAAAATCGTAGCTGTAGCTAATACTCGTCCTGAACTTCAAAGTGTTTATACAACATATAGTGTAAACTCTCCAATTTATGAATTTGAAGTAGACCGTGAAAAAGTTAAAAACTTAGGTTTAAATATTTCTGATGTATTTACTGCTCTTCAAGTAAACTTTGGTGGTACAGAAATCAATGACTTTAACCAATTTGGTCGTTCTTATAAAGTAGTAATGCAGGCAGAAAGTCAATTCCGTGATGAAGCTGATACTACTCGTTTCATCTTTATCCGAGGTTCCAATGGTCAAATGGTTCCATTGAACACATTAATTAAACCAAAATTAAATTCCGGACCTGCGATTATTTCTCGTTTCAATGCTAGCCGTAGTGTAACTATCCAAGGTAGTCCAAAACCAGGCTACAGCTCAGGTCAAGCAATGGCAGCTATTGAAGAAGTAATCAAACAAGAAGCTCCAAATGGCTTCAATATTGACTGGTCTGGTCAGAGCCGTGAAGAACGTGCAGCTACAAGTTCCACAGCTCAAGTTATGGTCTTAGCTCTTGTTTTCGTATTCTTATGTCTTGCAGCTCTTTACGAAAGCTGGAGTGTACCATATGCTGTATTATTAACAGTACCAACTGGTATCTTTGGTTCTTTGATTTCCGCTTATATTTTCAATATGCAAATAAGTATTTATATGCAAATTGGTATGATCGTAGTAATGGGCTTAGCAGCTAAAAACGCTATCCTTATCGTCGAATTCGCAAAAGTACGTTTTGATACTGGTATGCCAATTTTAAAAGCTACTCTTGAAGCTTCCAAACTTCGTTTACGTCCAATCATTATGACTTCACTTGCCTTCATTATTGGTTGTTTACCACTTGCTGTAGCAACTGGTGCAGGTGCAGCTGCTCGTAATAATATGGGTATCGCCGTTGTTGGTGGTATGATTGTAGCTACTGTCCTTGGTGTATTCTTGATTCCTGTTATGTATTTAGTGGTAATGAAAATTACTTCCAAACTTACTGGTAAATCTAAACAACCACCAAAATCTGAAATTGATAGATTTATGTAA	MSRFFINRPIFAIVISLIIVILGTISAFNLPIAQYPQISPPTITVSTTYTGANSDTVNETIAQVVEQQVNGVEGMDYMSSTSANDGSYNLQVVFKLGTNGDMDSVKVQNNAATATPSLPSDVQTFGLTTRKASSDMAMVLSLTSPNGTYDSVFLKNYADIYLVDKIKRVPGVGDLNVFGSDYSMRIWINPDKLAELGLTVADVVSAVKEQNTQAPAGTIGQLPAPRDQEFQYTGKIQGRLITPEEFGNIIIRSDANSGSFVRVKDIAKVETGARTNNIIAKHNNQNAVAFGVQLTSDANAMDTVSQVKQVLEESKADFPPDIEYDTVVDNTTYISESINEVIHTFIEALLLVMLIVYLFLQSWRATLIPMLAVPVSLIGTFATFVVLDFSINTLTLFGMVLAIGLVVDDAIVVIENVERHMAEDGLSPKEATGRAMDEVQGPVVAIAFTLASVFVPVAGLSGMTGILYRQFALTIAISMALSAFVALTLTPALCATMLKPHTADENKSNFGAFFIRFNQFMNWMTRGYVKYVAKLIGKAKLCVTALVIIVALMFGLFKIIPTTFIPAEDQGYYLGAVSLPEGTSLNNTDEVMTRLAEELKKNPGVSQVMGISGYDILSGGAKSSAATFFVGLDPWSERTSPETSINAEVGMAFKQGAMSYPEASIIAMNPPSLPGLGMVSGFTLQLLDMSGHTNEELDTITKKIVAVANTRPELQSVYTTYSVNSPIYEFEVDREKVKNLGLNISDVFTALQVNFGGTEINDFNQFGRSYKVVMQAESQFRDEADTTRFIFIRGSNGQMVPLNTLIKPKLNSGPAIISRFNASRSVTIQGSPKPGYSSGQAMAAIEEVIKQEAPNGFNIDWSGQSREERAATSSTAQVMVLALVFVFLCLAALYESWSVPYAVLLTVPTGIFGSLISAYIFNMQISIYMQIGMIVVMGLAAKNAILIVEFAKVRFDTGMPILKATLEASKLRLRPIIMTSLAFIIGCLPLAVATGAGAAARNNMGIAVVGGMIVATVLGVFLIPVMYLVVMKITSKLTGKSKQPPKSEIDRFM	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	99.43	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_76849_1 # 1 # 399 # -1 # ID=42306_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.459	k141_76849_1 	1	399	-	Strict	500	23.0978	PEDO-2	100.0	3003714	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	subclass B3 PEDO beta-lactamase	ATGTACTTCAAAAAAGCAGTCCAGATTCCCAATGAAAAAGGCAAAATCGTCTTCAGAACCAAAGGGGGATCTCGTTACGTCCTATATGAAATTGATCGTGTCTATAAGCCCGAGCGCAAGTACACCATCCCGAAGCGAAAAGTTATTGGCAAGGTTATCGATGGCAAAGAGGGTTGGATGTATCCAAACGAACTTTTTCAGAGTCTCTTTCCAAATACAGAGATCCCGCCGTCAGACGATGAGTTGCCGTTGCGTAGTTGCGCACTTAGCGTGGGTAGCTTTTTGGTTCTCTGTAATGTCATCCAGGAGTACGAACTCCGTGAGCTATTGACACCGCATTTTGGTGAATACACCGGTCTGCTTCTTGATTTGGCTTCGTACCTTATCGTTACCGAAGGT	MYFKKAVQIPNEKGKIVFRTKGGSRYVLYEIDRVYKPERKYTIPKRKVIGKVIDGKEGWMYPNELFQSLFPNTEIPPSDDELPLRSCALSVGSFLVLCNVIQEYELRELLTPHFGEYTGLLLDLASYLIVTEG	MKKIFLMVLFSCSLLGFAQTVTEPANNPKEWSQATEPFRIAGNLYYVGTYDLASYLIVTEKGNILINTGLANSLSIIKENIKALGFDYKSIKILLLTQAHFDHLGAMSEIKKETGAKLYVDEKDADALETGGKLDYELGKYGISFKPVKPDFLLKNNDKIKLGNTTLTMLHHPGHTKGSCSFIFDTKDKNSSYKILIANMPSIIVDRKFSEIASYKDIQKDYTETFKAMKKLDFDLWVASHASQFELHDKRKSGAPYNPKIFMDKSKFFKNLEDLENIFLEKIKN	46.67	gnl|BL_ORD_ID|2072|hsp_num:0	2229	True	loose hit with at least 95 percent identity pushed strict
k141_78404_4 # 4450 # 7554 # 1 # ID=43187_4;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=12bp;gc_cont=0.482	k141_78404_4	4450	7554	+	Strict	750	767.689	adeF	42.54	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAGTAAGTTTCTTTATAGATAGACCGGTCTTTTCGATGGTCATCTCCATCGTGATTGTGATTGTCGGTATTATCGGACTGACGATGCTTCCGGTGGACCAGTATCCTCAAATTACCCCTCCGGTGGTGAAGATCAGTGCTTCGTATCCGGGTGCCAGTGCCTTGACGGTGTCGCAGGCGGTGGCTACACCGATTGAGCAGGAAATCAACGGTACGCCCGGAATGCTTTATATGGAATCCAGCAGTTCTAACTCTGGTGGTTTTTCGGCTACCGTTACGTTTGATGTGTCGGCCGACCCGGATTTGGCTGCAGTGGAAATACAGAACCGTGTGAAGTTGGCAGAGTCTCGCTTGCCGGCTGAAGTGGTGCAGAACGGTATTTCGGTAGAAAAACAGGCGGCCAGTCAGCTGATGACCATCTGTTTGACTTCGGCTGATCCGAAGTTTGATGAAATCTACCTCAGTAACTTTGCAACCATCAACGTGCTTGACGTGATTCGTCGTATTCCCGGTGTGGGACGTGTGTCGAATATCGGTAGCCGTTATTATGCGATGCAGATCTGGGCTCAGCCGGATAAACTGGCTAACTTTGGCTTGACGGTGAAGGATTTGCAGGATGCCCTGAAAGATCAGAACCGTGAATCGGCAGCCGGTGTGCTGGGTCAGCAGCCGGTGAAGGGATTGGATGTGACGATTCCTATCACGACGCAGGGCCGTCTGTCTACGGTGAGTCAGTTTGAAGATATTGTGGTGCGTGCAAACCCGAATGGTTCTATCATCCGTTTGAAGGACGTGGCACGTGTGTCATTGGAAGCTTCTTCGTATAGCACGGAGAGTGGTATCAACGGTGAGAATGCAGCGGTGCTGGGTATTTATATGTTGCCGGGTGCCAATGCAATTGAGGTGGCCGAACGGGTGAAGGAGGCGATGAAGGAAATCAGCAGTAACTTTCCTGAAGGATTGTCGTATGAAATCCCGTTTGATATGACAACGTATATCTCTGAGTCTATCCATGAAGTGTATAAAACTTTGTTTGAAGCGTTGGTATTGGTGGTATTGGTGGTGTACTTGTCTTTGCAGAGCTGGCGGGCTACGGTAATTCCGGTGGTGGCTGTTCCTATTTCATTGATCGGTACATTTGGCTTTATGCTGATTTTTGGCTTCTCGCTCAATATTTTGACGCTGCTTGGATTGATTCTGGCCATCGGTATCGTGGTGGATGATGCCATTGTGGTGGTGGAAGGTGTGGAGCACATTATGGAGACAGAAAAACTGAGTCCGTATGAGGCTACAAAGAAGGCGATGAACGGGTTGGCCAGTGCGCTGATTGCTACGTCGCTGGTATTGGCAGCGGTGTTTGTGCCGGTGAGTTTCTTGAGTGGTATCACAGGACAGTTATATCGTCAGTTTACGGTGACAATTGTGGTATCTGTATTGATTTCTACCGTGGTGGCGCTGACGTTGAGTCCGGTCATGTGTTCGCTTATTCTGAAGCCGGACAGTGGTAAGAAGAAGAATGTCGTGTTCCGCAAGATCAATGAATGGCTGGCTTTGGGTAGCAACAAGTATGTGGGCTCTGTGACTCGTGTCATCAAGCATCCGCGCCGGGTGTTGAGTGGCTTCGGAGTGCTGCTGATTGCTATTCTGTTGATTCACCGGTTGATTCCGACCAGTTTCTTGCCGGTGGAAGACCAAGGTTATTTTAAGATTGAACTGGAATTGCCTGAAGGTACGACGTTGGAGCGTACACGTAATGTGACCGACCGTGCCATTGCGTATCTGGAAAAGAATCCGTATATCGGATACATTCAGAATGTGACGGGTAGCAGTCCGCGTATCGGCAGCAATCAGGGACGTACGGAACTGACGGTTATCCTCAAGCCGTGGGAAGAACGGAAATCAACGACCATTCAGGAGATTATGAAGGAGATTGAAATGCATCTGAAAGAATATCCGGAATGTAAGGTGTACTTGTCTACGCCTCCTGTTATTCCGGGTTTGGGTACTTCGGGTGGTTTTGAAATGCAGCTCGAAGCGCGTGGTGAAGCTACATTTGAGCAGCTGGTGGATGCGGCGGATACGCTGATGCATTATGCTTCTCAACACAAGGGTATTGCCGGCTTGTCTTCTTCGTTGCAGTCGGAAATTCCGCAGTTGTATTTTGATGTGGATCGCGATAAAGTGAAGTTGCTGGGTGTGCCTTTGGCTGATGTGTTCTCTACGATGAAGGCGTATACTGGTTCGGTGTATGTCAACGACTTTAATATGTTTAACCGTATTTATAAGGTATATATTCAGGCTGAAGCTCCGTATCGTGAACACAAGTCTAACATTAATCTTTTCTTTGTGAAGGCTTCCAATGGCGCGATGGTGCCGCTGACTTCATTGGGTAATGCTTCTTATACTACCGGACCGGGTAGCATCAAGCGTTTCAATATGTTTACTTCGGCGGTTATCAATGGTACTGCGGCGCAGGGATATAGTTCTGGCCAGGTGATGGAAACGATGGAGCAGATTGCTCAGCAGCATTTGCCCGATAATATCGGAGTGGAATGGAGTGGTCTTTCTTATCAGGAAAAGATGGCTGGCGGACAGACTGGCCTTGTGATGGCATTGGTGTTCCTGTTTGTGTTCTTGTTCCTGGCTGCTCAATATGAGAGCTGGACAGTGCCTATCGCGGTGTTGCTTTCGTTGCCGGTAGCTGCTTTTGGTGCCTATTTAGGTGTAGGACTTTGCGGTTTGGAGAATGATGTGTATTTCCAGATTGGCTTGGTGATGTTGATGGGATTGGCTGCCAAGAATGCGATTTTGATTGTTGAGTTTGCCAAAGTGCAGGTAGATAAGGGAGAAGATTTGATTGAGTCGGCTATTTATGCGTCTAAGTTGCGCTTCCGTCCGATTTTGATGACTTCCTTGGCCTTTGTGTTGGGTATGCTTCCGATGGTGTTGGCCAGCGGACCGGGTTCGGCAAGCCGCCAGGCAATCGGTACCGGTGTATTCTTCGGAATGATTTTTGCGATTATCTTTGGTATTATTCTCGTACCTTTCTTCTTTGTGCTGGTGTATAAGACGAAGTCGAAAATTTTAAATTTGAAGAAATAG	MKVSFFIDRPVFSMVISIVIVIVGIIGLTMLPVDQYPQITPPVVKISASYPGASALTVSQAVATPIEQEINGTPGMLYMESSSSNSGGFSATVTFDVSADPDLAAVEIQNRVKLAESRLPAEVVQNGISVEKQAASQLMTICLTSADPKFDEIYLSNFATINVLDVIRRIPGVGRVSNIGSRYYAMQIWAQPDKLANFGLTVKDLQDALKDQNRESAAGVLGQQPVKGLDVTIPITTQGRLSTVSQFEDIVVRANPNGSIIRLKDVARVSLEASSYSTESGINGENAAVLGIYMLPGANAIEVAERVKEAMKEISSNFPEGLSYEIPFDMTTYISESIHEVYKTLFEALVLVVLVVYLSLQSWRATVIPVVAVPISLIGTFGFMLIFGFSLNILTLLGLILAIGIVVDDAIVVVEGVEHIMETEKLSPYEATKKAMNGLASALIATSLVLAAVFVPVSFLSGITGQLYRQFTVTIVVSVLISTVVALTLSPVMCSLILKPDSGKKKNVVFRKINEWLALGSNKYVGSVTRVIKHPRRVLSGFGVLLIAILLIHRLIPTSFLPVEDQGYFKIELELPEGTTLERTRNVTDRAIAYLEKNPYIGYIQNVTGSSPRIGSNQGRTELTVILKPWEERKSTTIQEIMKEIEMHLKEYPECKVYLSTPPVIPGLGTSGGFEMQLEARGEATFEQLVDAADTLMHYASQHKGIAGLSSSLQSEIPQLYFDVDRDKVKLLGVPLADVFSTMKAYTGSVYVNDFNMFNRIYKVYIQAEAPYREHKSNINLFFVKASNGAMVPLTSLGNASYTTGPGSIKRFNMFTSAVINGTAAQGYSSGQVMETMEQIAQQHLPDNIGVEWSGLSYQEKMAGGQTGLVMALVFLFVFLFLAAQYESWTVPIAVLLSLPVAAFGAYLGVGLCGLENDVYFQIGLVMLMGLAAKNAILIVEFAKVQVDKGEDLIESAIYASKLRFRPILMTSLAFVLGMLPMVLASGPGSASRQAIGTGVFFGMIFAIIFGIILVPFFFVLVYKTKSKILNLKK	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	97.64	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_80117_1 # 3 # 146 # 1 # ID=44129_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.486	k141_80117_1 	3	146	+	Strict	500	20.4014	OXA-133	100.0	3001702	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	AGTTTGAAGAGGGATGGAGAAAAGGTGGTGTTTACCTACCAGACCACTGTGGGAGAGAAACGTTCTTTTACCACCGTTCCGTTTCTTTTGCTCGTGGTGAGTAAAGAGCAAGGCGGCACAGTGGTGTTGAACGAGGTACGTTGA	SLKRDGEKVVFTYQTTVGEKRSFTTVPFLLLVVSKEQGGTVVLNEVR	MNKYFTCYVVASLFFSGCTVQHNLINETQSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTTWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVERIDFGNAEIGQQVDNFWLIGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEENNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII	17.22	gnl|BL_ORD_ID|518|hsp_num:0	555	True	loose hit with at least 95 percent identity pushed strict
k141_80919_1 # 39 # 1085 # -1 # ID=44578_1;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.373	k141_80919_1	39	1085	-	Strict	500	538.88	tet(W/N/W)	72.05	3004442	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ACAGAAATGTATACTTCAATAAATGGTGAATTATGTAAGATTGATAGAGCTTATTCTGGAGAAATTGTTATTTTGCAAAATGAGTTTTTGAAGTTAAATAGTGTTCTTGGAGATACAAAACTATTGCCACAGAGAAAAAAGATTGAAAATCCGCACCCTCTACTACAAACAACTGTTGAACCGAGTAAACCTGAACAGAGAGAAATGTTGCTTGATGCCCTTTTGGAAATCTCAGATAGTGATCCGCTTCTACGATATTACGTGGATTCTACGACACATGAAATTATACTTTCTTTCTTAGGGAAAGTACAAATGGAAGTGATTAGTGCACTGTTGCAAGAAAAGTATCATGTGGAGATAGAACTAAAAGAGCCTACAGTCATTTATATGGAGAGACCGTTAAAAAATGCAGAATATACCATTCACATCGAAGTGCCGCCAAATCCTTTCTGGGCTTCCATTGGTTTATCTGTATCACCGCTTCCGTTGGGAAGTGGAATGCAGTATGAGAGCTCGGTTTCTCTTGGATACTTAAATCAATCGTTTCAAAATGCAGTTATGGAGGGGATACGCTATGGCTGTGAACAAGGATTGTATGGTTGGAATGTGACGGACTGTAAAATCTGTTTTAAGTATGGCTTATACTATAGCCCTGTTAGTACCCCAGCAGATTTTCGGATGCTTGCTCCTATTGTATTGGAACAAGTCTTAAAAAAAGCTGGAACAGAATTGTTAGAGCCATATCTTAGTTTTAAAATTTATGCGCCACAGGAATATCTTTCACGAGCATACAACGATGCTCCTAAATATTGTGCGAACATCGTAGACACTCAATTGAAAAATAATGAGGTCATTCTTAGTGGAGAAATCCCTGCTCGGTGTATTCAAGAATATCGTAGTGATTTAACTTTCTTTACAAATGGACGTAGTGTTTGTTTAACAGAGTTAAAAGGGTACCATGTTACTACCGGTGAACCTGTTTGCCAGCCCCGTCGTCCAAATAGTCGGATAGATAAAGTACGATATATGTTCAATAAAATAACTTAG	TEMYTSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVYQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRLVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAHKGEIVILPSDSLRLNDILGDKTQLPREMWSDVPFPMLRTTITPKTAEQRDRLLDALTQIADTDPLLHYEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQATVGEPIIQPRRPNSRLDKVRHMFSKIP	54.46	gnl|BL_ORD_ID|2556|hsp_num:0	2882		
k141_82619_1 # 1 # 465 # 1 # ID=45512_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.531	k141_82619_1 	1	465	+	Strict	200	46.2098	tet37	95.0	3002871	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	AAGTACGAGACGGAGCCAGGTTTGGTTATCTGCTACGGCACCATGTACGGTAACACCGAGCGTATGGCAGAAATCATCGCCCGTGCAGCAAGTAAGGCTGGCGTGAAGAACATCGTAATGTATAACATCTCGAAGACTCACCACAGCTACATCCTGCGCGACATCTTCCGCTACAAGGGCCTTATCGTAGGTGCTCCAACCTACAATGCCGGTCTTTATCACGAGATGGAGGTTCTCCTCTCCGAGCTTGCCAATAAGGACGTTAAGAACCACCTTCTTGGCTGGTACGGCTCTCATTGCTGGGCAAGCAAGGCTGTGGCAAAGATCCAGGAGTGGAACGAAACCAAGCTCCACTATGAGGCTGTAGGCGAGCCGGTAGATATGAAGCAGGCGATTACTCCAGAGGTAAAGGCGCAGTGCGAGGCTCTGGGTAAGGCGATGGCTGAGAAGCTGCTGGCAGAATAG	KYETEPGLVICYGTMYGNTERMAEIIARAASKAGVKNIVMYNISKTHHSYILRDIFRYKGLIVGAPTYNAGLYHEMEVLLSELANKDVKNHLLGWYGSHCWASKAVAKIQEWNETKLHYEAVGEPVDMKQAITPEVKAQCEALGKAMAEKLLAE	MVRYYSNIVGKYGIPVQNALKKLAGIHIDYICSTHGPVWHENVEKVVNLYDRMSKYETDPGLVICYGTMYGNTEDRTPSMYEYIWIKENREAKVVSSFAANIYLGWGR	142.59	gnl|BL_ORD_ID|730|hsp_num:0	774	True	loose hit with at least 95 percent identity pushed strict
k141_84219_1 # 2 # 256 # -1 # ID=46339_1;partial=10;start_type=ATG;rbs_motif=TAA;rbs_spacer=11bp;gc_cont=0.451	k141_84219_1 	2	256	-	Strict	550	21.9422	VEB-8	100.0	3002377	protein homolog model	n/a	n/a	monobactam; cephalosporin	antibiotic inactivation	VEB beta-lactamase	ATGAAAAAGATTTTTTTGATCTTAGCCTGGCTGCTGTGTGCAGTGAGCATGCGTGCCCAGTTCACTCACGGTACTACCGGCTTGCTGGAAATGCCGACTGCCGATATGCAGAAGGATAAGACGTTTATGTTGGGGGGTGGGTATCTGGATAATACGGTAACCCCTATGCGTTGGAATTATAACACTTGGAATTATTATCTGAATGTGACGATTTTTCCTTGGCTGGAGGTGGCTTATGCCTGTACCATTTTCAAT	MKKIFLILAWLLCAVSMRAQFTHGTTGLLEMPTADMQKDKTFMLGGGYLDNTVTPMRWNYNTWNYYLNVTIFPWLEVAYACTIFN	MKIVKRILLVLLSLFFTVEYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINNDFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKMWSPIKEEFPNGTTLTIEQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQNWATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTAGSNRLKGQLPKNTIVAHKTGTSGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK	28.43	gnl|BL_ORD_ID|909|hsp_num:0	969	True	loose hit with at least 95 percent identity pushed strict
k141_85179_1 # 1 # 198 # 1 # ID=46871_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.475	k141_85179_1 	1	198	+	Strict	650	21.1718	vanM	100.0	3002911	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	CCAATCACTCAGAAGGCTCTCGGTGTTCGTATGGGTAAAGGTAAGGGTACTGTTGAATATTGGGTATGCCCAATTCAGCCAGGTAAGGTACTCTTTGAACTCAGTGGTATCCCTGAGGAAGTAGCTCGTGAGGCTTTCCGTCTTGCAGCTGCCAAGTTATCTGTTACCACTACTTTCGTTCGTAAGGCGGTGATCTAA	PITQKALGVRMGKGKGTVEYWVCPIQPGKVLFELSGIPEEVAREAFRLAAAKLSVTTTFVRKAVI	MNRLKIAILFGGCSEEHNVSVKSAAEIANNIDIGKYEPIYIGITQSGVWKTCEKPCIDWDNEHCRSAVLSPDKKMHGLLIMQDKGYQIQRIDVVFSVLHGKSGEDGAIQGLFELSGIPYVGCDIQSSAVCMDKSLAYIIAKNAGIATPEFQVIYKDDKPAADSFTYPVFVKPARSGSSYGVNKVNSADELDSAIDLARQYDSKILIEQGVLGYEVGCAVLGNSFDLIVGEVDQIRLQHGIFRIHQEAEPEKGSENATITVPAELSAEERERIKEAAKNIYKALGCRGLSRVDMFLQDNGRIVLNEVNTMPGFTSYSRYPRMMVSAGITIPELIDHLIVLAVKE	18.95	gnl|BL_ORD_ID|1817|hsp_num:0	1924	True	loose hit with at least 95 percent identity pushed strict
k141_89416_42 # 51340 # 51504 # -1 # ID=49177_42;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=12bp;gc_cont=0.430	k141_89416_42 	51340	51504	-	Strict	750	20.4014	pmrA	100.0	3000822	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAAAAGTACGTTTGCACAGTTTGTGATTGGGTTTATGATCCAGAAGTAGGTGATCCAGAAGGTGGAATCGCTCCGGGAACTGCATTTGAAGATATTCCAGAAGATTGGGTTTGCCCTCTTTGTGGAGTAGGTAAGGAAGACTTTCAGCCGGTTGAAGAATAA	MKKYVCTVCDWVYDPEVGDPEGGIAPGTAFEDIPEDWVCPLCGVGKEDFQPVEE	MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISAALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAILTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANASSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGSAVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI	13.53	gnl|BL_ORD_ID|1974|hsp_num:0	2003	True	loose hit with at least 95 percent identity pushed strict
k141_89932_15 # 14546 # 14710 # 1 # ID=49455_15;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=11bp;gc_cont=0.455	k141_89932_15 	14546	14710	+	Strict	750	20.4014	pmrA	100.0	3000822	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAGAAGTACATTTGCACAGTATGCGATTGGGTTTATGATCCTGAAGTTGGAGATCCTGAAGGTGGCATTGCACCGGGAACAGCATTTGAGGATATTCCGGAAGATTGGGTTTGCCCGGTTTGTGGTGTCGGAAAAGAAGATTTCCAGCCGGTAGAAGAATAA	MKKYICTVCDWVYDPEVGDPEGGIAPGTAFEDIPEDWVCPVCGVGKEDFQPVEE	MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISAALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAILTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANASSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGSAVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI	13.53	gnl|BL_ORD_ID|1974|hsp_num:0	2003	True	loose hit with at least 95 percent identity pushed strict
k141_90379_1 # 1 # 120 # -1 # ID=49689_1;partial=10;start_type=ATG;rbs_motif=TAAAAA;rbs_spacer=10bp;gc_cont=0.450	k141_90379_1 	1	120	-	Strict	750	19.631	tet(40)	100.0	3000567	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGATCCTTGACGGATGGGGCTGCGGCGACCATCACAAAGACGATGTAATCTTTAACACTCCTACTCCTTATTGGGACAGTCTGTTGGCTAATTATCCTCATTCACAATTGCAGGCAAGT	MILDGWGCGDHHKDDVIFNTPTPYWDSLLANYPHSQLQAS	MFAKNSKAYSVYLLFRFVCSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVQEASCFLFEMPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFITGALEAWIASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPLILGGSLCLLLGLVMVRIMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLSTAHFLDDTVIPVIGPLNSVTWFGVISLIGNGLGILASQLLIARMEKKGTVSRTSVVMSTSAGYILFLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWMNDHVDEKMRATVFSTSGQLDSFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD	9.85	gnl|BL_ORD_ID|912|hsp_num:0	945	True	loose hit with at least 95 percent identity pushed strict
k141_90647_1 # 154 # 1374 # 1 # ID=49829_1;partial=00;start_type=ATG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.565	k141_90647_1	154	1374	+	Strict	750	791.571	tet(40)	98.28	3000567	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTTTGCTAAAAATTCAAAGGCATATTCTGTCTACCTGCTGTTCCGATTTGTCTGTTCCCTGGCGGTTTCTATGTCCACAGTGCTTTCCATCGTGTACCACCTGGAGGTGGTGCAGCTGGATGCTTTCCAGCTTGTCCTGGTAGGGACGGTTCTGGAGACCTCCTGCTTTCTGTTCGAGATACCCACCGGTGTGGTGGCGGATTTGTATAGCCGTCGGCGCTCGGTGCTGATTGGAATGTTCCTCTACGGCCTGGGCTTTCTGATGGAGGGTGCGCTACCGTGGTTCGCGCCGGTTCTGCTGGCCCAGGTTGTCTGGGGTTGCGGTGATACCTTCATCACCGGCGCTCTGGAGGCGTGGATTGCCTCGGAGGAAGAGGACAAACCCATAGACAAGGTGTTCCTGCGGGGCAGTCAAATGGGGCAAATCGGCGGCGTTCTGGGCGTGGTGCTGGGCACACTGCTGGGAAACATAAACCTGCAAATGCCTGTCATCTTGGGGGGCAGTTTGTGCTTGTTGTTGGGGCTGGTGTTGGTTCGCATCATGCCAGAAACCAACTTCTCCCCTGCTATTGAGGAACGGCAGGGCTTGCTTAAAGACTTTGTCTGCCTGTTCAAGCTCAACCTGGGCTTTGTGAAAGGCGCACCTGTGTTGCTGGCGCTCTTAGCAATCACACTATGCGGGGGACTTGCCAGTGAAGGCTTTGACCGGCTCTCCACCGCTCATTTTCTGGATGACACGGTAATACCCGTTATCGGGCCGCTGAACAGCGTCACTTGGTTCGGTGTTATCAGTCTTATCGGCAGCGGCTTAGGTATTCTGGCTTCTCAGTTGCTCATCGCCCGCATGGAGAAAAAAGGGACTGTCAGCCGAACCAGTGTGGTCATGTCCACCAGCGCCGGGTATATCCTGTGCCTGGTTCTCTTCGCGGTGGGGCGGAGCTTTTGGTTCATGTTGTTGGTGTTCCTGCTGGCGGGGCTTATGCGCACCATCAAGGAGCCTGTGCTGGCCGCCTGGATGAACGACCATGTGGATGAGAAAATGCGCGCCACAGTCTTTTCCACCAGCGGACAGCTGGACTCTTTCGGGCAGATCATCGGCGGGCCTATTGTGGGGCTGGTAGCCCAGCAGGTGTCCATACCCTGGGGGCTGGTCTGTACCGCTTTCCTGCTGTTGCCCGCGCTGTTCTTAGTGCCGGTGGCGGGAAAGAAGCGGGATTGA	MFAKNSKAYSVYLLFRFVCSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVLETSCFLFEIPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFITGALEAWIASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPVILGGSLCLLLGLVLVRIMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLSTAHFLDDTVIPVIGPLNSVTWFGVISLIGSGLGILASQLLIARMEKKGTVSRTSVVMSTSAGYILCLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWMNDHVDEKMRATVFSTSGQLDSFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD	MFAKNSKAYSVYLLFRFVCSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVQEASCFLFEMPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFITGALEAWIASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPLILGGSLCLLLGLVMVRIMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLSTAHFLDDTVIPVIGPLNSVTWFGVISLIGNGLGILASQLLIARMEKKGTVSRTSVVMSTSAGYILFLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWMNDHVDEKMRATVFSTSGQLDSFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD	100.00	gnl|BL_ORD_ID|912|hsp_num:0	945		
k141_91311_2 # 711 # 959 # -1 # ID=50192_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.514	k141_91311_2 	711	959	-	Strict	1000	22.7126	mecD	100.0	3004185	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	GGAGTCAAGCATGTGGCCCCCTGTAAGCCGGAGCAGGCTCAGCGAAACTCCGGCTACATGGTCGGAGGGACAAGTCCGTTCGGAACGCGAAAGAGCATGCCGGTTTATGTCGAAAAGACGATTTTGGAATTTGACCAAATCTTTATCAACGGCGGACGGAGGGGATATCAGGTAGGAATCGATCCGAAGATTCTGGTTGATGTTCTTGGTGCCCGTCCGGTGGAATGTGCCATCGAAAAACTAAGATAG	GVKHVAPCKPEQAQRNSGYMVGGTSPFGTRKSMPVYVEKTILEFDQIFINGGRRGYQVGIDPKILVDVLGARPVECAIEKLR	MKNIKVKILIVCSLCLISFFLYNLLKENEIDKIFSSIENRNVDEINENITFLSRNTFSKKQRYDRMNHIDNSLGIKKVNITDIKLLEEIVDTRKYSANMHYDSKFGKFTKKGYFEFEKNGESKRWELNWTPEVIIPGLTATNEVRVEELKSSRGEIVDRNGIPLAIDGEHYQVGIDPKNYNKKDSKQIAKLLNINESTLKNKLKQSWVKDGVFVPIKSYVELSDEIKNKIPEYGLSVNKIKGRTYPLKEASAHLLGYIGEINADELNDPKFKGYDSHSIVGKTGIEYMYDKELQNRDGLIVYITDDDGLTDSKEILVHKKPKNGKKIVLSIDSRVQNSIYNHLKDDNGSGTAMNPKTGELLALVSYPSFNPYDFMFGISNKKYQALLNDKKAPLLNKFQELTSPGSTQKLLTSIIGLNNGVINESKSYEINGKGWRKDGSWGGYKVTRFEVVNGRIDLEKAIAHSDNIFFARTTLEMGGKKFVRGMKDLGVGEETPSDYPVRTGQIANKINLERNLNNDILLADSGYGQGEILVNPIHILSIYSSLVNEGNMMAPKLNMEHKSKVWKKHITSQKNIDILTSSMRKVVTGTHKLDTERNYANFAGKTGTAELKMTQNEGLGTQIGWFVGYDQQNPNMMLAINVKNVEDKGMSSYNAQKFAQVMDDLYEHGARTYEPDSE	12.09	gnl|BL_ORD_ID|2484|hsp_num:0	2828	True	loose hit with at least 95 percent identity pushed strict
k141_92272_8 # 4413 # 4607 # 1 # ID=50711_8;partial=00;start_type=ATG;rbs_motif=AACAA;rbs_spacer=9bp;gc_cont=0.477	k141_92272_8 	4413	4607	+	Strict	400	20.7866	QnrS15	100.0	3004627	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	ATGCAAAAGTTTGAAAAAAAATCGGGTGAAAGGTGGGGCAGCAGGCTGAATAAATGGGCGTACATAGCGAATTGGGTATTTGAAGTGTTCTCGGAAGATGTGTGGTGTGTGGGGGTCGGTAGTGTTGGGGTGGTGGAAGGGAGGGGTATAAAAGCAAAAAAGACCGCCAAGAGTGGAAGCCTCTCAACAGTCTAA	MQKFEKKSGERWGSRLNKWAYIANWVFEVFSEDVWCVGVGSVGVVEGRGIKAKKTAKSGSLSTV	METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCRFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD	29.36	gnl|BL_ORD_ID|2237|hsp_num:0	3326	True	loose hit with at least 95 percent identity pushed strict
k141_93641_20 # 21276 # 21470 # 1 # ID=51435_20;partial=00;start_type=ATG;rbs_motif=AAAAA;rbs_spacer=8bp;gc_cont=0.431	k141_93641_20 	21276	21470	+	Strict	500	21.1718	FAR-1	100.0	3004784	protein homolog model	n/a	n/a	penam	antibiotic inactivation	FAR beta-lactamase	ATGTTTCAAAAAAGTTGTACCTTTGCAGCGTCAAACGAAAAAGATGACAAACGATCTGTGATTTTGGGCTATGGTGTAATGGTAACACAACAGATTCTGGTCCTGTTTTTCTTGGTTCGAGTCCGAGTAGCCCAACTTCCTATTTGCGGAGGTTCCCACGGAGGGAATATCCCATTCTTTTGGGCTATGGTGTAA	MFQKSCTFAASNEKDDKRSVILGYGVMVTQQILVLFFLVRVRVAQLPICGGSHGGNIPFFWAMV	MAAAAAIALLGGCGADAGSEPATTAASTTAPSTATDAATAEFAALEQRSGARLGVYAVDTTSGAEVAYRADERFGMASTFKGLACGALLREHPLSSGYFDQVVRYSREEVVSYSPVTETRVDTGMTVAELCHATITVSDNTAGNQILKLLGGPAGFTAFLRSLGDEVSRLDRWETELNEVPPGEERDTTTPAAVAANYRALVLGDVLAEPERAQLRDWLVANTTGDQRIRAGVPAGWTVGDKTGGGSHGGNNDVAVAWTETGDPIVIALLSHRTDPAAKADNALLAEATRAVVTALR	21.55	gnl|BL_ORD_ID|2155|hsp_num:0	3583	True	loose hit with at least 95 percent identity pushed strict
k141_93926_1 # 3 # 86 # 1 # ID=51593_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.310	k141_93926_1 	3	86	+	Strict	400	18.8606	vanRG	100.0	3002926	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GGCGAGGTTTCAGAAGAGCTATTTGAAAATGTAAAGAACTTGCCAACTTGTGAAGTTACAGATAATCATATAAAATTTAATTGA	GEVSEELFENVKNLPTCEVTDNHIKFN	MNEKILIVDDEKEIADLIELYLKNDGYKVYKFYNGIDALKCVESEKMDLAILDVMLPDVDGFHICQKIRERYFYPIIMLTAKVEDADKIMGLTIGADDYITKPFNPLEVAARVKTQLRRYVCYNNAADIEKENVLVTEYDINGLVINKNTHKCTLYGKAVTLTPIEFSVLWYLCENRGKVISSEELFENVWGEKFLDNNNTVMAHIGRLREKLKEPARNPKFIKTVWGVGYTIEE	11.49	gnl|BL_ORD_ID|1541|hsp_num:0	1635	True	loose hit with at least 95 percent identity pushed strict
k141_93946_4 # 5184 # 5288 # -1 # ID=51603_4;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.610	k141_93946_4 	5184	5288	-	Strict	700	19.631	tet(A)	100.0	3000165	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TGGAACGGCTGGGCCAACAGCGTCAATGAGGAAGGCCGCCACGAGATCCTGGAGCCGGACGAGGCCATGACCAGCGAGTGGAGCATCACCATCGAGAAGGTCTGA	WNGWANSVNEEGRHEILEPDEAMTSEWSITIEKV	MSTNLSVIKNPRVQSDQRRLVRRPDVKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACAPVLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPALRRGLWRNSSNSRCT	8.02	gnl|BL_ORD_ID|1835|hsp_num:0	1808	True	loose hit with at least 95 percent identity pushed strict
k141_95521_3 # 1988 # 2059 # 1 # ID=52457_3;partial=01;start_type=ATG;rbs_motif=TAAAA;rbs_spacer=12bp;gc_cont=0.444	k141_95521_3 	1988	2059	+	Strict	2130	21.557	mtrD	100.0	3000811	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCAAACAAGAAGTTTAACAGTTGGATCAAGAATATATGCATGGGATGGGGCTTCATCATGGCCGGCAGT	MANKKFNSWIKNICMGWGFIMAGS	MAKFFIDRPIFAWVISIFIIAAGIFGIKSLPVSQYPSVAAPTITLRATYPGASAQVMEDSVLSVIERNMNGVEGLDYMSTSADSSGSGSVSLTFTPDTDENLAQVEVQNKLSEVLSTLPATVQQYGVTVSKARSNFLMIVMLSSDVQSTEEMNDYAQRNIVPELQRIEGVGQVRLFGAQRAMRIWVDPKKLQNYNLSFADVGSALSAQNVQISAGSIGSLPAVRGQTVTATVTAQGQLGTAEEFGNVILRANTDGSNVYLKDVARVGLGMEDYSSSTRLNGVNTTGMAVMLSNSGNAMATAKAVKERMATLEKYFPQGMSWKTPYDTSKFVEISIEKVIHTLIEAMVLVFVVMYLFLQNIRYTLIPTIVVPISLLGGFAFISYMGMSINVLTMFAMVLVIGIVVDDAIVVVENVERIMAGEGLPPKEATKKAMGQISGAVIGITAVLISVFVPLAMFSGATGNIYKQFALTMASSIAFSAFLALTLTPALCATMLKTIPKGHHEEKKGFFGWFNKKFNSWTHGYEGRVAKVLRKTFRMMVVYIGLAVVGVFLFMRLPTSFLPTEDQGFVMVSVQLPAGATQERTNATLAQVTQLAKSIPEIENIITVSGFSFSGSGQNMAMGFAILKDWNERTAPGSDAVAIAGKLTGMMMGTLKDGFGIAVVPPPILELGNGSGLSINLQDRNNTGHTALLAKRNELIQKMRASGLFDPSTVRAGGLEDSPQLKIDINRAAAAAQGISFADIRTALASALSSSYVSDFPNQGRLQRVMVQADEDARMQPADILNLTVPNKSGVAVPLSTIATVSWENGTEQSVRFNGYPSMKLSASPATGVSTGQAMAAVQKMVDELGGGYSLEWGGQSREEAKGGSQTLILYGLAVAAVFLVLAALYESWSIPLAVILVIPLGLIGAAAGVTGRNLFEGLLGSVPSFANDIYFQVGFVTVMGLSAKNAILIIEFAKDLQAQGKSAVEAALEAARLRFRPIIMTSFAFILGVVPLYIAGGASSASQRAIGTTVFWGMLIGTLLSVFLVPLFYVVVRKFFKETAHEHEMAVKHAAEAGITGSDDSQH	2.25	gnl|BL_ORD_ID|1829|hsp_num:0	1938	True	loose hit with at least 95 percent identity pushed strict
k141_95522_1 # 3 # 110 # -1 # ID=52458_1;partial=10;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.426	k141_95522_1 	3	110	-	Strict	500	19.631	OXA-440	100.0	3003596	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAGAAAGCTAATGGTTTTTATGGCGGCGATGGGAATCCTGTTCTTGTCCGGCTGTACAGACAATACGGAATCATCCATTTCCAAAGACTCTGTTTCAGAAATAGAA	MRKLMVFMAAMGILFLSGCTDNTESSISKDSVSEIE	MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDKKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII	13.19	gnl|BL_ORD_ID|2147|hsp_num:0	3510	True	loose hit with at least 95 percent identity pushed strict
k141_97893_1 # 1 # 117 # 1 # ID=53728_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.427	k141_97893_1 	1	117	+	Strict	500	19.631	rmtD2	100.0	3004677	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGCATCCTGTGTATTTCGTTATGAGAGATGCATCGGCTGCATCGGACAAGGTGATAGACAACTTCGACCAGCTGTTTGAAGCATATAGCAAAGATACGGTAAGGAAAATCCTGTAA	MHPVYFVMRDASAASDKVIDNFDQLFEAYSKDTVRKIL	MSELKEKLLASKKYRDVCPDTIERIWRECSAKFKKEKDADKAAREALHGVTGAFMTEREYKRAMELAATRDWEALLGMHASTRERLPVESMDRVFDQLFEAIGTPARILDLACGLNPVYLAHRLPNAAIAGVDISGQCVNVIRAFGGAEARLGDLLCEIPEDEADAALMFKVLPLLERQRTGAAMEALMRVNAEWIVASFPTRSLGGRNVGMEKHYSEWMEAHVPENRAIAARLTGENELFYVLKRK	15.38	gnl|BL_ORD_ID|2285|hsp_num:0	3376	True	loose hit with at least 95 percent identity pushed strict
k141_101230_11 # 5323 # 5643 # -1 # ID=55500_11;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.349	k141_101230_11 	5323	5643	-	Strict	300	22.7126	lnuA	100.0	3002835	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	GTGAGAATTAAAAAAGGTGATAAAGTAAAAGTTATTACAGGTGCTTACAAAGGCACAATCGGTGAAGTAAAAGCTGTATTCCCTAAGGAAGACAGAGTTGTCGTTGAAGGTGTTAACATGGTAAAAAAACACTTGAAACCAACTCAAGCAAATCCAGAAGGTGGAATTGTTGAAAAAGAAGCTAAAATCCACGTTTCAAATGTAATGCTTTATGATGAAAAAGCAAAAGTTGCTAGCCGTATTACAACAAAAGTTGAAGTTGTAGATGGTAAAAATGTAAAAACACGCGTCTTCAAAAAGAGCGGTAACGAAGTGAAGTAG	MRIKKGDKVKVITGAYKGTIGEVKAVFPKEDRVVVEGVNMVKKHLKPTQANPEGGIVEKEAKIHVSNVMLYDEKAKVASRITTKVEVVDGKNVKTRVFKKSGNEVK	MKNNNVTEKELFYILDLFEHMKVTYWLDGGWGVDVLTGKQQREHRDIDIDFDAQHTQKVIQKLEDIGYKIEVHWMPSRMELKHEEYGYLDIHPINLNDDGSITQANPEGGNYVFQNDWFSETNYKDRKIPCISKEAQLLFHSGYDLTETDHFDIKNLKSIT	65.84	gnl|BL_ORD_ID|22|hsp_num:0	27	True	loose hit with at least 95 percent identity pushed strict
k141_101376_4 # 2483 # 3211 # -1 # ID=55583_4;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.321	k141_101376_4 	2483	3211	-	Strict	400	24.6386	IND-2a	100.0	3002258	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IND beta-lactamase	ATGAGGAATCTAGAAGATATAAAAAGAAGTGGATTTAAAATCATTGAACAAAAAAGAGAAGAATTTATGAAACAAAGTATCCTCTCTGATGAATTTTTAGATTTATTGGATAAGAATAAGAAACCATTCGATTTATTGATGTCTTATTATCGTTGTGCGGTAATGGAGATAGAAACAAAGTTCAGAGTATTAGATCAGGAGTACTCTTTAGAATATGATGGTAATCCCATTGAAAGTATTAAGTCACGTATTAAATCATATGATAGTATTGCGAGAAAAGTAAGACGCAAGAATATTCCAATGACTATGGAATCATTAGAGGAAAATATAAGAGATATTGCAGGAGTCAGAGTTGTTTGTTCATTTCCTGAAGATATTTATGAACTTGCAGATAGCTTCTTAAGACAGGATGATATTACTTTGATTGAGATGAAGGATTATATTAAAAATCCTAAACCTAGTGGTTATCGTAGTTTGCACTTAATTGTGCAGGTACCAATCTTTTTGCAGAAGACAAAGAAGTATGTTTATGTAGAAGTACAGCTTCGTACTATTGCGATGGACTTCTGGGCAAGTTTGGAACATAAATTACGCTATAAGAAGAATATTCCTGAAGATGAAGCAAAGCTTATTGCTCAGGAACTTTATGACTGTTCAGTAGAAAGTGCTAAATTAGATGAACGTATGCAGAAGATACGTTCAATGATGAATAAAGGAGAATCTGAATAG	MRNLEDIKRSGFKIIEQKREEFMKQSILSDEFLDLLDKNKKPFDLLMSYYRCAVMEIETKFRVLDQEYSLEYDGNPIESIKSRIKSYDSIARKVRRKNIPMTMESLEENIRDIAGVRVVCSFPEDIYELADSFLRQDDITLIEMKDYIKNPKPSGYRSLHLIVQVPIFLQKTKKYVYVEVQLRTIAMDFWASLEHKLRYKKNIPEDEAKLIAQELYDCSVESAKLDERMQKIRSMMNKGESE	MKKSIQLLMMSMFLSPLINAQVKDFVIEPPVKPNLYLYKSFGVFGGKEYSANAVYLTTKKGVVLFDVPWQKEQYQTLMDTIQKRHHLPVIAVFATHSHDDRAGDLSFYNQKGIKTYATAKTNELLKKDGKATSTEIIKTGKPYKIGGEEFMVDFLGEGHTVDNVVVWFPKYKVLDGGCLVKSRTATDLGYTGEANVKQWPETMRKLKTKYAQATLVIPGHEEWKGGGHVQHTLDLLDKNKKPE	99.59	gnl|BL_ORD_ID|1268|hsp_num:0	1349	True	loose hit with at least 95 percent identity pushed strict
k141_102566_3 # 2270 # 3121 # 1 # ID=56244_3;partial=01;start_type=ATG;rbs_motif=AAAA;rbs_spacer=4bp;gc_cont=0.353	k141_102566_3 	2270	3121	+	Strict	1200	573.933	tetM	98.59	3000186	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAAAATTATTAATATTGGAGTTTTAGCTCATGTTGATGCAGGAAAAACTACCTTAACAGAAAGCTTATTATATAACAGTGGAGCGATTACAGAATTAGGAAGCGTGGACAAAGGTACAACGAGGACGGATAATACGCTTTTAGAACGTCAGAGAGGAATTACAATTCAGACAGGAATAACCTCTTTTCAGTGGGAAAATACGAAGGTGAACATCATAGACACGCCAGGACATATGGATTTCTTAGCAGAAGTATATCGTTCATTATCAGTTTTAGATGGGGCAATTCTACTGATTTCTGCAAAAGATGGCGTACAAGCACAAACTCGTATATTATTTCATGCACTTAGGAAAATGGGGATTCCCACAATCTTTTTTATCAATAAGATTGACCAAAATGGAATTGATTTATCAACGGTTTATCAGGATATTAAAGAGAAACTTTCTGCCGAAATTGTAATCAAACAGAAGGTAGAACTGTATCCTAATATGTGTGTGACGAACTTTACCGAATCTGAACAATGGGATACGGTAATAGAGGGAAACGATGACCTTTTAGAGAAATATATGTCCGGTAAATCATTAGAAGCATTGGAACTCGAACAAGAGGAAAGCATAAGATTTCATAATTGTTCCCTGTTCCCTGTTTATCACGGAAGTGCAAAAAACAATATAGGGATTGATAACCTTATAGAAGTGATTACGAATAAATTTTATTCATCAACACATCGAGGTCCGTCTGAACTTTGCGGAAATGTTTTCAAAATTGAATATACAAAAAAAAGACAACGTCTTGCATATATACGCCTTTATAGTGGAGTACTACATTTACGAGATTCGGTTAGAGTATCA	MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIEGNDDLLEKYMSGKSLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYSSTHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVS	MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIEGNDDLLEKYTSGKLLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYSSTHRGQSELCGKVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT	44.44	gnl|BL_ORD_ID|1596|hsp_num:0	1692	True	loose hit with at least 95 percent identity pushed strict
k141_104361_7 # 9734 # 12844 # -1 # ID=57207_7;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=11bp;gc_cont=0.449	k141_104361_7	9734	12844	-	Strict	750	759.214	adeF	41.51	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAGTGAGTTTCTTTATCGACAGACCGGTCTTTTCGGCTGTCATCTCTATATTAATAGTTATTGTGGGTATTATCGGACTGCAAATGTTGCCGATAGACCAGTACCCTCAAATCACTCCTCCGGTAGTGAAGATCAGTGCATCTTATCCGGGTGCAAGTGCCGTGACTGTATCGCAGGCTGTTGCTACACCGATAGAGCAGGAACTTAACGGTACTCCTGGTATGCTTTATATGGAGTCGAACAGCTCCAACTCAGGAGGTTTCTCGGCAACTGTAACATTCGATATTTCAGCAGATCCTGATTTGGCTGCGGTAGAAATACAGAACCGTATCAAGCTGGCGGAATCGAGTCTTCCTGCCGAAGTTGTCCAAAATGGTATTTCGGTGGAAAAACAGGCAGCCAGCCAGTTGATGACCATCTGTCTTCGTTCGGATGATCCGAAGTTTGACGAAATTTATTTGAGTAACTTTGCGACAATCAATGTGCTCGACTTGCTTCGTCGTGTGCCTGGAGTAGGACGTGTGTCAAATATCGGTAGCCGCTATTACGCGATGCAGATATGGGTGGATCCGGCCAAACTGGCTAATTTCGGACTGACTGTACAGGATGTTCAGAATGCTTTAAAAGATCAGAACCGTGAGTCGGCAGCTGGTGTGCTGGGACAGCAGCCGGTCAGCGGATTGGATATTACCATCCCTATAACGGCTCAGGGCCGTCTTTCTACGGTTAGCCAGTTCGAAGAAATCGTGCTTCGTGCTAATGCCGACGGTTCGCTTATCCGTATGCGTGATGTTGCACGCGTTTCGCTTGAAGCTTCCTCGTATGCTACGGAGAGTGGTATAAACGGAGGTAATGCGGCTGTATTGGGTATTTACATGTTGCCTGGTGCAAACGCAATGGATGTAGCAGAAAAAGTAAAGGAAACGATGGAGGAAATCAGTAAGAATTTCCCTGAAGGATTGCAGTATGAGATACCGTTTGATATAACGACATATATTTCAGAATCTATTCATGAGGTATATAAAACCTTGTTCGAGGCATTGGTTCTGGTTATTATCGTGGTATTCCTTTCTCTGCAAAGCTGGCGTGCAACGGTTATCCCGATTGTGGCTGTGCCCATCTCCTTGATTGGAACATTCGGTTTTATGCTTATATTCGGCTTCTCGCTTAATATGCTTACTTTGCTGGGATTGATTCTTGCCATCGGTATTGTGGTGGATGATGCCATTGTGGTAGTAGAAAATGTTGAACGTATCATGGAAGAAGAAAAGCTTAGTCCATATGAAGCTACTAAGAAAGCTATGGACGGACTGACAGGTGCTTTGATTGCAACTTCAATGGTTCTTGCAGCAGTATTCGTTCCGGTAAGTTTCCTGTCAGGTATTACAGGTCAGCTGTATCGCCAGTTCAGTGTGACTATTGCCGTATCTGTAATCCTTTCTACTGTTGTAGCATTGACTTTGAGCCCGGTAATGTGTTCGCTCATTTTGAAGCCAACCGATCCTAATAAGCCGAAAAATCGTGTGTTTACATTCATCAATAAATGGCTTGCTATTGGAAATACTAAATATGTAGCAGGTATAAAGCGAGTTGTTAAACATCCGCGTCGGGTGATAGTCGGTTTTGGTATCGTAATTATATGTATATTTATGTTCCACCGTCTGGTTCCTACCAGCTTCCTTCCTACTGAAGATCAGGGATTCTTTACTGTAGAGCTTGAACTTCCGGAAGGTACTACACTGGAAAGAACCCGTGAGGTAACCGACAGAGCTGTAGCTTTCCTGATGAAAGATCCGTCTGTAGAATATGTTCAGAACGTTACCGGTAGTAGTCCGCGTGTAGGAACCAGTCAGGCCCGCAGTCAGCTTACCGTGATACTGAAAGAATGGAAACAGCGAGATGATACAACTATCGGACAAATCATGCAGGATGTTCAGGATGAACTGAAGCAGTATCCTGAGTGCAAGGTCTATTTGTCTACTCCTCCTGTTATTCCGGGGCTGGGTACTTCAGGTGGTTTCGAAATGCAGCTTGAGGCTCGTGGAGATGCAACTTATGATGATCTGGTTCGTGCTACCGATACATTGATGTATTATGCTTCGCAACGTAAGGAGTTTGCAGGACTTTCTACTTCGTTGCAGGCTGAAATACCTCAGTTGTATTTCGATGTTGACCGTGATAAAGTCAAATTGTCGGGAGTGCCGATGGCAGATGTCTTCTCTACCATGAAAGCTTATACAGGTTCGGTATATGTGAACGACTTTAATATGTTCAACCGTATTTATCGTGTATATATTCAGGCTGAGGCCCCTTATCGTGAGCACCGTGACAATATCGGCTTGTATTTCGTGAGAGGAAGTGACGGCGATATGATTCCGCTGACTTCACTGGGTACAACCGATTATACGACTGGTCCGGGTAGTATTAAGCGATTCAATATGTTTAATACTTCCATTATTCGCGGTACGGCAGCCAATGGCGCCAGCTCCGGACAGGTAATGGAGATTCTGGAACAGATTGCACGCGAAAAACTTCCAAGTAACATTGGTGTTGAGTGGAGTGGACTTTCTTATCAGGAAAAGCAGGCGGGAGGTCAGACCGGAGCCATTATCGCATTGGTATTCTTGTTCGTATTTTTGTTCCTTGCTGCACTGTATGAAAGTTGGAGTATTCCTATTGCCGTGCTTATTTCACTTCCGGTAGCTGTGCTTGGAGCGTACGCCGGTGTAGCTTTATGTGGATTGGAAAATGATACCTATTTCCAGATTGGTTTGGTTATGTTGATTGGTCTGGCAGCCAAGAATGCCATTTTGATTGTTGAGTTTGCCAAAGAGGAAGTAGATAATGGAAAAGATCTGGTGGAAGCAGCTTTGCATGCAGCTCATCTTCGTTTCCGTCCTATCCTGATGACATCACTGGCTTTCATTCTGGGTATGGTTCCTATGGTTATTGCAACCGGACCGGGTTCGGCCAGCCGTCAAGCTATCGGAACGGGTGTATTCTTTGGTATGATTGTCGCTGTGACGGTAGGTATCTTGCTTGTGCCTTTCTTCTTTGTGATGATTTATAAGGCGAAAAACAAGCTGAAAACAAAAAAAGCTAATTAA	MKVSFFIDRPVFSAVISILIVIVGIIGLQMLPIDQYPQITPPVVKISASYPGASAVTVSQAVATPIEQELNGTPGMLYMESNSSNSGGFSATVTFDISADPDLAAVEIQNRIKLAESSLPAEVVQNGISVEKQAASQLMTICLRSDDPKFDEIYLSNFATINVLDLLRRVPGVGRVSNIGSRYYAMQIWVDPAKLANFGLTVQDVQNALKDQNRESAAGVLGQQPVSGLDITIPITAQGRLSTVSQFEEIVLRANADGSLIRMRDVARVSLEASSYATESGINGGNAAVLGIYMLPGANAMDVAEKVKETMEEISKNFPEGLQYEIPFDITTYISESIHEVYKTLFEALVLVIIVVFLSLQSWRATVIPIVAVPISLIGTFGFMLIFGFSLNMLTLLGLILAIGIVVDDAIVVVENVERIMEEEKLSPYEATKKAMDGLTGALIATSMVLAAVFVPVSFLSGITGQLYRQFSVTIAVSVILSTVVALTLSPVMCSLILKPTDPNKPKNRVFTFINKWLAIGNTKYVAGIKRVVKHPRRVIVGFGIVIICIFMFHRLVPTSFLPTEDQGFFTVELELPEGTTLERTREVTDRAVAFLMKDPSVEYVQNVTGSSPRVGTSQARSQLTVILKEWKQRDDTTIGQIMQDVQDELKQYPECKVYLSTPPVIPGLGTSGGFEMQLEARGDATYDDLVRATDTLMYYASQRKEFAGLSTSLQAEIPQLYFDVDRDKVKLSGVPMADVFSTMKAYTGSVYVNDFNMFNRIYRVYIQAEAPYREHRDNIGLYFVRGSDGDMIPLTSLGTTDYTTGPGSIKRFNMFNTSIIRGTAANGASSGQVMEILEQIAREKLPSNIGVEWSGLSYQEKQAGGQTGAIIALVFLFVFLFLAALYESWSIPIAVLISLPVAVLGAYAGVALCGLENDTYFQIGLVMLIGLAAKNAILIVEFAKEEVDNGKDLVEAALHAAHLRFRPILMTSLAFILGMVPMVIATGPGSASRQAIGTGVFFGMIVAVTVGILLVPFFFVMIYKAKNKLKTKKAN	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	97.83	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_104916_1 # 3 # 704 # -1 # ID=57501_1;partial=10;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.658	k141_104916_1 	3	704	-	Strict	650	24.2534	vanC	100.0	3000368	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	ATGACCGAACAAGAAAACAACGACCGCACGAAGCTTCTGCTCAAGGATGAAAGCCGCTCGCGCTATGTCCTCTGGGCGGCGGGCGGAGTTCTGGCCGCGCTCGTGGCAGGCGCCTGGTACTGGTATCAGGGCACGCAGAACACCAACGCCGTCAAGTACGTGACCGAGGCCGTCGAGCGCGGGGACGTGCACGTCAGCGTGTCCGCGGACGGCACGCTCGCACCTGTGCGCACCGTCTCGCTCGGTTCCGAGCTTTCGGGCATCGTGCGCGAGGTAAACGTCGACGTCAACGACGAGATCAAGGAGGGCCAGAGCCTCATCGTGCTTGACAAGCGCAATCTGGAGGCGAAGGTGCTTCAGAACAGGGCTTCGCTGCGAAGCGCGGAGGCCAGCCGCAGGCAGAGTGCGGCGAGCCTGAGGGAGGCGGAGCTCAAGCTCAAGCGCATGCAGGAGCTCAATCGTCTCTCCAAGGGCACCATGCCGAGCAAGACCGAGCTTGAGACGCAGGCCGCGTCCGTCGACACGGCGCGCGCGGCGGTCGCCGTGGCCGATGCGAACATCGCCGACGCCATGGCCTCGCTCCAGACGGCTGAGAACGATCTCTCCAAGGCCGACATCAAGTCTCCCATCGACGGCGTGGTGCTCGCCCGTTCGGTCGAGCCCGGCTATGCGGTGGCGGCAAGCCTGCAGGCGGTCGAGCTG	MTEQENNDRTKLLLKDESRSRYVLWAAGGVLAALVAGAWYWYQGTQNTNAVKYVTEAVERGDVHVSVSADGTLAPVRTVSLGSELSGIVREVNVDVNDEIKEGQSLIVLDKRNLEAKVLQNRASLRSAEASRRQSAASLREAELKLKRMQELNRLSKGTMPSKTELETQAASVDTARAAVAVADANIADAMASLQTAENDLSKADIKSPIDGVVLARSVEPGYAVAASLQAVEL	MKKIAVLFGGNSPEYSVSLTSAASVIQAIDPLKYEVMTIGIAPTMDWYWYQGNLANVRNDTWLEDHKNCHQLTFSSQGFILGEKRIVPDVLFPVLHGKYGEDGCIQGLLELMNLPYVGCHVAASALCMNKWLLHQLADTMGIASAPTLLLSRYENDPATIDRFIQDHGFPIFIKPNEAGSSKGITKVTDKTALQSALTTAFAYGSTVLIQKAIAGIEIGCGILGNEQLTIGACDAISLVDGFFDFEEKYQLISATITVPAPLPLALESQIKEQAQLLYRNLGLTGLARIDFFVTNQGAIYLNEINTMPGFTGHSRYPAMMAEVGLSYEILVEQLIALAEEDKR	68.22	gnl|BL_ORD_ID|423|hsp_num:0	455	True	loose hit with at least 95 percent identity pushed strict
k141_106488_2 # 536 # 622 # -1 # ID=58368_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.402	k141_106488_2 	536	622	-	Strict	500	19.631	OXA-665	100.0	3004478	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	TTTGAGTTGACTTCTGAAGTGTACAACAGGGTAGCCGAAAAGCGTCTAAACTTCGGGAATCTCCTCTCAAACAAACTACTTAGATAG	FELTSEVYNRVAEKRLNFGNLLSNKLLR	MKKNLFACLVLSTALTQVACSTLQTTADPSTQASTAQQSIKSYFDEVQTKGVIVIKQDGQLQTYGNDLSRANTEYVPASTFKILNALIGLENHKVTLNEVFKWDGQKRSFPTWEKDMNLAEAMKLSAVPVYQELARRIGVDLMAQEVKRLNFGNAQIGTQVDNFWLVGPLKVTPVQEVEFVEQLAHKQLPFKPEVQETVQQMILLQEVKGNKIYAKSGWGMDLDPQVGWLTGWVEQPNGKKVAFSLNMEMKPKMSGSIRNEITLKALENLGVI	10.26	gnl|BL_ORD_ID|2647|hsp_num:0	2910	True	loose hit with at least 95 percent identity pushed strict
k141_106590_2 # 542 # 616 # -1 # ID=58423_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.373	k141_106590_2 	542	616	-	Strict	1650	19.631	Listeria monocytogenes mprF	100.0	3003770	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	TGTGCGAGAGCCGTTGGAATGGTACTTAGATGGAAAAGTGGAAAATGGAAAAGTAAAAGTCTTGTAGAATTATAG	CARAVGMVLRWKSGKWKSKSLVEL	MKEKLMQAYAWFQKNSTVVKIVFITFVMAFVIFEIINIATGIDYPSLKENLTSQSPEQIFIMFIVGLIAVTPMLLYDYVIVKLLPGKFSPSHVIASGWITNTFTNIGGFGGVLGASLRASFYGKNASHKEILLAISKIALFLVSGLSIYCLVSLATLLIPGFADHFVNYWPWLLAGGLYFPILFTITKWKSKSLFVDLPIKRELTLIIASLLEWGFAFGCFAIIGTLMGEPVDIFKVFPLFVIASVIGIASMVPGGVGTFDVVMILGLSQLGVSQELALAWMLFYRIFYYIIPFVVGLLFFVQKAGKKVNDFLEGLPLLFLQKVAHRFLVIFVYGSGLLLILSSAVPNAIYHVPFLYKIMPFNFLFTSQITIVAFGFLLLGLARGIECKTKKAYIITVIVLGCAIFNTLARVFSMKQAIFLGIVLLCLFLARNEFYREKLVYTWSKVIIDSIIFIVCLAGYIVIGIYNSPNIKHSKEIPDYLRIASEHLWLVGFVGVFIAVVSLVIIYIYLSTTKEKLGSPFEAVKVREHLAKWGGNEVSHTMFLRDKLLFWAAEGEVLFSYRIIADKMVIMGEPTGNMDKMEAAIEEVMMNADRFGYRPVFYEVRGTMIPYLHDHGFDFIKLGEEGFVDVQNFTMSGKKKKGERALMNKLEREGYTFEIIEPPFNHDTWTTLRAVSDEWLDGREEKGFSLGFFDTYYLEQAPIAIAKNGEGTIVGFASMMPSYTDEMTSIDLMRYSKEAPSGIMDFLFINLFEKAKEDGFQTFNAGMAPLANVGESKYAFLGERLAGLVYRYSQGFYGFKGLRNFKSKYVTEWEQKFVAFRKRSSIAFTMLQLMILVGKKRPLANSQVVLDFPLEEETKKPDSE	2.77	gnl|BL_ORD_ID|2108|hsp_num:0	2279	True	loose hit with at least 95 percent identity pushed strict
k141_106948_2 # 722 # 811 # -1 # ID=58621_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.433	k141_106948_2 	722	811	-	Strict	500	19.631	OXA-364	100.0	3001551	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GGTTATACATACAAAGACACCGACCAAGGGAAATGGATAATCTGGGGCGGTGATGCATGGGAAAATATTGATGGTAGCCCTCTTGAGTAA	GYTYKDTDQGKWIIWGGDAWENIDGSPLE	MPLRLPLRALGAALSLFALAGAPASAAVLCTVVADAADGRIVFQQGTQAACAERYTPASTFKLPIALMGADAGILQGAHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYASAFQYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLPLKPAAYDLAETLFDAGEAGGWRLYGKTGTGSPGSNGVYTPDNAYGWFVGWARKDGRQLVFARLLQDEKATRPNAGLRARDELLREWPAMADAPRQ	10.55	gnl|BL_ORD_ID|2140|hsp_num:0	3481	True	loose hit with at least 95 percent identity pushed strict
k141_107531_2 # 590 # 787 # -1 # ID=58957_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.429	k141_107531_2 	590	787	-	Strict	710	20.7866	efrB	100.0	3003949	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; rifamycin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	CATACTTCTTTTGTAATTGCTCACAGATTGTCTACCATACGAAGAGCAGATGTGATTCTGGTGGTAAAGGACGGGAAAATCATTGAGCAGGGAACCCATAAGGAATTGCTTCAGGCAAAGGGCTATTATTATGAGCTGTATTCCAGACAGTTTGAAGAAGAGGCTGCCATGGGAATTTTATCAGGGCAGGAGCAGTGA	HTSFVIAHRLSTIRRADVILVVKDGKIIEQGTHKELLQAKGYYYELYSRQFEEEAAMGILSGQEQ	LDTCRIFRRNAKSPVNIAKHAKFIRRLKWLCSENMTGFSVLKLYVRKKKPLKGFKQVNHRFKWFGFKASFISGLMLPLVQMTAYGTYIGVAVLGSYYVVAGVIVVGQLQAFIQYIWQISQPMGNITQLSAALQSASASTMRIFEILDEPEEELNEQDVPLPEPILGSVEFENVSFSYDPEKPLIRNLNFKVDAGQMVAIVGPTGAGKTTLINLLMRFYDVTEGAIKIDGIDTKKMNRSDVRSVFGMVLQDAWLYKGTIADNIRFGKLDATDYEVVDAAKTANVDHFIRTMPDGYEMEINSEGDNVSLGQKQLLTIARAVISDPKILILDEATSSVDTRLEALIQKAMDRVMEGRTSFVIAHR	17.96	gnl|BL_ORD_ID|2240|hsp_num:0	2422	True	loose hit with at least 95 percent identity pushed strict
k141_110805_2 # 727 # 909 # -1 # ID=60734_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.617	k141_110805_2 	727	909	-	Strict	1000	22.3274	mecD	100.0	3004185	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	GTGGGCGGCACGAGTCCCTTCGGCACCCGAAAGAAGATGCCGGTCTACGTCCAGAAGACCATTCTCGAGCTTGACCATATCTTCATCAACGGCGGGCGACGGGGCTATCAGGTCGGCATCGATCCCAAGGTGCTCGTCGACGTGCTCGGCGGCATCCCCGTCGACTGCGCGAACGAGGAGTAG	VGGTSPFGTRKKMPVYVQKTILELDHIFINGGRRGYQVGIDPKVLVDVLGGIPVDCANEE	MKNIKVKILIVCSLCLISFFLYNLLKENEIDKIFSSIENRNVDEINENITFLSRNTFSKKQRYDRMNHIDNSLGIKKVNITDIKLLEEIVDTRKYSANMHYDSKFGKFTKKGYFEFEKNGESKRWELNWTPEVIIPGLTATNEVRVEELKSSRGEIVDRNGIPLAIDGEHYQVGIDPKNYNKKDSKQIAKLLNINESTLKNKLKQSWVKDGVFVPIKSYVELSDEIKNKIPEYGLSVNKIKGRTYPLKEASAHLLGYIGEINADELNDPKFKGYDSHSIVGKTGIEYMYDKELQNRDGLIVYITDDDGLTDSKEILVHKKPKNGKKIVLSIDSRVQNSIYNHLKDDNGSGTAMNPKTGELLALVSYPSFNPYDFMFGISNKKYQALLNDKKAPLLNKFQELTSPGSTQKLLTSIIGLNNGVINESKSYEINGKGWRKDGSWGGYKVTRFEVVNGRIDLEKAIAHSDNIFFARTTLEMGGKKFVRGMKDLGVGEETPSDYPVRTGQIANKINLERNLNNDILLADSGYGQGEILVNPIHILSIYSSLVNEGNMMAPKLNMEHKSKVWKKHITSQKNIDILTSSMRKVVTGTHKLDTERNYANFAGKTGTAELKMTQNEGLGTQIGWFVGYDQQNPNMMLAINVKNVEDKGMSSYNAQKFAQVMDDLYEHGARTYEPDSE	8.85	gnl|BL_ORD_ID|2484|hsp_num:0	2828	True	loose hit with at least 95 percent identity pushed strict
k141_112323_23 # 19203 # 19343 # -1 # ID=61577_23;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.433	k141_112323_23 	19203	19343	-	Strict	400	20.7866	catB9	100.0	3002681	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	GAGAAGAAAGAATTTCTTAACAGCTTTGTAGAACAGGTGGACATTTACGAGCAGGAGCAGCCAGATGGCAGATTCCTGAAGCACATAAAGTTCCGTTTTCCGGTGTATTTTGGAGACAGAGAGACACAGGAACTTTGTTAG	EKKEFLNSFVEQVDIYEQEQPDGRFLKHIKFRFPVYFGDRETQELC	MNFFTSPFSGIPLDQQVTNPNIIVGKHSYYSGYYHGHSFDDCVRYLHPERDDVDKLVIGSFCSIGSGAVFMMAGNQGHRSDWISTFPFFYQDNDNFADARDGFTRSGDTIIGHDVWIGTEAMIMPGVKIGHGAIIASRSVVTKDVAPYEVVGSNPAKHIKFRFSDVEIAMLLEMAWWNWPESWLKESMQSLCSSDIEGLYLNWQSKART	22.01	gnl|BL_ORD_ID|93|hsp_num:0	106	True	loose hit with at least 95 percent identity pushed strict
k141_114569_2 # 490 # 729 # -1 # ID=62804_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.442	k141_114569_2 	490	729	-	Strict	1000	21.9422	vga(E) Staphylococcus cohnii	100.0	3004715	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	TTAGAACAGTGGAAGCGTGAAAAAAGAACGATTCTGTTTGTAACGCATGATGTGGAAGAAGCGCTATATCTTTCGCAGAGAGTTTTTGTATTGCATGGAAGACCCGTCACTAGGGTAGAAAGTATAGAAGTACCGCTTTCTTATCCTAGAACAAGAGAACAGTTAGAACAGCCTGAGCTTTTAGCGCTGAAAGAAGAACTGATCGGTCAGCTCAGAGCGGAGACGGGAGGAGAACAATGA	LEQWKREKRTILFVTHDVEEALYLSQRVFVLHGRPVTRVESIEVPLSYPRTREQLEQPELLALKEELIGQLRAETGGEQ	MLLFEGTSIKKQLHDRVLFDIDLIQVHDNQRIGLVGRNGTGKTSLLKIITGEELPDEGNISPFTSVKLVPQFKESRLEKSGGEITQQYLQNAFNGNPGLLLLDEPTTHLDTERIAWLEKKIRNYQGAAVVVSHDRTFLNNVCTDIWEIEKNTLKIFKGNYDEYAKQKEILKKQKQTEFEKYEREKQKLERAIRQKEERAQRATKKPKNLSSSEARIVGAKTHYANIQKKLRSSAKALETRLEQLDKVDKVKELPEIKMDMLNEENLTNQSVLRAENIKGEIEERKLWEPFSLYLYGGDKVAIIGKNGSGKTTLLKKIVKQDEGVTIPEKVKIGYFSQHLTILNDEKSIIENVQSTSSQNETLIRTVLARMHFWDEDVYKKVGILSGGEKVKLALAKLFLSEVNMLVLDEPTNFLDIAALEALETLMKSYHGTILFVTHDRMLVKNIATKIIDIKDGKITVFDGSYEAYEEWLENKTKSNNDDQLLLIETKISDVLGRLSLEPSQELEDEFQRLLKEKKELTRGE	15.08	gnl|BL_ORD_ID|2307|hsp_num:0	3400	True	loose hit with at least 95 percent identity pushed strict
k141_115584_5 # 2350 # 4290 # 1 # ID=63354_5;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.379	k141_115584_5	2350	4290	+	Strict	500	985.712	tet(W/N/W)	72.53	3004442	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAAAATAATCAATATCGGCATTCTCGCCCATGTAGACGCAGGAAAGACGACCTTAACGGAAAGCCTGCTTTATACAAGTGGAGCGATTTTAGAATTAGGTAGCGTAGATAAGGGAACGACAAGGACAGACACTATGTTTTTGGAACGTCAGCGTGGAATTACCATTCAGGCAGCCGTTACTTCTTTCAACTGGAACGGCTACAAAATCAATATTGTAGACACTCCCGGACATATGGACTTTTTAACAGAAGTATATCGTTCTTTGTCTGTTCTTGACGGGGCAGTTTTAGTGATTTCTGCGAAAGACGGTGTACAGGCTCAAACCCGGATACTATTCCATGCACTCCAAAAAATGAATATACCAACAATCATTTTTATAAACAAGATAGACCAGTACGGAATTAACCTGCATAATACTTATCAAAATATCAAAGAAAAACTTTCGACTGATATTATCATTATGCAGAATGTAACATTGACTCCAGAAGTATCACTGGAAAATATCACGGATTTAGAAAAATGGGACGCTGTAATTGCAGGAAATGACAGACTTTTAGAAAAGTATATTGCAGGGGAAACATTGACGGTACAGGAATTAAAACAGGAAGAATATGGACGGGTTCAGAAAGGTTCTTTGTTTCCAATATATCATGGAAGTGCAAAAAACAACATAGGGACACAACAGCTCATTGAAGTCATTTCAGATATTTTTTGTTCCGAAATGGATAAAAGCCAGTCAGAACTATGCGGAAGTGTTTTCAAAATTGAATATACAGACCGAAAGCAGAGATTAGCCTATTTACGCCTTTACAGTGGAACATTACACTTACGGGATACCATTATATTGTCAGAAAAGAAGAAAATGAAACTTACTGAAATGTATATTCCTTCAAATGGAGAAATGATACAGACGGAAATTGCCCGTTCCGGAGATATTGTTATTTTGCCTAACGATATATTAAAATTGAATGATATTGTGGGAAACGAAAAAATGTTGCCATGCAACGCATGGAATGACAATCCTGTACCCATGCTGCGGACAATGATTGAACCGATAAAACCAGAACAAAGAGAGTATTTATTGGACGCTCTTACAGAAATTGCAGATACAGATCCCCTTTTACGTTATTATGTTGATACGATAACACATGAAATCATCATTTCTTTTTTAGGAACGGTGCAGTTAGAAGTTATCTGTTCTCTGCTGACTGAAAAATACCATATAGACATAAACGTCAAAGAGCCTACGGTTATTTATCTGGAAAAGCCATTACAAAAGGCAGATTATACGATTCATATTGAAGTGCCGCCAAATCCTTTTTGGGCGTCGATTGGCTTATCGGTAACTCCGCTTCCAATAGGCAGCGGAATACAGTACGAAAGCAAAGTTTCCCTCGGTTACTTAAACCAAAGTTTCCAAAATGCAGTAATGGACGGTATTGATTATGGATTGGAGCAGGGATTGTATGGCTGGAAAGTAACAGATTGTAAAATTTGTTTTGAATATGGTGTTTATTACAGCCCTGTCAGCACTCCCGCAGATTTTCGCTTCCTTGCCCCTATTGTACTGGAACAAGTATTGAAAAAAACTGGAACGCAATTATTAGAGCCGTATCTTTCGTTTACTCTTTTTACACCGCAGGAATATCTTTCCCGTGCATATAACGACGCACCACAATACTGTGCAATTATTGAAACAAGCCAACTGAAAAATGATGAAGTCATTTTTACGGGACATATTCCTGTACGTTGTATTAGTGCATACCGTAATGCTTTAACTCTATATACAAATGGGCAAGCAGTTTGTTTGACAGAATTAAAAGGCTATCAAGCTGCTGCTTGTGAACCAGTTATTCAATCACGCCGCCCCAATAGCCGAATAGATAAAGTACGCCATATGTTTAATAAAAAAACTGAACACCTTTCTAATGAAGCGTAA	MKIINIGILAHVDAGKTTLTESLLYTSGAILELGSVDKGTTRTDTMFLERQRGITIQAAVTSFNWNGYKINIVDTPGHMDFLTEVYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMNIPTIIFINKIDQYGINLHNTYQNIKEKLSTDIIIMQNVTLTPEVSLENITDLEKWDAVIAGNDRLLEKYIAGETLTVQELKQEEYGRVQKGSLFPIYHGSAKNNIGTQQLIEVISDIFCSEMDKSQSELCGSVFKIEYTDRKQRLAYLRLYSGTLHLRDTIILSEKKKMKLTEMYIPSNGEMIQTEIARSGDIVILPNDILKLNDIVGNEKMLPCNAWNDNPVPMLRTMIEPIKPEQREYLLDALTEIADTDPLLRYYVDTITHEIIISFLGTVQLEVICSLLTEKYHIDINVKEPTVIYLEKPLQKADYTIHIEVPPNPFWASIGLSVTPLPIGSGIQYESKVSLGYLNQSFQNAVMDGIDYGLEQGLYGWKVTDCKICFEYGVYYSPVSTPADFRFLAPIVLEQVLKKTGTQLLEPYLSFTLFTPQEYLSRAYNDAPQYCAIIETSQLKNDEVIFTGHIPVRCISAYRNALTLYTNGQAVCLTELKGYQAAACEPVIQSRRPNSRIDKVRHMFNKKTEHLSNEA	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVYQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRLVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAHKGEIVILPSDSLRLNDILGDKTQLPREMWSDVPFPMLRTTITPKTAEQRDRLLDALTQIADTDPLLHYEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQATVGEPIIQPRRPNSRLDKVRHMFSKIP	101.10	gnl|BL_ORD_ID|2556|hsp_num:0	2882		
k141_118718_1 # 765 # 1712 # 1 # ID=65052_1;partial=01;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.520	k141_118718_1	765	1712	+	Strict	500	623.239	tet(W/N/W)	96.84	3004442	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAAAATAATCAATATTGGAATTCTTGCCCATGTAGACGCTGGAAAGACGACCTTGACGGAGAGCCTGCTATATGCCAGCGGAGCCATTTCAGAACCGGGGAGCGTCGAAAAAGGGACAACGAGGACGGACACCATGTTTTTGGAGCGGCAGCGTGGGATTACCATTCAAGCGGCAGTCACTTCCTTCCAGTGGCACAGATGTAAAGTTAACATTGTGGATACGCCCGGCCACATGGATTTTTTGGCGGAGGTGTACCGCTCTTTGGCTGTTTTAGATGGGGCCATCTTGGTGATCTCCGCTAAAGATGGCGTGCAGGCCCAGACCCGTATTCTGTTCCATGCCCTGCGGAAAATGAACATTCCCACCGTTATCTTTATCAACAAGATCGACCAGGCTGGCGTTGATTTGCAGAGCGTGGTTCAGTCTGTTCGGGATAAGCTCTCCGCCGATATTATCATCAAGCAGACGGTGTCGCTGTCCCCGGAAATAGTCCTGGAGGAAAATACCGACATAGAAGCATGGGATGCGGTCATCGAAAATAACGATAAATTATTGGAAAAGTATATCGCAGGAGAACCAATCAGCCGGGAAAAACTTGTGCGGGAGGAACAGCGGCGGGTTCAAGACGCCTCCCTGTTCCCGGTCTATTATGGCAGCGCCAAAAAGGGCCTTGGCATTCAACCGTTGATGGATGCGGTGACAGGGCTGTTCCAACCGATTGGGGAACAGGGGAGCGCCGCCCTATGCGGCAGCGTTTTCAAGGTGGAGTATACAGATTGCGGCCAGCGGCGTGTCTATCTACGGCTATACAGCGGAACGCTGCGCCTGCGGGATACGGTGGCCCTGGCCGGGAGAGAAAAGCTGAAAATCACAGAGATGCGTATTCCATCCAAAGGGGAAATTGTTCGGACAGACACCGCTTATCAGGGTGAAATTGTTATCCTT	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQPIGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAYQGEIVIL	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVYQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRLVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAHKGEIVILPSDSLRLNDILGDKTQLPREMWSDVPFPMLRTTITPKTAEQRDRLLDALTQIADTDPLLHYEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQATVGEPIIQPRRPNSRLDKVRHMFSKIP	49.45	gnl|BL_ORD_ID|2556|hsp_num:0	2882		
k141_118720_1 # 2 # 517 # -1 # ID=65053_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.531	k141_118720_1 	2	517	-	Strict	1300	351.288	tetW	100.0	3000194	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	CGGGATAAGCTCTCCGCCGATATTATCATCAAGCAGACGGTGTCGCTGTCCCCGGAAATAGTCCTGGAGGAAAATACCGACATAGAAGCATGGGATGCGGTCATCGAAAATAACGATGAATTATTGGAAAAGTATATCGCAGGAGAACCAATCAGCCGGGAAAAACTTGCGCGGGAGGAACAGCAGCGGGTTCAAGACGCCTCCCTGTTCCCAGTCTATCATGGCAGCGCCAAAAATGGCCTTGGCATTCAACCGTTGATGGATGCGGTGACAGGGCTGTTCCAACCGATTGGGGAACAGGGGGGCGCCGCCCTATGCGGCAGCGTTTTCAAGGTTGAGTACACCGATTGCGGCCAGCGGCGTGTCTATCTACGGTTATACAGCGGAACGCTGCGCCTGCGGGATACGGTGGCCCTGGCCGGGAGAGAAAAGCTGAAAATCACAGAGATGCGTATTCCATCCAAAGGGGAAATTGTTCGGACAGACACCGCTTATCAGGGTGAAATTGTTATCCTT	RDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAYQGEIVIL	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM	26.92	gnl|BL_ORD_ID|362|hsp_num:0	389	True	loose hit with at least 95 percent identity pushed strict
k141_124445_2 # 1481 # 1705 # 1 # ID=68055_2;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=11bp;gc_cont=0.422	k141_124445_2 	1481	1705	+	Strict	500	22.7126	OXA-60	100.0	3001808	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGAAACAAAAAACAAAGCAAAACAGCTCTTTCATCGGCTACCTTCCCGTCTGAAGTTTGGAATCATGCAATATGTAGTGATGAATCTTTTTCTGGTTGTGCTGAATTATGCAACCTCTCCACAGTGCTGGTGGGCAGGATGGGTGGCCTTGGGGTGGGGATTAAGTCTGCTGTTAAAGCTCATATCGTGGTATTATATTAGTGATAATGAGGAGGAAAAGTAA	METKNKAKQLFHRLPSRLKFGIMQYVVMNLFLVVLNYATSPQCWWAGWVALGWGLSLLLKLISWYYISDNEEEK	MLSRYSKTLAFAVVACTLAISTATAHAELVVRNDLKRVFDDAGVSGTFVLMDITADRTYVVDPARAARSIHPASTFKIPNSLIAFDTGAVRDDQEVLPYGGKPQPYEQWEHDMALPEAIRLSAVPIYQEVARRVGFERMQAYVDAFDYGNRQLGSAIDQFWLRGPLEISAFEEARFTSRMALKQLPVKPRTWDMVQRMLLIEQQGDAALYAKTGVATEYQPEIGWWAGWVERAGHVYAFALNIDMPREGDMAKRIPLGKQLMRALEVWPAP	27.31	gnl|BL_ORD_ID|38|hsp_num:0	47	True	loose hit with at least 95 percent identity pushed strict
k141_125225_3 # 1020 # 1124 # -1 # ID=68489_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.610	k141_125225_3 	1020	1124	-	Strict	700	19.631	tet(A)	100.0	3000165	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TGGAACGGCTGGGCCAACAGCGTCAATGAGGAAGGCCGCCACGAGATCCTGGAGCCGGACGAGGCCATGACCAGCGAGTGGAGCATCACCATCGAGAAGGTCTGA	WNGWANSVNEEGRHEILEPDEAMTSEWSITIEKV	MSTNLSVIKNPRVQSDQRRLVRRPDVKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACAPVLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPALRRGLWRNSSNSRCT	8.02	gnl|BL_ORD_ID|1835|hsp_num:0	1808	True	loose hit with at least 95 percent identity pushed strict
k141_128235_2 # 628 # 693 # 1 # ID=70093_2;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.561	k141_128235_2 	628	693	+	Strict	1900	18.4754	MuxB	100.0	3004074	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCTTTTCGTCATGGATTAAAATGGCTGGCAGCCGCAGGGCTGAGTCTGGCCATGGCCGGATGC	MSFRHGLKWLAAAGLSLAMAGC	MNPSRPFILRPVATTLLMVAILLSGLIAYRFLPISALPEVDYPTIQVVTLYPGASPEIMTSSITAPLENQLGQIPGLNEMSSSSSGGASVITLQFSLQSNLDVAEQEVQAAINAAQSLLPNDLPNQPVFSKVNPADAPILTLAVMSDGMPLPQIQDLVDTRLAQKISQISGVGLVSISGGQRPAVRVRANPTALAAAGLSLEDLRSTVTSNNLNGPKGSFDGPTRASTLDANDQLRSADAYRDLIIAYKNGSPLRIRDVASVEDDAENVRLAAWANNLPAVVLNIQRQPGANVIEVVDRIKALLPQLQSTLPGNLDVQVLTDRTTTIRASVKDVQFELALAVALVVMVTFLFLRNVYATLIPSFAVPLSLIGTFGVMYLSGFSINNLTLMALTIATGFVVDDAIVMVENIARYLEQGDSPLEAALKGSKQIGFTIISLTFSLIAVLIPLLFMGDVAGRLFREFAITLAVAILISGFVSLTLTPMLSAKLLRHIDEDQQGRFARAAGRVIDGLIAQYAKALRVVLRHQPLTLLVAIATLALTALLYLAMPKGFFPVQDTGVIQGVAEAPQSISFQAMSERQRALAEVVLKDPAVASLSSYIGVDGSNPTLNTGRLLINLKPHSERDVTASEVIQRLQPELDHLPGIKLYMQPVQDLTIEDRVARTQYQFTLQDADPDVLAEWVPKLVARLQELPQLADVASDWQDKGLQAYLNIDRDTASRLGVKLSDIDSVLYNAFGQRLISTIFTQATQYRVVLEVAPQFQLGPQALEQLYVPSSDGTQVRLSSLAKVEERHTLLAINHIAQFPSATLSFNLAKGYSLGEAVEAIRGVEASLELPLSMQGSFRGAALAFEASLSNTLLLILASVVTMYIVLGILYESFIHPVTILSTLPSAGVGALLALMLAGQEIGIVAIIGIILLIGIVKKNAIMMIDFALDAERNEGKPPHEAIYQACLLRFRPILMTTMAALLGALPLMLAGGAGAELRQPLGITMVGGLLLSQVLTLFTTPVIYLYFDRLARRWAAWRKQRGLDLNTEAGFDGDAGR	2.11	gnl|BL_ORD_ID|2428|hsp_num:0	2718	True	loose hit with at least 95 percent identity pushed strict
k141_129699_3 # 634 # 711 # -1 # ID=70861_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.705	k141_129699_3 	634	711	-	Strict	400	20.0162	QnrD2	100.0	3002789	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	ACGCAGGTGGAGAAGGACGCGCTGGGCATCGGCGGCGGCATGGTCGGCCTCTGCGACCTCACAGGCGGTGCGCGATGA	TQVEKDALGIGGGMVGLCDLTGGAR	MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRTNLDGVKLDGEQAFQLVESLGVIVHR	11.68	gnl|BL_ORD_ID|485|hsp_num:0	517	True	loose hit with at least 95 percent identity pushed strict
k141_130963_7 # 11144 # 11221 # 1 # ID=71510_7;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.359	k141_130963_7 	11144	11221	+	Strict	650	18.8606	tetA(58)	100.0	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGACGTTAAGATTATGGCTGTTAATGACCCCCCTGAACAACCACCATTAATTTTTAAAAGAAATAGCAAGTATACC	MDVKIMAVNDPPEQPPLIFKRNSKYT	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	7.58	gnl|BL_ORD_ID|2286|hsp_num:0	2517	True	loose hit with at least 95 percent identity pushed strict
k141_131111_1 # 3 # 95 # 1 # ID=71584_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.495	k141_131111_1 	3	95	+	Strict	400	19.631	vanRE	100.0	3002924	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATAGGGCAGGGACTGTCCGAATTGACGCCTGTGGAGATAGTAGGTTATGAGGTCTATGAGGCAGGAATCCCATTGGCTTTAGACAATGGGTAG	IGQGLSELTPVEIVGYEVYEAGIPLALDNG	MAKILILDDEKEIVSLLSTLLSNEGYEVYEAMSGKESLEIIENNKIDLAILDVMLPDISGFDVLQSIREKQFFPVLMLTARGQDMDKITGLSMGADDYIVKPFNPFEVLARVKTQLRRYQTYNSQSIDETNEYAKNGLNISVNSRKVFLYDEEIKLTPIEFDILWYLCRNEGRVISSEELFEKVWKEDYLENNNTVMAHIAKIREKMHEKPRQPNIIKTVWGVGYTIEK	13.10	gnl|BL_ORD_ID|650|hsp_num:0	691	True	loose hit with at least 95 percent identity pushed strict
k141_133622_5 # 1177 # 1254 # -1 # ID=72949_5;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.705	k141_133622_5 	1177	1254	-	Strict	400	20.0162	QnrD2	100.0	3002789	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	ACGCAGGTGGAGAAGGACGCGCTGGGCATCGGCGGCGGCATGGTCGGCCTCTGCGACCTCACAGGCGGTGCGCGATGA	TQVEKDALGIGGGMVGLCDLTGGAR	MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRTNLDGVKLDGEQAFQLVESLGVIVHR	11.68	gnl|BL_ORD_ID|485|hsp_num:0	517	True	loose hit with at least 95 percent identity pushed strict
k141_133996_2 # 518 # 652 # 1 # ID=73145_2;partial=01;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.437	k141_133996_2 	518	652	+	Strict	375	22.3274	vanXI	100.0	3003725	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanX; glycopeptide resistance gene cluster	ATGCTTTGTAAGGAATTGACAGAGAAAATCGAAGAAGTATATCCGGTTTCGTATGCATGTGAGTGGGATAATGTAGGGCTTCTTGTCGGACGAGCCAACAAAGAGGTGAAAAGCGTTTATCTTGCGCTGGATGTG	MLCKELTEKIEEVYPVSYACEWDNVGLLVGRANKEVKSVYLALDV	MKSDFVFVDELVSGIRWDAKYATWDNFTGKPVDGYAANRIVGTRALCAALEKARENAASLGFGLLLWDGYRPQCAVDCFLRWSKQPEDGRTKQKHYPNIDRSEIIEKGYVAAKSGHSRGSAIDLTLYHLASGTLVPMGGDFDLMDSVSHHGAHGISQAEARNRQYLCSIMEASGFVSYACEWWHYSLKHEPYPNTYFDFLIA	22.28	gnl|BL_ORD_ID|2094|hsp_num:0	2243	True	loose hit with at least 95 percent identity pushed strict
k141_134176_4 # 1442 # 2407 # -1 # ID=73251_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.360	k141_134176_4	1442	2407	-	Strict	600	656.366	CfxA3	99.07	3003003	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	ATGGAAAAAAACAGAAAAAAACAAATCGTAGTTTTGTGTATAGCTTTAGTTTGCATTTTCATCTTGGTATTTTCATTGTTCCATAAATCAGCGACAAAAGATAGCGCAAATCCTCCTTTAACAAATGTTTTGACTGATAGTATTTCTCAAATTGTCTCAGCTTGTCCTGGTGAAATTGGTGTGGCGGTTATTGTTAATAACAGAGATACGGTTAAGGTCAATAATAAGAGTGTTTATCCTATGATGAGTGTGTTTAAGGTTCATCAGGCATTAGCTCTTTGCAATGACTTTGACAATAAAGGAATTTCACTTGATACCTTGGTAAATATAAATAGGGATAAACTTAACCCAAAGACTTGGAGTCCTATGCTGAAAGATTATTCAGGACCAGTCATATCATTGACAGTAAGAGATTTGCTGCGTTATACTCTTACTCAGAGTGACAACAATGCAAGCAACCTTATGTTTAAGGATATGGTTAATGTCGCTCAAACAGATAGTTTTATAGCCACACTCATCCCTCGTTCAAGTTTTCAGATAGCTTATACGGAAGAGGAAATGTCGGCTGACCATAACAAGGCTTACTCTAACTATACATCTCCTCTTGGTGCTGCAATGTTGATGAATCGTTTGTTTACTGAAGGTCTTATCGATGATGAGAAACAAAGTTTCATTAAGAATACGTTAAAAGAATGCAAAACAGGTGTAGATAGGATAGCAGCTCCACTTCTTGATAAAGAAGGGGTTGTTATAGCGCATAAGACAGGTTCAGGTGATGTTAATGAAAATGGCGTTCTTGCAGCTCACAATGATGTTGCCTATATATGTCTGCCTAATAATGTCAGCTATACCTTAGCGGTATTTGTTAAGGATTTCAAGGGAAATGAATCACAAGCGTCACAATATGTTGCGCATATATCAGCTGTAGTATATTCTTTATTAATGCAGACTTCGGTAAAATCTTAA	MEKNRKKQIVVLCIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLNPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNVSYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	100.00	gnl|BL_ORD_ID|1790|hsp_num:0	1895		
k141_134189_8 # 8152 # 8316 # 1 # ID=73261_8;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=11bp;gc_cont=0.436	k141_134189_8 	8152	8316	+	Strict	750	20.4014	pmrA	100.0	3000822	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAAAAGTACATTTGCACAGTTTGCGATTGGGTTTACGATCCTGAAGTAGGTGATCCTGAAGGTGGTATCGCTCCTGGAACTGCATTCGAAGATATTCCGGAAGATTGGGTTTGCCCGGTTTGCGGTGTAGGAAAAGAAGATTTTCAGCCTGTAGAAGATTAA	MKKYICTVCDWVYDPEVGDPEGGIAPGTAFEDIPEDWVCPVCGVGKEDFQPVED	MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISAALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAILTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANASSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGSAVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI	13.53	gnl|BL_ORD_ID|1974|hsp_num:0	2003	True	loose hit with at least 95 percent identity pushed strict
k141_134542_4 # 2114 # 2266 # 1 # ID=73451_4;partial=01;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.314	k141_134542_4 	2114	2266	+	Strict	400	20.0162	QnrA6	100.0	3002712	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	ATGAAAAAATTTCCAGAAAATTTCTTTTGGGGAGCTGCTGCAAGTGGACCTCAGACAGAAGGAATAACAAATAAAGTAAATAAATCAATATGGGATATTTGGTTTGAAAAAGAACCTGAAAGATTTTACAATCAAATTTCTCCATATGTAGTC	MKKFPENFFWGAAASGPQTEGITNKVNKSIWDIWFEKEPERFYNQISPYVV	MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD	23.39	gnl|BL_ORD_ID|1577|hsp_num:0	1673	True	loose hit with at least 95 percent identity pushed strict
k141_134799_5 # 3001 # 3174 # -1 # ID=73572_5;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.345	k141_134799_5 	3001	3174	-	Strict	300	117.472	lnuC	96.49	3002837	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	CCGGTAGAAACTTTTTCGGGTAAAGGAAGAATTGAGGAAATAGAGGTTTCCTGTATTGAACCATATAGTCAAGTAATGTTCCATCTGGGATACGAGTTTGATGAAAATGATGCACATGATGTGAAGTTATTGTGTGAGACATTTCATATCGAAATTCCAAATGAGTATAGATAA	PVETFSGKGRIEEIEVSCIEPYSQVMFHLGYEFDENDAHDVKLLCETFHIEIPNEYR	MVNITDVNQIFQFAIDAEIKVFLDGGWGVDALLGYQSRAHNDIDIFVEKNDYQNFIEIMKANGFYEIKMEYTTLNHTVWEDLKNRIIDLHCFEYTDEGEILYDGDCFPVETLSGKGRIEEIEVSCIEPYSQVMFHLGYEFDENDAHDVKLLCETLHIEIPNEYR	34.76	gnl|BL_ORD_ID|350|hsp_num:0	376	True	loose hit with at least 95 percent identity pushed strict
k141_135825_1 # 1 # 207 # 1 # ID=74106_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.338	k141_135825_1 	1	207	+	Strict	400	22.3274	ErmA	100.0	3000347	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATCTTTATAGCGGATTATATTGAACCGGGCAGAATATCTGCTCCAAATCTTTCTGAAATTAGAAAAATCTCTTTTGAGAATTTGGATATAGCAATGTTCCGTATTTTAGACGATACATTGCTATATCTTGCAAAAAAAGGTGGAGTTATCGACCCGGCGACAGAAGAAACTTATCAGTATTATAAAATATATGGAAACATTCCGTAG	IFIADYIEPGRISAPNLSEIRKISFENLDIAMFRILDDTLLYLAKKGGVIDPATEETYQYYKIYGNIP	MNQKNPKDTQNFITSKKHVKEILNHTNISKQDNVIEIGSGKGHFTKELVKMSRSVTAIEIDGGLCQVTKEAVNPSENIKVIQTDILKFSFPKHINYKIYGNIPYNISTDIVKRITFESQAKYSYLIVEKGFAKRLQNLQRALGLLLMVEMDIKMLKKVPPLYFHPKPSVDSVLIVLERHQPLISKKDYKKYRSFVYKWVNREYRVLFTKNQFRQALKHANVTNINKLSKEQFLSIFNSYKLFH	27.98	gnl|BL_ORD_ID|932|hsp_num:0	985	True	loose hit with at least 95 percent identity pushed strict
k141_139431_1 # 2 # 892 # -1 # ID=76032_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.536	k141_139431_1	2	892	-	Strict	500	573.163	tet(W/N/W)	93.27	3004442	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	TACAGCGGAACGCTGCGCCTGCGGGATACGGTGGCCCTGGCCGGGAGAGAAAAGCTGAAAATCACAGAGATGCGTATTCCATCCAAAGGGGAAATTGTTCGGACAGACACCGCTTATCAGGGTGAAATTGTTATCCTTCCCAGCGACAGCGTGAGGTTAAACGATGTATTAGGGGACCAAACCCGGCTCCCTCGTAAAAGGTGGCGCGAGGACCCCCTCCCCATGCTGCGGACGACGATTGCGCCGAAAACGGCAGCGCAAAGAGAACGGCTGCTGGACGCTCTTACGCAACTTGCGGATACTGACCCGCTTTTGCGTTGCGAAGTGGATTCCATCACCCATGAGATCATTCTTTCTTTTTTGGGCCGGGTGCAGTTGGAGGTTGTTTCCGCTTTGCTGTCGGAAAAATACAAGCTTGAAACAGTGGTAAAGGAACCCTCCGTCATTTATATGGAGCGGCCGCTCAAAGCAGCCAGCCACACCATCCATATCGAGGTGCCGCCCAACCCGTTTTGGGCATCCATAGGACTGTCTGTTACACCACTCTCGCTTGGCTCCGGTGTACAATACGAGAGCCGGGTTTCGCTGGGATACTTGAACCAGAGTTTTCAAAACGCTGTCAGGGATGGTATCCGTTACGGGCTGGAGCAGGGCTTGTTCGGCTGGAACGTAACGGACTGTAAGATTTGCTTTGAATACGGGCTTTATTACAGTCCGGTCAGCACGCCGGCGGACTTCCGCTCATTGGCCCCGATTGTATTGGAACAGGCATTGAAGGAATCAGGGACGCAACTGCTGGAACCTTATCTCTCCTTCACCCTCTATGCGCCCCGGGAATATCTTTCCAGGGCTTATCATGATGCACCGAAATACTGTGCCACCATCGAAACG	YSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFTLYAPREYLSRAYHDAPKYCATIET	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVYQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRLVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAHKGEIVILPSDSLRLNDILGDKTQLPREMWSDVPFPMLRTTITPKTAEQRDRLLDALTQIADTDPLLHYEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQATVGEPIIQPRRPNSRLDKVRHMFSKIP	46.48	gnl|BL_ORD_ID|2556|hsp_num:0	2882		
k141_140299_1 # 421 # 561 # -1 # ID=76497_1;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.461	k141_140299_1 	421	561	-	Strict	1300	20.4014	vanTE	100.0	3002971	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	TCGGCACAGTTCAAAGTATTTGAGATCCGGCAGCAGGGAGATTCGTGGTATGGCAAAATTGCTGAAACCGCGGATAACTGGGCTCTTCTGAAGGATGAAAAAATCAATTATGCCATCATGACTCCACAGGAAGGTGCCTGA	SAQFKVFEIRQQGDSWYGKIAETADNWALLKDEKINYAIMTPQEGA	MKHRANGIDLFRIFAATMVVAIHTFPFQSIAPFLDEVITLTVFRVAVPFFFMITGYFLLGRLSLNFSYNNNQRVKKYLYKIGMIYLYSILLYFPLSLLNGTISLKMNILLLLKVFIFDGTFYHLWYFPASIIGTILVTLLLRSIGFKLTVAFSTCLYLVGLGGDSWYGITNQVPLLNKLYTFIFSWSDYTRSGVFFTPVFLCLGIFAYRVSKKLTASKILNLLFYVFIIGMTFESIFLHRFTNVKHDSMYLLLPSCALILFLMLLNWQPKLKVKESADLTLLVYILHPLVIVIVHSISKYIPILKNSLLNFLLVVVCSFILAQLLLNLKRKLRVSKQKIPFERASKEISASAIHHNINEIRKIIPKNTNIMGVVKANAYGCGMVEVAYELEKIGISFFCVATIEEAIALRKSGNQGDILILGYTHPNRINDIKKYNLIQSIVSEEHGKVLNLKKIPIRCHLQVDTGMHRLGVTPNVTIIQQMYLFSNLKIEGIYSHLGSSDSLEQESIARTNTQIFLFNNILSDLEQMGISYGYTHIQSSYGILNYPELSFDFVRIGILCYGFLSDYNSPTKIPIDLQPIVKVKASLITERIVEAGEYVGYGLGAKVEKRTRIGVVSIGYADGIPRALSNAKLTLEFKGQSIKQIGNICMDMMLVDLSEVEDISLNDELIVLPNISKIADEEQTITNELLSRLGSRLGTELN	6.55	gnl|BL_ORD_ID|1234|hsp_num:0	1308	True	loose hit with at least 95 percent identity pushed strict
k141_144537_1 # 3 # 80 # -1 # ID=78765_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.449	k141_144537_1 	3	80	-	Strict	1650	18.8606	Brucella suis mprF	100.0	3003772	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGAAACGAAAAGGACTCAGGGGACTGGTATTTTTTTGTCTGATGGTACTGCTGCTCTGCGGACTGAATGATATTTTG	MKRKGLRGLVFFCLMVLLLCGLNDIL	MLWWDDISMSLIDDEIPSSQPQVSGRHFGWLKQYQHFLFPIAGIAIALLAIYVLENLLRHTSRTETLAALHNISWTTLALAVFFTALSYAAVALYDVVAVDTIAPNQIPRRIAAVAGAAGYAISNALGFSLLTGGALRYRIYAAEGISLADIGKIVGTSWFAIWFALIIMVGAALLIDPQDVPFLSAIDIRIDIVAGILILGGIGWLIYWLSHGERNVSIGSFSLRLPNSKGALTQIFAGVVDVGAAAATLYVLLPEGAVPSFAVFALVYVIAIVLGIASHAPGGLGAFEATIIAGLGLGGKPDAIAGLLAYRLIYTVLPLVVATAGILIWEVMRRRHMLDKQARFAKRLVEPLVPGLSASIIFLGGIILLISGATPDMRYRVKLLSDIVPEFLVEMSHLAASLVGVALLIVARGLSKRLERAWVAAMVLLLCGAVFSIAKGLDWEEASILCLFALSLWGFRDSFYRRPIAGPFELSWNWIATVGTTVLVSTWLGFFVYRHIEYSSDLWWDFAWNGNAPRFLRATVLVFAVVAAVGLHSIINRHGQRRRKVDHSIPDAVPALVARCPHTDAALAMLGDKQFLLAPDDSAFIMYAQSGGSLIALGEPIGDAEAGKELAWSFHSLADRLALRTVFYGVGPQSLPLFLDMGLIALKLGEVARVDLTDFSLEGPRRQPFRYADRKVDKDGLTFEIIPAADVPPLIPRLRAISDAWLDHKSGSEKGFSLGYFNDEYLKRFDIAVLKKDGEIVAFANIWRGADKYEITVDLMRYMPNVHKLLMDALFAKLLTFSKQEGYKWFNLGAAPLSGLSGSRLASRWNRFGSFIYRRGADLYHFDGLKAFKEKFDPVWTPHYMVCPGGLETPRALLDATTLINGSPLEFIRK	2.95	gnl|BL_ORD_ID|2109|hsp_num:0	2281	True	loose hit with at least 95 percent identity pushed strict
k141_145703_1 # 2 # 73 # -1 # ID=79379_1;partial=10;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.458	k141_145703_1 	2	73	-	Strict	1000	20.4014	MCR-9.1	100.0	3004684	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGTACGTTGATCCAAAAACAGGCCGTAGCATCTTAGGGCTATGGGACGAAGAAAAACAACAGTGGGTTCTT	MYVDPKTGRSILGLWDEEKQQWVL	MPVLFRVKVIPLVLLLAMIFAFLLNWPILLHFYEILSHLEHVKIGFVISIPFVLVAALNVVFMPFSVRFLLKPFFALLFITGSLVSYSTLKYKVMFDQTMIQNIIETNPQEAHSYLNGSIIIWFVFTGILPAILLFSIKIQYPEKWYKGIAYRLLSVLASLSLIAGVAALYYQDYASVGRNNSTLNKEIIPANYAYSTFQYVKDTYFTTKVPFQTLGNDAKRVVAHEKPTLMFLVIGETARSQNFSMNGYSRDTNAFTSKSGGVISFKNMHSCGTATAISVPCMFSNMNRTEYDSKKASNSENFLDIVQKTGVSLLWKENDGGCKGVCSRIPTVEIKPSDNPKLCDGKTCHDEVMLENLDDEIAKMPGDKLVAFHIIGSHGPTYYLRYPAEHRHFMPECARSDIENCTQEQLVNTYDNTLRYTDYVLAEMIEKLKNYSDQYNTVLLYVSDHGESLGESGLYLHGTPYKLAPDQQTHIPMQVWMSPGFIAGKHINMSCLENNAAKKSYSHDNLFSSILGLWDVSTSVYNPDRDLFRECRG	4.45	gnl|BL_ORD_ID|2300|hsp_num:0	3383	True	loose hit with at least 95 percent identity pushed strict
k141_145719_1 # 1 # 399 # -1 # ID=79392_1;partial=10;start_type=ATG;rbs_motif=TAAA;rbs_spacer=12bp;gc_cont=0.459	k141_145719_1 	1	399	-	Strict	500	23.0978	PEDO-2	100.0	3003714	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	subclass B3 PEDO beta-lactamase	ATGTACTTCAAAAAAGCAGTCCAGATTCCCAATGAAAAAGGCAAAATCGTCTTCAGAACCAAAGGGGGATCTCGTTACGTCCTATATGAAATTGATCGTGTCTATAAGCCCGAGCGCAAGTACACCATTCCGAAGCGAAAAGTTATTGGCAAGGTTATCGATGGTAAAGAGGGTTGGATGTACCCCAACGAACTTTTTCAGAATCTTTTCCCAAATACAGAGATCCCGCCGTCAGACGATGAGTTGCCGTTGCGTAGCTGCGCACTTAGCGTGGGTAGCTTTTTGGTTCTCTGTAATGTCATCCAGGAGTACGAACTCCGTGAGCTATTGACACCGCATTTTGGTGAATACACCGGTCTGCTTCTTGATTTGGCTTCGTACCTTATCGTTACCGAAGGT	MYFKKAVQIPNEKGKIVFRTKGGSRYVLYEIDRVYKPERKYTIPKRKVIGKVIDGKEGWMYPNELFQNLFPNTEIPPSDDELPLRSCALSVGSFLVLCNVIQEYELRELLTPHFGEYTGLLLDLASYLIVTEG	MKKIFLMVLFSCSLLGFAQTVTEPANNPKEWSQATEPFRIAGNLYYVGTYDLASYLIVTEKGNILINTGLANSLSIIKENIKALGFDYKSIKILLLTQAHFDHLGAMSEIKKETGAKLYVDEKDADALETGGKLDYELGKYGISFKPVKPDFLLKNNDKIKLGNTTLTMLHHPGHTKGSCSFIFDTKDKNSSYKILIANMPSIIVDRKFSEIASYKDIQKDYTETFKAMKKLDFDLWVASHASQFELHDKRKSGAPYNPKIFMDKSKFFKNLEDLENIFLEKIKN	46.67	gnl|BL_ORD_ID|2072|hsp_num:0	2229	True	loose hit with at least 95 percent identity pushed strict
k141_146211_3 # 986 # 2212 # -1 # ID=79656_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.374	k141_146211_3 	986	2212	-	Strict	800	752.281	mel	95.31	3000616	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGGAAAAATACAACAATTGGAAACTTAAGTTTTATACAATATGGGCAGGGCAGGCAGTATCATTAATCACTAGTGCCATCCTGCAAATGGCGATCATTTTTTACCTTACAGAGAAAACAGGATCTGCGATGGTCTTGTCTATGGCTTCACTAGTAGGTTTTTTACCCTATGCGGTCTTTGGACCAGCTATTGGTGTATTAGTGGATCGTCATGATAGGAAGAAGATAATGATTGGTGCTGATTTAATTATCGCAGCAGCTGGGGCAGTGCTTGCTATTGTTGCATTGTATATGGAGCTACCTATCTGGATGGTTATGGTAGTATTGTTTATCCGTAGCATTGGAACAGCTTTTCACACCCCGGCTCTCAATGCGGTTACACCACTTTTAGTACCAGAAGAACAGCTTACGAAATGTGCAGGCTATAGTCAGTCTTTGCAGTCTATAAGCTATATTGTTAGTCCGGCGGTTGCAGCACTCTTATACTCCGTTTGGGAACTAAATGCTATTATTGCCATCGATGTATTGGGTGCTGTGATTGCATCTATTACGGTAGCAATTGTACGTATTCCTAAGCTGGGTGATCAAGTGCAAAGTTTGAAACCAAATTTCATACGAGAAATGAAAGAAGGAATGGCTGTACTACGGCAAAATAAAGGATTATTTGCTTTATTACTCGTTGGAACATTATATATGTTTGTTTATATGCCCATAAATGCATTATATCCTTTAATCACTATGGAATATTTTAATGGTACACCGATGCATATTTCTATTACGGAGATTGCTTATGCCTCTGGTATGTTGATAGGGGGTCTATTATTAGGGTTATTTGGGAATTACCAAAAGCGAATCTTATTAATAACGGCATCCATTTTTATGATGGGGATAAGCTTAACCATTTCAGGATTACTTCCCCAAAGTGGATTTTTCATATTTGTAGTCTGCTGTGCAATAATGGGGCTTTCGGTTCCGTTTTACAGCGGTGTGCAAACAGCTCTTTTTCAGGAGAAAATTAAGCCTGAATATTTAGGACGTGTATTTTCTTTAACTGGAAGTATCATGTCTCTTGCTATGCCAATTGGGTTAATTCTTTCTGGATTCTTTGCTGATAGAATCGGTGTAAATCATTGGTTTTTACTATCAGGTATTTTAATTATTTGCATTGCAATAGTTTGCCCAATGATAACTGAGATTAGAAAATTAGATTTAAAACAAAATTCATAG	MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVFGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHTPALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVIASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINALYPLITMEYFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLTISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMPIGLILSGFFADRIGVNHWFLLSGILIICIAIVCPMITEIRKLDLKQNS	MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVFGPAIGVLVDRHDRKKIMIGADLIIAAAGSVLTIVAFYMELPVWMVMIVLFIRSIGTAFHTPALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVIASITVAIVRIPKLGDRVQSLDPNFIREMQEGMAVLRQNKGLFALLLVGTLYMFVYMPINALFPLISMDYFNGTPVHISITEISFASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLTISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMPIGLILSALFADRIGVNHWFLLSGTLIICIAIVCPMINEIRKLDLK	100.74	gnl|BL_ORD_ID|1160|hsp_num:0	1231	True	loose hit with at least 95 percent identity pushed strict
k141_147333_4 # 1774 # 2559 # 1 # ID=80270_4;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.248	k141_147333_4	1795	2559	+	Perfect	500	510.76	OXA-85	100.0	3001780	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGTTATTATTTATGTTCTCGATTATTTCTTTTGGTAATGAAAATCAATTTATGAAAGAGATTTTTGAAAGAAAAGGTTTAAACGGAACTTTTGTTGTTTATGATTTAAAAAATGATAAAATTGATTATTATAATTTGGATAGAGCTAATGAGAGATTTTATCCTGCTTCATCATTTAAAATTTTTAATACTTTGATAGGATTAGAAAATGGGATAGTAAAAAACGTTGATGAAATGTTTTATTATTATGATGGTTCTAAAGTTTTTCTTGATTCATGGGCAAAAGATTCGAATTTAAGATATGCAATAAAAGTATCTCAAGTTCCAGCTTATAAAAAGCTTGCAAGAGAATTGGGAAAAGAAAGAATGCAAGAAGGATTAAATAAATTAAATTATGGAAATAAGGAAATAGGTAGTGAGATTGATAAGTTTTGGTTAGAAGGTCCATTAAAAATAAGTGCAATGGAACAAGTTAAATTATTAAATCTATTATCACAGTCGAAACTTCCTTTTAAATTAGAAAATCAAGAACAAGTAAAAGATATTACGATTTTAGAGAAAAAAGATGATTTTATTTTACATGGAAAAACTGGGTGGGCTACTGATAATATAGTTGTTCCTATTGGTTGGTTTGTAGGTTGGATAGAAACTTCTGATAATATATATTCATTTGCTATTAATTTAGATATTTCTGATAGTAAATTTTTACCTAAACGTGAAGAAATTGTAAGAGAATATTTCAAAAATATAAATGTTATAAAATAA	MLLFMFSIISFGNENQFMKEIFERKGLNGTFVVYDLKNDKIDYYNLDRANERFYPASSFKIFNTLIGLENGIVKNVDEMFYYYDGSKVFLDSWAKDSNLRYAIKVSQVPAYKKLARELGKERMQEGLNKLNYGNKEIGSEIDKFWLEGPLKISAMEQVKLLNLLSQSKLPFKLENQEQVKDITILEKKDDFILHGKTGWATDNIVVPIGWFVGWIETSDNIYSFAINLDISDSKFLPKREEIVREYFKNINVIK	MLLFMFSIISFGNENQFMKEIFERKGLNGTFVVYDLKNDKIDYYNLDRANERFYPASSFKIFNTLIGLENGIVKNVDEMFYYYDGSKVFLDSWAKDSNLRYAIKVSQVPAYKKLARELGKERMQEGLNKLNYGNKEIGSEIDKFWLEGPLKISAMEQVKLLNLLSQSKLPFKLENQEQVKDITILEKKDDFILHGKTGWATDNIVVPIGWFVGWIETSDNIYSFAINLDISDSKFLPKREEIVREYFKNINVIK	102.76	gnl|BL_ORD_ID|268|hsp_num:0	289	True	possible complete gene, reference contained within open reading frame
k141_148781_8 # 2920 # 3249 # -1 # ID=81029_8;partial=00;start_type=GTG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.464	k141_148781_8 	2920	3249	-	Strict	300	23.0978	lnuA	100.0	3002835	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	GTGAAGATCAAAAAAGGTGACAAAGTCCAGGTTATCACCGGGGCTTATAAAGGAACTGTCGGCGAAGTTGTCCGTGCCTTCCCCAAGGAAGACAAAGTAATCGTCGAAGGTGTAAACATCGTTAAGAAACACCAGAAACCCACTCAGGCAAACCCTGAAGGCGGCATCATCGAAAAAGAAGCAAAGATCCACGTTTCCAACGTAATGCTCTACGATGAAAAAGCCAAAACCGCCAGCCGCGTTTCCATCAAGGAAGAAGTTGTTGACGGCAAGAAAATCAAAACCCGCGTCTTCAAGAAGAGCGGTAACGAACTGAAAGAGAAGAAGTAG	MKIKKGDKVQVITGAYKGTVGEVVRAFPKEDKVIVEGVNIVKKHQKPTQANPEGGIIEKEAKIHVSNVMLYDEKAKTASRVSIKEEVVDGKKIKTRVFKKSGNELKEKK	MKNNNVTEKELFYILDLFEHMKVTYWLDGGWGVDVLTGKQQREHRDIDIDFDAQHTQKVIQKLEDIGYKIEVHWMPSRMELKHEEYGYLDIHPINLNDDGSITQANPEGGNYVFQNDWFSETNYKDRKIPCISKEAQLLFHSGYDLTETDHFDIKNLKSIT	67.70	gnl|BL_ORD_ID|22|hsp_num:0	27	True	loose hit with at least 95 percent identity pushed strict
k141_148850_1 # 1 # 498 # 1 # ID=81058_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.289	k141_148850_1 	1	498	+	Strict	400	335.495	ErmG	98.8	3000522	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	CATTTTACTGCTGAATTGGTAAAGAGATGTAATTTTGTTACGGCGATAGAAATTGATTCTAAATTATGTGAGGTAACTCGTAATAAGCTCTTAAATTATCCTAACTATCAAATAGTAAATGATGATATACTGAAATTTACATTTCCTAGCCACAATCCATATAAAATATTTGGCAGCATACCTTACAACATAAGCACAAATATAATTCGAAAAATTGTTTTTGAAAGTTCAGCCACAATAAGTTATTTAATAGTGGAATATGGTTTTGCTAAAAGGTTATTAGATACAAACAGATCACTAGCATTGCTGTTAATGGCAGAGGTAGATATTTCTATATTAGCAAAAATTCCTAGGTATTATTTCCATCCAAAACCTAAAGTGGATAGCGCATTAATTGTATTAAAAAGAAAGCCAGCAAAAATGGCATTTAAAGAGAGAAAAAAATATGAAACTTTTGTAATGAAATGGGTTAACAAAGAGTATGAAAAACTGTTTACA	HFTAELVKRCNFVTAIEIDSKLCEVTRNKLLNYPNYQIVNDDILKFTFPSHNPYKIFGSIPYNISTNIIRKIVFESSATISYLIVEYGFAKRLLDTNRSLALLLMAEVDISILAKIPRYYFHPKPKVDSALIVLKRKPAKMAFKERKKYETFVMKWVNKEYEKLFT	MNKVNIKDSQNFITSKYHIEKIMNCISLDEKDNIFEIGAGKGHFTAELVKRCNFVTAIEIDSKLCEVTRNKLLNYPNYQIVNDDILKFTFPSHNPYKIFGSIPYNISTNIIRKIVFESSATISYLIVEYGFAKMLLDTNRSLALLLMAEVDISILAKIPRYYFHPKPKVDSTLIVLKRKPAKMAFKERKKYETFVMKWVNKEYEKLFTKNQFNKALKHARIYDINNISFEQFVSLFNSYKIFNG	68.03	gnl|BL_ORD_ID|935|hsp_num:0	989	True	loose hit with at least 95 percent identity pushed strict
k141_160741_4 # 3308 # 3472 # -1 # ID=87052_4;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=12bp;gc_cont=0.424	k141_160741_4 	3308	3472	-	Strict	750	20.4014	pmrA	100.0	3000822	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAAAAGTACATTTGCACAGTATGCGATTGGGTTTATGACCCAGAAACTGGTGATCCAGAAAGCGGAATTGCTCCGGGAACATCATTCGAAGATATACCGGAAGATTGGGTTTGTCCTGTTTGTGGAGTAGGTAAAGAAGACTTCCAGCCAGTAGAAGAATAA	MKKYICTVCDWVYDPETGDPESGIAPGTSFEDIPEDWVCPVCGVGKEDFQPVEE	MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISAALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAILTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANASSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGSAVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI	13.53	gnl|BL_ORD_ID|1974|hsp_num:0	2003	True	loose hit with at least 95 percent identity pushed strict
